Home Cart Sign in  
Chemical Structure| 152459-95-5 Chemical Structure| 152459-95-5

Structure of Imatinib
CAS No.: 152459-95-5

Chemical Structure| 152459-95-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Imatinib (STI571) is an orally bioavailable tyrosine kinase inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR, and c-kit kinase activity by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation and inhibiting enzyme activity semicompetitively. It also inhibits SARS-CoV and MERS-CoV.

Synonyms: STI571; CGP-57148B

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Jiang, Qi ; Ghosh, Rittik K ; Valdivia-Berroeta, Gabriel A ; Walder, Brennan J ; Luo, Laibin ;

Abstract: We focused on the critical role of crystallization of active pharmaceutical ingredients (APIs) in drug development, with particular emphasis on stability, solubility, and the feasibility of drug formulation and manufacturing. We explored polymorphism in APIs and the formation of multicomponent crystals, including salt and cocrystal screening, underscoring the significance of regulatory and intellectual property considerations in recognizing salts and cocrystals of solid forms. Our study led to the design of seven new multicomponent crystalline forms of imatinib, an oncology API. Using X-ray crystallography and solid-state NMR, we elucidated hydrogen bonding interactions and proton transfer, unveiling multicomponent interactions in the crystalline solid forms along the salt−cocrystal continuum. Most of the new solid forms demonstrated improved aqueous solubility compared to that of the free base form. This research provides valuable insights into the structural details of solid forms of pharmaceutical compounds and emphasizes the importance of understanding solid-state interactions for the rational design of crystalline APIs, thereby enhancing the drug development process.

Purchased from AmBeed: ;

Kwangwoon Lee ; Marco Barone ; Amanda L. Waterbury ; Hanjie Jiang ; Eunju Nam ; Sarah E. DuBois-Coyne , et al.

Abstract: Biochemical crosstalk between two or more histone modifcations is often observed in epigenetic enzyme regulation, but its functional signifcance in cells has been difcult to discern. Previous enzymatic studies revealed that Lys14 acetylation of histone H3 can inhibit Lys4 demethylation by lysine-specifc demethylase 1 (LSD1). In the present study, we engineered a mutant form of LSD1, Y391K, which renders the nucleosome demethylase activity of LSD1 insensitive to Lys14 acetylation. K562 cells with the Y391K LSD1 CRISPR knockin show decreased expression of a set of genes associated with cellular adhesion and myeloid leukocyte activation. Chromatin profling revealed that the cis-regulatory regions of these silenced genes display a higher level of H3 Lys14 acetylation, and edited K562 cells show diminished H3 mono-methyl Lys4 near these silenced genes, consistent with a role for enhanced LSD1 demethylase activity. These fndings illuminate the functional consequences of disconnecting histone modifcation crosstalk for a key epigenetic enzyme.

Purchased from AmBeed:

Alternative Products

Product Details of Imatinib

CAS No. :152459-95-5
Formula : C29H31N7O
M.W : 493.60
SMILES Code : O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4
Synonyms :
STI571; CGP-57148B
MDL No. :MFCD05662257
InChI Key :KTUFNOKKBVMGRW-UHFFFAOYSA-N
Pubchem ID :5291

Safety of Imatinib

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H341-H351-H360-H362
Precautionary Statements:P201-P202-P260-P263-P264-P270-P280-P308+P313-P405-P501

Related Pathways of Imatinib

RTK

Isoform Comparison

Biological Activity

Target
  • PDGFR

    PDGFR, IC50:100 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
GIST48 0.5, 1 µM 72 h Evaluate the effect of imatinib on proliferation and apoptosis of GIST48 cells. Results showed that imatinib treatment increased apoptosis, with nuclear fragmentation increasing from 0.1% to 50.1%. PMC7000686
GIST430/654 0.5, 1 µM 72 h Evaluate the effect of imatinib on proliferation and apoptosis of GIST430/654 cells. Results showed that imatinib treatment increased apoptosis, with nuclear fragmentation increasing from 1.6% to 12.3%. PMC7000686
GIST882 0.05, 0.5 µM 72 h Evaluate the effect of imatinib on proliferation and apoptosis of GIST882 cells. Results showed that imatinib treatment increased apoptosis, with nuclear fragmentation increasing from 0.9% to 15.3%. PMC7000686
GIST-T1 0.05, 0.5 µM 72 h Evaluate the effect of imatinib on proliferation and apoptosis of GIST-T1 cells. Results showed that imatinib treatment increased apoptosis, with nuclear fragmentation increasing from 2.2% to 17.7%. PMC7000686
K562 cells 200 nM 24 and 48 h Combination of imatinib with GSI reduced K562 colony formation and enhanced the inhibition of NOTCH1 signaling PMC4314772
Abl pre-B cells 3 µM 2 days To arrest abl pre-B cells in G0/G1 phase PMC8416021
K562 cells 3 μM To evaluate the cytotoxic effect of Imatinib on K562 cells, results showed that erythropoietin (EPO) conferred resistance to Imatinib. PMC5424814
BaF3-BA cells 3 μM To evaluate the cytotoxic effect of Imatinib on BaF3-BA cells, results showed that the presence of IL-3 conferred resistance to Imatinib. PMC5424814
BaF3-LTBA cells 3 μM To evaluate the cytotoxic effect of Imatinib on BaF3-LTBA cells, results showed that the presence of IL-3 conferred resistance to Imatinib. PMC5424814

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse Pten/Braf/Bcat-STA mouse model Oral gavage 200 mg/kg Daily Imatinib significantly slowed the growth of the primary tumor in Pten/Braf/Bcat-STA mice but did not alter the frequency of metastasis. PMC3241928
Mice Atherosclerosis model Intraperitoneal injection 100 mg/kg Once daily for seven days Imatinib treatment resulted in significant reductions in the percentage of Myh11 -eYFP+ and Myh11 -eYFP+ ACTA2+ cells in the fibrous cap, indicating that non-SMC-derived cells were unable to compensate for the rapid loss of SMC-derived ACTA2+ cells. PMC7905710
Mice A431, LLC, and T241 tumor models Oral 50 mg/kg Once daily, until primary tumor removal Imatinib significantly inhibited TAM recruitment in A431, LLC, and T241 tumors, indicating that PDGFRs mediate PDGF-BB-induced TAM infiltration. PMC4859070
Mice AT-GFP mice Intraperitoneal injection 50 mg per mouse Four times a week for 4 weeks Imatinib treatment improved glucose sensitivity and blunted subcutaneous and visceral fat expansion. Additionally, imatinib treatment displaced AT-GFP+APCs from their vascular niche and inhibited white adipocyte differentiation. PMC5490270
Mice BCR-ABL-induced chronic myeloid leukemia model Intraperitoneal injection 75 mg/kg Twice daily for 3 months To evaluate the therapeutic effect of Imatinib on BCR-ABL-induced leukemia in mice, results showed that Imatinib alone could not completely eradicate leukemic cells, but the combination of DFC and BCI completely eradicated leukemic cells. PMC5424814
Nude mice CML xenograft model Subcutaneous injection 20 mg/kg Once daily for 14 days Evaluate the effect of USP10 inhibition on CML xenograft models PMC6488640
Balb/c nude mice K562 cell xenograft model Intraperitoneal injection 100 mg/kg body weight 10 consecutive days Overexpression of RalA reduced overall survival of recipient mice undergoing IM treatment, indicating that RalA imparts some resistance to IM. PMC4991475

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01400074 Chronic Myeloid Leukemia Phase 3 Unknown June 2014 Korea, Republic of ... More >> Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Less <<
NCT01083589 Non-small Cell Lung Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00154349 Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Less << Phase 2 Completed - -
NCT00038675 Chronic Myelomonocytic Leukemi... More >>a Chronic Myeloid Leukemia Polycythemia Vera Hypereosinophilic Syndrome Mastocytosis Less << Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02174445 Chronic Myeloid Leukemia Phase 3 Suspended(very slow recruitmen... More >>t rate and a lot of pat. didn't fulfil BCR-ABL requirements) Less << June 2019 Germany ... More >> Universitätsklinikum Aachen Aachen, Germany, 52074 Praxis Dr. Bruder / Dr. Heinrich / Prof. Bangerter Augsburg, Germany, 86150 Universitätsklinikum Bonn Bonn, Germany, 53105 Gemeinschaftspraxis Dresden, Germany, 01307 Praxis Dr. Hauch Erfurt, Germany, 99084 Internistische Schwerpunktpraxis Erlangen oncosearch Erlangen, Germany, 91052 Praxis für Hämatologie/Onkologie Dres. Rudolph, Sengpiel, von Verschuer Essen, Germany, 45136 University Medical Center Freiburg, Germany, 79106 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07747 Universitätsklinik Köln Köln, Germany, 50937 Gemeinschaftspraxis Hämatologie/Onkologie Magdeburg, Germany, 39104 Klinikum Mannheim GmbH Universitätsklinikum Mannheim, Germany, 68167 Überörtliche Gemeinschaftspraxis Hämato-Onkologie Pasing/Fürstenfeldbruck Munich, Germany, 81241 Klinikum rechts der Isar, Technische Universität München München, Germany, 81675 Onkologische Praxis Oldenburg Oldenburg, Germany, 26121 Medizinische Statistik Saarbrücken, GbR Saarbrucken, Germany, 66113 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00080665 Breast Cancer Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01991379 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 1 Phase 2 Recruiting November 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Ping Chi, MD    646-888-4166       Contact: William Tap, MD    646-888-4163       Principal Investigator: Ping Chi, MD, PhD Less <<
NCT01316250 Chronic Myelogenous Leukemia Not Applicable Recruiting January 2019 Lebanon ... More >> American University of Beirut Medical Center Recruiting Beirut, Lebanon Contact: Ali Bazarbachi, MD, PhD    9613612434    bazarbac@aub.edu.lb    Principal Investigator: Ali Bazarbachi, MD, PhD Less <<
NCT01137916 Aggressive Fibromatosis|Desmoi... More >>d Tumor Less << PHASE2 COMPLETED 2025-12-16 University of Heidelberg, Mann... More >>heim University Medical Center, Mannheim, 68167, Germany Less <<
NCT02130557 Leukemia, Myelogenous, Chronic... More >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Less << Phase 3 Active, not recruiting April 4, 2020 -
NCT01172548 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - -
NCT00290771 Recurrent Glioblastoma Multifo... More >>rme (GBM) Less << Phase 2 Terminated(Lack of efficacy) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00290771 - Terminated(Lack of efficacy) - -
NCT02272777 Leukemia Phase 3 Completed - China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 51000 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210008 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Fuzhou, China, 350001 Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT02130557 - Active, not recruiting - -
NCT00852566 Chronic Myeloid Leukemia Phase 2 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland, 00029 Norway Bergen University Central Hospital Bergen, Norway Rikshospitalet Oslo, Norway, 0027 St. Olavs Hospital Trondheim, Norway, 7006 Sweden Lund University Hospital Lund, Sweden, 22185 Karolinska University Hospital Stockholm, Sweden, 17176 Uppsala University Hospital Uppsala, Sweden, 75185 Less <<
NCT00237185 Unresectable or Metastatic Mal... More >>ignant Gastrointestinal Stromal Tumor (GIST) Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Dept of Sarcoma Oncology Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health Sciences University Dept. of Oregon Health Sci. Portland, Oregon, United States, 97201 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Australia, Victoria Novartis Investigative Site Geelong, Victoria, Australia, 3220 Finland Novartis Investigative Site Helsinki, Finland, FIN-00029 Less <<
NCT00237185 - Completed - -
NCT00928642 - Completed - -
NCT01316458 Prostatic Neoplasm ... More >> Genital Neoplasms, Male Neoplasms, Abdominal Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases Antineoplastic Agents Imatinib Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany Novarts Investigative Site Berlin, Germany Novartis Investigative Site Bonn, Germany Novartis Investigative Site Borken, Germany Novartis Investigative Site Darmstadt, Germany Novartis Investigative Site Fürth, Germany Novartis Investigative Site Gardelegen, Germany Novarts Investigative Site Hamburg, Germany Novartis Investigative Site Köln, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Ulm, Germany Novartis Investigative Site Wesel, Germany Novartis Investigative Site Wuppertal, Germany Less <<
NCT00928642 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 2 Completed - United States, Washington ... More >> Madigan Army Medical Center Tacoma, Washington, United States, 98431 Less <<
NCT01216085 CML Imatinib Phase 2 Completed - -
NCT01383447 - Terminated(This study was halt... More >>ed prematurely by the NCI for low accrual.) Less << - -
NCT01383447 Philadelphia Chromosome Positi... More >>ve Adult Precursor Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Terminated(This study was halt... More >>ed prematurely by the NCI for low accrual.) Less << - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT01066468 Chronic Myeloid Leukemia (CML)... More >> Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN) Less << Phase 1 Terminated - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 117997 Less <<
NCT00354913 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00090987 Sarcoma Phase 2 Completed - United States, California ... More >> Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Desert Regional Medical Center Comprehensive Cancer Center Palm Springs, California, United States, 92262 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Florida University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Joan Karnell Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19106 United States, Washington Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT00354913 - Completed - -
NCT01227356 Health Care Quality ... More >> Health Care Evaluation Less << Phase 2 Completed - Sweden ... More >> Bengt Simonsson Uppsala, Sweden, S-75185 Uppsala University Hospital Uppsala, Sweden, S-753 20 Uppsala University Hospital Uppsala, Sweden, S-75320 Less <<
NCT00441155 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT01089595 - Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << - -
NCT00136409 Myelofibrosis ... More >> Myeloid Metaplasia Agnogenic Myeloid Metaplasia Chronic Myelomonocytic Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00090987 - Completed - -
NCT02257541 Advanced Gastrointestinal Stro... More >>mal Tumor (GIST) Less << Phase 1 Phase 2 Active, not recruiting October 2019 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States United States, Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01011998 Chronic Myelogenous Leukemia Phase 2 Withdrawn(Withdrawn due to lac... More >>k of accrual per Center DSMP, with PI concurrence) Less << - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Less <<
NCT01504984 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Seodaemun-gu, Korea, Republic of Less <<
NCT00354523 Solid Tumor T... More >>hyroid Cancer Less << Phase 1 Phase 2 Terminated(Study closed follow... More >>ing Phase I portion, insufficient activity to continue to Phase II.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00278876 Sarcoma Gastr... More >>ointestinal Stromal Tumors Less << Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Goyang, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Seoul Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01089595 GIST Metastat... More >>ic Disease Less << Phase 2 Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << - United States, Missouri ... More >> Siteman Cancer Center, Washington University School of Mediciine St Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01117987 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - -
NCT00115739 Thyroid Cancer PHASE2 TERMINATED 2025-08-10 University of Michigan Cancer ... More >>Center, Ann Arbor, Michigan, 48109, United States Less <<
NCT01117987 - Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - -
NCT00115739 Thyroid Cancer PHASE2 TERMINATED 2025-08-10 University of Michigan Cancer ... More >>Center, Ann Arbor, Michigan, 48109, United States Less <<
NCT00124748 Leukemia, Myeloid, Chronic Pha... More >>se Less << Phase 3 Terminated(This study was prem... More >>aturely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose) Less << - -
NCT00278876 - Completed - -
NCT03343600 Patients Who Have Received All... More >>o-HSCT Less << Phase 2 Recruiting March 30, 2020 Taiwan ... More >> Tzu Chi General Hospital Not yet recruiting Hualien City, Taiwan Contact: Chi-Cheng Li, MD       kevinlcc1234@gmail.com    Far Eastern Memorial Hospital Not yet recruiting New Taipei City, Taiwan Contact: Shih-Chiang Lin, MD          National Cheng Kung Hospital Not yet recruiting Tainan, Taiwan Contact: Tsai-Yun Chen, MD       teresa@mail.ncku.edu.tw    National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Chien-Ting Lin, MD    +886 2 23123456 ext 63019    antony.linct@gmail.com    Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Ming-Shen Dai, MD. PhD. Less <<
NCT00677092 Nephrogenic Systemic Fibrosis Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00124748 - Terminated(This study was prem... More >>aturely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose) Less << - -
NCT00677092 - Completed - -
NCT01673009 - Completed - -
NCT01673009 Neurofibromatosis Phase 2 Completed - United States, Indiana ... More >> Indiana University Indianapolis, Indiana, United States, 46202 Less <<
NCT03609424 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Not yet recruiting August 30, 2020 -
NCT03228303 Chronic Myeloid Leukemia Early Phase 1 Not yet recruiting August 1, 2020 -
NCT00764595 Gastrointestinal Stromal Tumor... More >> Metastatic Cancer Less << Phase 2 Completed - Japan ... More >> Aichi Cancer Center Nagoya, Aichi, Japan, 464-8681 Aichi Medical University Nagoya, Aichi, Japan, 480-1195 Hirosaki University, School of Medicine Hirosaki, Aomori, Japan, 036-8562 National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan, 737-0023 Hokkaido University Hospital Sapporo, Hokkaido, Japan, 060-8648 Kanagawa Cancer Center Yokohama, Kanagawa, Japan, 241-0815 International Goodwill Hospital Yokohama, Kanagawa, Japan, 245-0006 Kochi Medical School Nankoku, Kochi, Japan, 783-8505 Kyoto Second Red Cross Hospital Kanigyou-ku, Kyoto, Japan, 602-8026 University of Miyazaki Hospital Kiyotake, Miyazaki, Japan, 889-1692 Niigata Prefectural Central Hospital Joetsu, Niigata, Japan, 943-0192 Nagaoka Chuo General Hospital Nagaoka, Niigata, Japan, 940-8653 Oita University Hospital Yufu, Oita, Japan, 879-5593 Kawasaki Medical School Kurashiki, Okayama, Japan, 701-01 Ryukyu University Hospital Nishiharacho, Okinawa, Japan, 903-0215 Sakai Municipal Hospital Sakai, Osaka, Japan, 590-0064 Osaka University Hospital Suita, Osaka, Japan, 565-0871 Toyonaka Municipal Hospital Toyonaka, Osaka, Japan, 560-8565 Saitama Medical University International Medical Center Hidaka, Saitama, Japan, 350-1241 Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan, 431-3192 University of Yamanashi Hospital Chuo, Yamanashi, Japan, 409-3898 Kyushu University Hospital Fukuoka, Japan, 812-8582 Fukushima Medical University Hospital Fukushima, Japan, 960-1295 Kagoshima University Kagoshima, Japan, 890-8520 Kimitsu Chuo Hospital Kisarazu-city, Japan, 292-8535 Kochi Health Sciences Center Kochi, Japan, 781-8555 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Niigata University Medical and Dental Hospital Niigata, Japan, 951-8510 Niigata Cancer Center Hospital Niigata, Japan, 951-8566 Okayama University Hospital Okayama, Japan, 700-8558 Juntendo University Shizuoka Hospital Shizuoka, Japan, 410-2295 Shizuoka Cancer Center Shizuoka, Japan, 411-8777 Tokushima University Hospital Tokushima, Japan, 770-8503 Tokyo Metropolitan - Komagome Hospital Tokyo, Japan, 113-0021 Keio University Hospital Tokyo, Japan, 160-8582 Toyama University Hospital Toyama, Japan, 930-0194 Less <<
NCT01275222 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York College of Physicians & Surgeons of Columbia University New York, New York, United States, 10032 United States, Pennsylvania Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Belgium Novarts Investigative Site Edegem, Belgium, 2650 Novarts Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex 08, France, 69373 Novartis Investigative Site Marseille, France, 13005 Novartis Investigative Site Villejuif, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koln, Germany, 50973 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Tubingen, Germany, 72076 Less <<
NCT00613054 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01545427 Scleroderma Phase 2 Terminated(Frequent adverse ev... More >>ents occurred early in treatment with poor tolerability.) Less << - Canada, Ontario ... More >> Lawson Health Research Institute London, Ontario, Canada, N6A 4V2 Less <<
NCT01541709 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Yoon-Koo Kang, MD, PhD    +82-2-3010-3230    ykkang@amc.seoul.kr    Contact: Min-Hee Ryu, MD, PhD    +82-2-3010-5935    miniryu@amc.seoul.kr Less <<
NCT02115672 Chronic Myeloid Leukemia Phase 1 Phase 2 Withdrawn(loss of support) November 2018 Israel ... More >> Chaim Sheba Medical Center Tel-Hashomer, Israel, 52621 Less <<
NCT00171912 Hypereosinophilic Syndrome ... More >> Systemic Mastocytosis Chronic Myelomonocytic Leukemia Dermatofibrosarcoma Less << Phase 2 Completed - Australia ... More >> Novartis Investigative Site East Melbourne, Australia Less <<
NCT02185937 Gastrointestinal Stromal Tumor... More >> Major Gastrectomy Less << Phase 1 Terminated(inclusion was too s... More >>low) Less << - Netherlands ... More >> Radboudumc Nijmegen, Netherlands Less <<
NCT00243191 Dermatofibrosarcoma Protuberan... More >>s Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Pennsylvania Pennsylvania Onc/Hem Assoc. Philadelphia, Pennsylvania, United States, 19106 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00243191 - Completed - -
NCT03454503 Philadelphia Chromosome-positi... More >>ve Chronic Myeloid Leukemia in Chronic Phase Less << COMPLETED 2020-12-28 National Cancer Institute (NCI... More >>), Cairo, 11796, Egypt Less <<
NCT00867113 - Completed - -
NCT00867113 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 2 Completed - -
NCT00455559 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - -
NCT01781975 Diabetes Mellitus, Type I ... More >> Diabetes Mellitus, Insulin-Dependent, 1 Type 1 Diabetes Mellitus Insulin-Dependent Diabetes Mellitus 1 IDDM Less << Phase 2 Completed - United States, California ... More >> University of California-San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Australia, Victoria Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia, 3050 Less <<
NCT01781975 - Completed - -
NCT01578213 Chronic Myeloid Leukemia Phase 4 Active, not recruiting June 2019 Canada, Quebec ... More >> McGill University - Jewish General Hospital Division of Hematology and Department of Oncology Montréal, Quebec, Canada, H3T 1E2 Germany Charité University of Berlin - Clinic of Medicine - Hematology and Oncology Berlin, Germany, 13353 Israel Chaim Sheba Medical Center - Division of Hematology, BMT and CBB Tel Hashomer, Israel, 52621 Italy Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele" Catania, Italy/Catania, Italy, 95124 Università di Firenze Azienda Ospedaliera - Universitaria Careggi Firenze, Italy/Firenze, Italy, 50134 Azienda Ospedaliera San Gerardo di Monza Monza, Italy/MB, Italy, 20052 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC di Ematologia Milano, Italy/Milano, Italy, 20162 IRCCS Policlinico San Matteo Pavia - Istituto di Ematologia Pavia, Italy/Pavia, Italy, 27100 A.O. Bianchi-Melacrino-Morelli U.O. Ematologia Reggio Calabria, Italy/Reggio Calabria, Italy, 89124 Universita di Tor Vergata Ospedale S. Eugenio Rome, Italy/Rome, Italy, 00142 Ospedale S. Bortolo (USSL 6) Vicenza, Italy/Vicenza, Italy, 36100 Ospedale Niguarda Ca' Granda - U.O. Ematologia Milano, MI, Italy, 20162 IRCCS A.O.U. San Martino Genova, Italy, 16132 Spain Hospital Universitario Miguel Servet - Hematologia Zaragoza, Spain Less <<
NCT00858806 Chronic Myeloid Leukemia PHASE2 COMPLETED 2025-12-14 Chair of Haematology, Bone Mar... More >>row Transplant Unit, Brescia, 25123, Italy Less <<
NCT03328117 Acute Lung Injury Phase 1 Completed - United Kingdom ... More >> PAREXEL Early Phase Clinical Unit London, United Kingdom Less <<
NCT00902174 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT00424515 Mucosal Melanoma|Acral/Lentigi... More >>nous Melanoma|Chronically Sun Damaged Melanomas Less << PHASE2 COMPLETED 2025-07-11 University of Colorado at Denv... More >>er Health Sciences Center, Denver, Colorado, 80045, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00424515 Mucosal Melanoma|Acral/Lentigi... More >>nous Melanoma|Chronically Sun Damaged Melanomas Less << PHASE2 COMPLETED 2025-07-11 University of Colorado at Denv... More >>er Health Sciences Center, Denver, Colorado, 80045, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02431403 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Recruiting - Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of Contact: Ji Sook Park       dongahicrc5@naver.com    Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of Contact: Jin Hwa Kong    +82-51-890-6987    velika-jh@nate.com    Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of Contact: Saet Byeol Park       siou7777@naver.com    Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Younghee Kim    +82-51-240-7899    shinyspring@naver.com    Ulsan University Hospital Recruiting Ulsan, Korea, Republic of Contact: Mi Sun Jeon       uuh3103@naver.com Less <<
NCT01460693 Myeloid Leukemia, Chronic, Chr... More >>onic Phase Less << Phase 3 Completed - United Kingdom ... More >> Freeman Hospital Newcastle-upon-Tyne, United Kingdom, NE7 7DN Less <<
NCT02268435 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Withdrawn(Dovitinib Production... More >> stopped) Less << November 2016 -
NCT03262974 - Recruiting December 2020 Egypt ... More >> South Egypt Cancer Institute Recruiting Assiut, Egypt Contact: Mohammed S. Molla, MSc Less <<
NCT00902174 - Completed - -
NCT01898377 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting July 2018 Korea, Republic of ... More >> Seoul National University Children's Hospital Seoul, Chongno-gu, Korea, Republic of Less <<
NCT01827930 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 3 Terminated(Difficulties of enr... More >>olment of Patient) Less << - France ... More >> Institut Bergonié Bordeaux, Aquitaine, France, 33000 Less <<
NCT03722420 Chronic Myeloid Leukemia, Chro... More >>nic Phase Less << Phase 3 Not yet recruiting December 31, 2023 -
NCT01751919 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Tumor Less << Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Daegu, Korea, Republic of Less <<
NCT02495519 Fibromatosis PHASE2 COMPLETED 2025-06-18 Severance Hospital, Yonsei Uni... More >>versity Health System, Seoul, 120-752, Korea, Republic of Less <<
NCT01404715 Healthy Phase 1 Completed - United States, California ... More >> Ucsf Ctsi Crc San Francisco, California, United States, 94143 Less <<
NCT01819389 Leukemia, Myeloid, Chronic, BC... More >>R-ABL Positive Less << Phase 3 Completed - Mexico ... More >> Servicio de Hematologia, Hospital Universitario "José E. Gonzalez" Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT01140360 - Completed - -
NCT02317159 Chronic Myeloid Leukemia PHASE4 UNKNOWN 2025-07-17 -
NCT01140360 Neurofibromatosis ... More >> Neurofibromas Less << Phase 1 Phase 2 Completed - United States, Indiana ... More >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT02461849 Advanced, Refractory Cancer PHASE2 UNKNOWN 2025-12-22 Samsung Medical Center, Seoul,... More >> Korea, Republic of Less <<
NCT00702689 Sclerotic Graft Versus Host Di... More >>sease Imatinib Mesylate Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02924714 Gastrointestinal Stromal Tumor Not Applicable Recruiting November 2022 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: Øyvind S Bruland          Principal Investigator: Øyvind S Bruland Less <<
NCT01097694 Asthma Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Massachusetts Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19140 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT03131999 Lymphangioleiomyomatosis Phase 1 Phase 2 Recruiting January 31, 2019 United States, New York ... More >> Columbia University Recruiting New York, New York, United States, 10032 Contact: Jeanine D'Armiento, MD, PhD    212-305-3745    jmd12@cumc.columbia.edu    Contact: Laura Fonseca    212-305-3745    lf2560@cumc.columbia.edu    United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Charlie Strange, MD    843-442-8061    strangec@musc.edu    Contact: Kimberly Brown, MS    843-792-6474    brownkl@musc.edu Less <<
NCT01795716 Chronic Myeloid Leukemia Phase 1 Completed - China ... More >> Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai, China, 200025 Less <<
NCT01097694 - Completed - -
NCT00787384 Hypereosinophilic Syndrome|Chr... More >>onic Eosinophilic Leukemia|Chronic Idiopathic Hypereosinophilia Less << PHASE2 COMPLETED 2025-12-07 USC Ematologia Ospedali Riunit... More >>i di Bergamo, Bergamo, 24128, Italy|Divisione di Ematologia Spedali Civili di Brescia, Brescia, Italy|USC Ematologia Azienda Ospedaliera Università Careggi, Firenze, 50134, Italy|UO Ematologia, Azienda Ospedaliera ULSS6, Vicenza, 36100, Italy Less <<
NCT01222013 Acute Lymphoblastic Leukemia (... More >>ALL) Philadelphia Chromosome-positive (Ph+) Less << Phase 2 Suspended(Study was suspended ... More >>before recruitment, due to logistic issues.) Less << - -
NCT00702689 - Completed - -
NCT01294202 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center at UMC North Tucson, Arizona, United States, 85719 United States, Illinois Robert H. Lurie Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02459 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health and Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2412 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77230-1402 Less <<
NCT01795716 - Completed - -
NCT01221376 Chronic Myeloid Leukemia (CML)... More >> With Philadelphia Chromosome-positive (Ph+) Less << Phase 2 Unknown December 2013 Brazil ... More >> Hospital Santa Marcelina Sao Paulo, SP, Brazil, 08270-070 Less <<
NCT01297777 Systemic Mastocytosis Phase 4 Completed - Spain ... More >> Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle Toledo, Spain, 45071 Less <<
NCT01151852 - Completed - -
NCT02363361 Cervical Spinal Cord Injury PHASE2 UNKNOWN 2025-12-21 -
NCT03688568 Neurofibroma, Plexiform Phase 2 Recruiting September 1, 2021 United States, Indiana ... More >> Riley Hospital for Children - Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Kent Robertson, MD    317-944-8784    krobert@iu.edu    Contact: Leah Engelstad, RN    317-944-2832    leovermy@iu.edu Less <<
NCT01151852 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Less <<
NCT02685046 Colonic Neoplasms PHASE2 TERMINATED 2019-09-01 Meander Medical Center, Amersf... More >>oort, Utrecht, 3813TZ, Netherlands|Diakonessenhuis, Utrecht, 3582KE, Netherlands|University Medical Center Utrecht, Utrecht, 3584CX, Netherlands Less <<
NCT02614404 Plasmodium Falciparum Malaria Phase 1 Phase 2 Recruiting February 2018 Vietnam ... More >> A Tuc Recruiting Huong Hoa, Quang Tri, Vietnam, 520000 Contact: Ho Van Binh, MD    +84.166.920.5896 Less <<
NCT03193281 Chronic Myeloid Leukemia Phase 2 Recruiting December 31, 2023 New Zealand ... More >> Auckland City Hospital Recruiting Auckland, New Zealand Contact: Kate Gorton          Principal Investigator: Peter Browett          Middlemore Hospital Recruiting Auckland, New Zealand Contact: Kate Gorton          Principal Investigator: Gordon Royle          Christchurch Hospital Recruiting Christchurch, New Zealand Contact: Kate Gorton          Principal Investigator: Emma-Jane McDonald          Dunedin Hospital Recruiting Dunedin, New Zealand Contact: Kate Gorton          Principal Investigator: Lucy Pemberton          Palmerston North Hospital Recruiting Palmerston North, New Zealand Contact: Kate Gorton          Principal Investigator: Bart Baker          Wellington Hospital Recruiting Wellington, New Zealand Contact: Kate Gorton          Principal Investigator: Victoria Campion Less <<
NCT02413736 Sarcoma PHASE3 ACTIVE_NOT_RECRUITING 1933-05-01 Helsinki University Central Ho... More >>spital, Helsinki, 00029, Finland Less <<
NCT03674099 Multiple Sclerosis Phase 2 Recruiting July 30, 2021 Denmark ... More >> Rigshospitalet Not yet recruiting Copenhagen, Denmark, 2100 Contact: FinnThorup Sellebjerg, MD       finn.thorup.sellebjerg@regionh.dk    Norway Haukeland sjukhus Not yet recruiting Bergen, Norway, 5021 Contact: Kjell Morten Myhr, MD       kjell-morten.myhr@helse-bergen.no    Akershus University Hospital Not yet recruiting Lørenskog, Norway, 1478 Contact: Trygve Holmöy, MD       trygve.holmoy@medisin.uio.no    Rikshospitalet, Oslo Not yet recruiting Oslo, Norway, 0372 Contact: Hanne Flinstad Harbo, MD       h.f.harbo@medisin.uio.no    Ullevåls sjukhus Not yet recruiting Oslo, Norway, 0424 Contact: Elisabeth G Celius, MD       uxelgu@ous-hf.no    Sweden Karolinska Universityhospital, Huddinge Recruiting Huddinge, Stockholm, Sweden, 14186 Contact: Katharina Fink, MD       Katharina.Fink@sll.se    Neurology Sahlgrenska Hospital Not yet recruiting Göteborg, Sweden, 41345 Contact: Jan Lycke, MD       jan.lycke@neuro.gu.se    Linköping University Hospital Not yet recruiting Linköping, Sweden, 58185 Contact: Charlotte Dahle, MD       Charlotte.Dahle@regionostergotland.se    Akademiskt specialistcentrum Not yet recruiting Stockholm, Sweden, 11341 Contact: Fredrik Piehl, MD    +46-851779840    Fredrik.Piehl@ki.se    Karolinska Universitetssjukhuset, Solna Not yet recruiting Stockholm, Sweden, 17176 Contact: Tomas Olsson, MD    +46707213598    Tomas.Olsson@ki.se    Uppsala University Hospital Not yet recruiting Uppsala, Sweden, 75185 Contact: Joachim Burman, MD       joachim.burman@akademiska.se Less <<
NCT02462538 ALK+ Anaplastic Large Cell Lym... More >>phoma Less << Phase 1 Phase 2 Recruiting June 2021 Austria ... More >> Universitätsklinik für Innere Medizin V Recruiting Innsbruck, Austria, A-6020 Contact: Angelina Rauth    0043512504 ext 23382    studienambulanz.haematologie@uki.at    Principal Investigator: Wolfgang Willenbacher, Dr          AKH Linz, Innere Medizin 3, Zentrum f. Haematologie u. med. Onkologie Recruiting Linz, Austria, A-4021 Contact: Bettina Pfleger    +43 7327806 ext 6207    bettina.pfleger@akh.linz.at    Contact: Elisabeth Morbitzer    +43 7327806 ext 6204    elisabeth.morbitzer@akh.linz.at    Principal Investigator: Michael A. Fridrik, Univ.Doz.Dr          Universitätsklinik der PMU, Universitätsklinik für Innere Medizin III Recruiting Salzburg, Austria, 5020 Contact: Michaela Schachner, Mag.    +43 662 4482 ext 2847    m.schachner@salk.at    Principal Investigator: Richard Greil, Univ.Prof.Dr          Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abteilung für Hämatologie und Hämostaseologie Recruiting Wien, Austria, 1090 Contact: Natascha Vydra    + 43 1 40400 ext 44100    natascha.vydra@meduniwien.ac.at    Principal Investigator: Ulrich Jäger, Univ.Prof.Dr Less <<
NCT02146846 Chronic Myelogenous Leukemia TERMINATED 2025-07-17 Shahid-Bahonar hospital, Kerma... More >>n, Iran, Islamic Republic of Less <<
NCT02852486 Leukemia, Chronic Myeloid Phase 2 Recruiting June 2022 Brazil ... More >> Centro de Hematologia e Hemoterapia - Universidade Estadual de Campinas Recruiting Campinas, SP, Brazil, 13083-868 Contact: Katia B Pagnano, MD    55-19-35218740    kborgia@unicamp.br    Contact: Márcia T Delamain, MD    55-19-35218740    marciatd@unicamp.br    Principal Investigator: Katia B Pagnano, MD          Sub-Investigator: Márcia T Delamain, MD          Sub-Investigator: Gislaine O Duarte, MD          Sub-Investigator: Erich V De Paula, MD          Sub-Investigator: Carmino A De Souza, MD Less <<
NCT03239886 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Not Applicable Active, not recruiting January 31, 2020 Brazil ... More >> Centro de Pesquisa Clínica da Hematologia do HCFMUSP São Paulo, Sao Paulo, Brazil Less <<
NCT03639922 Acute Ischaemic Stroke Phase 3 Recruiting June 2022 Sweden ... More >> Mälarsjukhuset Eskilstuna Not yet recruiting Eskilstuna, Sweden, 633 49 Contact: Christina Widhe Qvist, MD       christina.widhe.qvist@dll.se    Sahlgrenska Universitetssjukhuset Not yet recruiting Göteborg, Sweden, 413 45 Contact: Jan-Erik Karlsson, MD       Jan-erik.karlsson@vgregion.se    Centralsjukhuset Kristianstad Not yet recruiting Kristianstad, Sweden, 291 85 Contact: Axel Andersson, MD       axel.p.andersson@skane.se    Skånes Universitetssjukhus Lund Not yet recruiting Lund, Sweden, 221 85 Contact: Jesper Pettersson, MD       jesper.pettersson@skane.se    Skånes Universitetssjukhus Malmö Not yet recruiting Malmö, Sweden, 205 02 Contact: Jesper Pettersson, MD       jesper.pettersson@skane.se    Skaraborgs sjukhus Skövde Recruiting Skövde, Sweden, 541 42 Contact: Björn Cederin, MD       bjorn.cederin@vgregion.se    Capio S:t Görans Hospital Not yet recruiting Stockholm, Sweden, 112 81 Contact: Ulrika Löfmark Höjeberg       ulrika.lofmark@capiostgoran.se    Södersjukhuset Recruiting Stockholm, Sweden, 118 83 Contact: Mihaela Romanitan       mihaela.romanitan@sodersjukhuset.se    Karolinska Universitetssjukhuset Huddinge Not yet recruiting Stockholm, Sweden, 141 86 Contact: Konstantinos Kostulas, MD       konstantinos.kostulas@sll.se    Karolinska Universitetssjukhuset Solna Recruiting Stockholm, Sweden, 171 76 Contact: Christina Sjöstrand       christina.sjostrand@ki.se    Danderyds sjukhus Not yet recruiting Stockholm, Sweden, 182 88 Contact: Ann-Charlotte Laska, MD       ann-charlotte.laska@ds.se    Sundsvalls Sjukhus Not yet recruiting Sundsvall, Sweden, 856 43 Contact: Fredrik Björk, MD       fredrik.bjorck@rvn.se    Uppsala Akademiska Sjukhus Not yet recruiting Uppsala, Sweden, 751 85 Contact: Lars Sjöblom       Lars.sjoblom@akademiska.se    Västmanlands sjukhus Västerås Not yet recruiting Västerås, Sweden, 721 89 Contact: Andreas Ranhem, MD       andreas.ranhem@ltv.se Less <<
NCT02260505 Gastrointestinal Stromal Tumor... More >>s Resected Gastrointestinal Stromal Tumors Non-metastatic High Risk of Recurrence KIT Gene Mutation Less << Phase 3 Recruiting December 2020 France ... More >> Institut Paoli-Calmettes Not yet recruiting Marseille, Bouches du Rhône, France, 13273 Contact: François BERTUCCI, Pr    +33 4 91 22 35 37    bertuccif@ipc.unicancer.fr    Principal Investigator: François BERTUCCI, Pr          Sub-Investigator: Slimane DERMERCHE, Dr          Sub-Investigator: Delphine PERROT, Dr          Sub-Investigator: Magali PROVANSAL, Dr          Centre Hospitalier Universitaire La Timone Recruiting Marseille, Bouches du Rhône, France, 13386 Contact: Florence DUFFAUD, Pr    +33 4 91 38 57 08    florence.duffaud@ap-hm.fr    Principal Investigator: Florence DUFFAUD, Pr          Sub-Investigator: Sébastien SALAS, Dr          CHRU de Besançon - Hôpital Minjoz Recruiting Besançon, Doubs, France, 25030 Contact: Elsa KALBACHER, Doctor    + 33 3 81 66 81 66    ekalbacher@chu-besancon.fr    Sub-Investigator: Loïc CHAIGNEAU, Doctor          Principal Investigator: Elsa KALBACHER, Doctor          Institut Bergonié Recruiting Bordeaux, Gironde, France, 33076 Contact: Antoine ITALIANO, Dr    +33 5 24 07 19 47    a.italiano@bordeaux.unicancer.fr    Principal Investigator: Antoine ITALIANO, Dr          Sub-Investigator: Sophie COUSIN, Dr          Sub-Investigator: Maud TOULMONDE, Dr          Centre Hospitalier Universitaire Toulouse Purpan Not yet recruiting Toulouse, Haute-Garonne, France, 31059 Contact: Rosine GUIMBAUD, Pr    +33 5 61 77 96 49    Guimbaud.r@chu-toulouse.fr    Principal Investigator: Rosine GUIMBAUD, Pr          Centre Régional de Lutte contre le Cancer de Montpellier Not yet recruiting Montpellier, Hérault, France, 34298 Contact: Didier CUPISSOL, Dr    +33 4 67 61 31 83    didier.cupissol@icm.unicancer.fr    Principal Investigator: Didier CUPISSOL, Dr          Sub-Investigator: Nelly FIRMIN, Dr          AP-HP Hôpital Européen Georges Pompidou Recruiting Paris, Ile de France, France, 75908 Contact: Bruno LANDI, Dr    +33 1 56 09 35 55    bruno.landi@aphp.fr    Principal Investigator: Bruno LANDI, Dr          Sub-Investigator: Anne-Laure POINTET, Dr          Institut de Cancérologie de l'Ouest Recruiting Saint-Herblain, Loire Atlantique, France, 44805 Contact: Elisabeth BOMPAS, Dr    +33 2 40 67 99 39    emmanuelle.bompas@ico.unicancer.fr    Principal Investigator: Elisabeth BOMPAS, Dr          Sub-Investigator: Frédéric ROLLAND, Dr          Sub-Investigator: Damien VANSTEENE, Dr          Sub-Investigator: Marie ROBERT, Dr          Sub-Investigator: Akila BENINE DANDEC, Dr          Sub-Investigator: Mathilde COLOMBIE, Dr          Sub-Investigator: Carole GOURMELON, Dr          Sub-Investigator: Audrey ROLLOT, Dr          Institut de cancérologie LUCIEN NEUWIRTH Recruiting Saint-priest-en-jarez, Loire, France, 42270 Contact: Olivier COLLARD, Dr    00 334 77 91 70 34    olivier.collard@icloire.fr    Principal Investigator: Olivier COLLARD, Dr          Sub-Investigator: Cecile VASSAL, Dr          Centre Hospitalier universitaire Robert Debré Recruiting Reims, Marne, France, 51092 Contact: Olivier BOUCHE, Pr    +33 3 26 78 71 72    obouche@chu-reims.fr    Principal Investigator: Olivier BOUCHE, Pr          Sub-Investigator: Julien VOLET, Dr          Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-les-Nancy, Meurthe et Moselle, France, 54519 Contact: Maria RIOS, Dr    +33 3 83 59 85 66    m.rios@nancy.unicancer.fr    Principal Investigator: Maria RIOS, Dr          Centre Oscar Lambret Recruiting Lille, Nord, France, 59020 Contact: Nicolas PENEL, Pr    +33 3 20 29 59 20    n-penel@o-lambret.fr    Sub-Investigator: Farid EL HAJBI, Dr          Principal Investigator: Nicolas PENEL, Dr          Sub-Investigator: Charlotte PEUGNIEZ, Dr          Centre Léon Bérard Recruiting Lyon, Rhône, France, 69008 Contact: Jean-Yves BLAY, Pr    +33 4 78 78 27 57    jean-yves.blay@lyon.unicancer.fr    Principal Investigator: Jean-Yves BLAY, Pr          Sub-Investigator: Olivia BALLY, Dr          Sub-Investigator: Philippe CASSIER, Dr          Sub-Investigator: Isabelle RAY-COQUART, Dr          Sub-Investigator: Nathalie MARQUES, Dr          Sub-Investigator: Matthieu SARABI, Dr          Institut de Cancérologie Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Axel LE CESNE, Dr    +33 1 42 11 43 16    axel.lecesne@gustaveroussy.fr    Principal Investigator: Axel LE CESNE, Dr          Sub-Investigator: Julien DOMONT, Dr          Sub-Investigator: Sarah DUMONT, Dr          Sub-Investigator: Olivier MIR, Dr          AP-HP Hôpital Saint-Antoine Not yet recruiting Paris, France, 75571 Contact: Isabelle TROUILLOUD, Dr    +33 1 48 29 23 29    isabelle.trouilloud@aphp.fr    Sub-Investigator: Pauline AFCHAIN, Dr          Sub-Investigator: Thierry ANDRE, Dr          Sub-Investigator: Marie-Line GARCIA, Dr          Sub-Investigator: Daniel LOPEZ-TRABADA-ATAZ, Dr          CHRU Strasbourg - Hôpital Hautepierre Not yet recruiting Strasbourg, France, 67098 Contact: Jean-Emmanuel KURTZ, Pr    +33 3 88 12 78 82    emmanuel.kurtz@chru-strasbourg.fr    Sub-Investigator: Laure DE COCK, Dr          Sub-Investigator: Laure PIERARD, Dr Less <<
NCT02303899 Mesothelioma, Malignant Phase 2 Active, not recruiting December 2017 Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT03578367 CML Chronic M... More >>yelogenous Leukemia Leukemia, Myeloid Chronic Hematologic Diseases Less << Phase 2 Recruiting October 11, 2021 United States, Maryland ... More >> Saint Agnes Healthcare Cancer Institute Recruiting Baltimore, Maryland, United States, 21229 Contact: Chris Hopmann    410-368-2966    chopmann@ascension.org    Principal Investigator: Carole Miller          Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 Czechia Novartis Investigative Site Recruiting Brno - Bohunice, Czechia, 639 01 France Novartis Investigative Site Recruiting Bordeaux, France, 33076 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Spain Novartis Investigative Site Recruiting Sevilla, Andalucia, Spain, 41009 United Kingdom Novartis Investigative Site Recruiting London, United Kingdom, W12 0HS Less <<
NCT02177825 Plexiform Neurofibromas Phase 2 Recruiting December 2020 Canada, Quebec ... More >> CHU Sainte-Justine Recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: Sophie Morin, RN, CCRP    514-345-4969 ext 2741    sophie.morin@recherche-ste-justine.qc.ca    Contact: Mary-Ellen French, RN    514-345-4969    mary-ellen.french@recherche-ste-justine.qc.ca    Principal Investigator: Sébastien Perreault, MD/FRCPC Less <<
NCT01742299 GIST and CML Phase 4 Recruiting April 21, 2023 -
NCT03469011 Papillary Thyroid Cancer Phase 1 Not yet recruiting June 30, 2020 -
NCT00685828 Gastrointestinal Stromal Tumor Phase 3 Unknown - -
NCT00052949 Recurrent Small Cell Lung Canc... More >>er Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00088231 Acute Myelogenous Leukemia ... More >> Agnogenic Myeloid Metaplasia Chronic Myelogenous Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00323063 Breast Cancer Phase 2 Terminated(Slow accrual) - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, New Jersey Cooper Hospital/University Medical Center Camden, New Jersey, United States, 08103 Rutgers Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Mountainside Hospital Montclair, New Jersey, United States, 07042 Jersey Shore Cancer Center at Jersey Shore University Medical Center Neptune City, New Jersey, United States, 07754 Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 NJ Medical School Newark, New Jersey, United States, 07103 Less <<
NCT00122473 Dermatofibrosarcoma Phase 1 Phase 2 Completed - Germany ... More >> Skin Cancer Unit, German Cancer Research Center and Department of Dermatology, University Hospital of Mannheim Mannheim, Baden-Württemberg, Germany, 68167 Department of Dermatology, ElbeKliniken - Klinikum Buxtehude Buxtehude, Niedersachsen, Germany, 21614 Department of Dermatology, The Saarland University Hospital Homburg/Saar, Saarland, Germany, 66424 Department of Dermatology, Martin-Luther-University Halle-Wittenberg Halle/Saale, Sachsen-Anhalt, Germany, 06097 Less <<
NCT00327262 Chronic Myeloid Leukemia PHASE3 UNKNOWN 2025-12-08 Medical University Innsbruck, ... More >>Innsbruck, Tyrol, 6020, Austria Less <<
NCT00281996 Pancreatic Cancer Phase 1 Terminated(Closed to accrual t... More >>o allow enrollment on another more promising trial.) Less << - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00084825 Metastatic Cancer ... More >> Prostate Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00881049 Metastatic Melanoma Phase 2 Completed - China, Bejing ... More >> Beijing Cancer Hospital Beijing, Bejing, China, 10036 Less <<
NCT01131325 CML Philadelp... More >>hia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels Less << Phase 4 Terminated - United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada CCC of Nevada (1) Las Vegas, Nevada, United States, 89109 United States, Texas Cancer Center of the High Plains Amarillo, Texas, United States, 79106 Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) Dallas, Texas, United States, 75246 Less <<
NCT00103168 Gastrointestinal Stromal Tumor Phase 3 Completed - -
NCT00323063 - Terminated(Slow accrual) - -
NCT00047502 Chronic Myelogenous Leukemia Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT00193258 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 1 Phase 2 Completed - -
NCT00424385 - Completed - -
NCT00424385 Prostate Cancer Phase 1 Completed - United States, Illinois ... More >> Oncology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00193258 - Completed - -
NCT00040105 Leukemia, Myeloid, Chronic Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03241199 Chronic Myeloid Leukemia ... More >> Philadelphia Chromosome Positive CML Less << Phase 2 Recruiting January 1, 2021 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Carol Cheung, MBBS    852 22553111 ext 3456    drcarolcheung@gmail.com    Contact: Crosby Lu, MMedSc    852 22553111 ext 1654    khlu@hku.hk Less <<
NCT02421926 - Withdrawn May 2023 Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyong-gi Province, Korea, Republic of Korea University Ansan Hospital Ansan, Korea, Republic of Busan National University Hospital Busan, Korea, Republic of Haeundae Paik Hospital Busan, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Gachon University Gil Hospital Incheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soonchyunhyang University Hospital Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT00219752 Chronic Myeloid Leukemia Phase 2 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00451997 Leukemia, Myeloid ... More >> Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00403156 Choroidal Neovascularization Phase 1 Withdrawn(Lack of recruitment) - United States, New York ... More >> Vitreous Retina Macula Consultants of New York, P.C. New York, New York, United States, 10022 Less <<
NCT00667953 Melanoma Adva... More >>nced Melanoma Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00481247 Myeloid Leukemia, Chronic Phase 3 Completed - -
NCT00481247 - Completed - -
NCT00171223 Leukemia, Myelogenous, Chronic... More >>, BCR-ABL Positive Less << PHASE2 COMPLETED 2013-11-29 UCLA Medical Center, Los Angel... More >>es, California, 90095, United States|H. Lee Moffet Cancer Center & Research Institute/Univ of South Florida, Tampa, Florida, 33612, United States|Northwestern Univ meical School/Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, 60611, United States|Johns Hopkins Oncology Center, Baltimore, Maryland, 21231, United States|Dana Faber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Wayne State University/Kamanos Cancer Center, Detroit, Michigan, 48201, United States|C/O V. Ward - Washington Univ. school of Medicine, Saint Louis, Missouri, 63110, United States|New York Presbyterian Hospital, New York, New York, 10021, United States|Oregon Health & sciences University, Portland, Oregon, 97239, United States|MD Anderson Cancer Center, University of Texas, Houston, Texas, 77030, United States|Novartis Investigative Site, Lille, France|Novartis Investigative Site, Pessac, France|Novartis Investigative Site, Poitiers, France|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Leipzig, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Mannheim, Germany|Novartis Investigative Site, Bologna, Italy|Novartis Investigative Site, Milano, Italy|Novartis Investigative Site, Monza, Italy|Novartis Investigative Site, Orbassano, Italy|Novartis Investigative Site, Pavia, Italy|Novartis Investigative Site, Rome, Italy|Novartis Investigative Site, Udine, Italy|Novartis Investigative Site, Basel, Switzerland|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Newcastle upon Tyne, United Kingdom Less <<
NCT00867334 Colorectal Neoplasm ... More >> Colorectal Cancer Less << Phase 1 Phase 2 Completed - United States, Virginia ... More >> Virginia Cancer Specialists, PC Fairfax, Virginia, United States, 22031 Inova Fairfax Hospital Department of Surgery Falls Church, Virginia, United States, 22042 Less <<
NCT00171249 Philadelphia Positive Chronic ... More >>Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York New York Presbyterian Hospital New York, New York, United States, 10021 United States, Oregon Oregon Health & Sciences University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 France Novartis Investigative Site Pessac, France Novartis Investigative Site Poitiers, France Germany Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Mannheim, Germany Italy Novartis Investigative Site Monza, Italy United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00324077 Myeloid Leukemia, Chronic, Chr... More >>onic-Phase Less << Phase 1 Withdrawn(Insufficient Enrollm... More >>ent) Less << - United States, California ... More >> Local Institution Los Angeles, California, United States Local Institution San Francisco, California, United States United States, New York Local Institution New York, New York, United States Less <<
NCT00408460 Malignant Pleural Effusion ... More >> Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00408460 - Completed - -
NCT00245128 - Terminated(Per PI, results fro... More >>m another similar study were published prior to study analysis. Negative study results were published therefore analysis was not completed) Less << - -
NCT00068783 Recurrent Neuroendocrine Carci... More >>noma of the Skin Stage II Neuroendocrine Carcinoma of the Skin Stage III Neuroendocrine Carcinoma of the Skin Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00245128 Chronic Myeloproliferative Dis... More >>orders Less << Phase 2 Terminated(Per PI, results fro... More >>m another similar study were published prior to study analysis. Negative study results were published therefore analysis was not completed) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00401024 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00446004 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations) Pittsburgh, Pennsylvania, United States, 15232 / 15213 Less <<
NCT00500110 Prostate Cancer Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00500110 - Completed - -
NCT00183833 Colon Cancer ... More >>Colorectal Cancer Less << Phase 1 Completed - United States, California ... More >> USC/Norris Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01275196 Chronic Myeloid Leukemia Phase 3 Completed - China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Fuzhou, China, 350001 Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Nan Jing, China, 210008 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT00268229 Leukemia Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00030394 Childhood Chronic Myelogenous ... More >>Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01735968 3rd Line GIST Phase 1 Completed - United States, Oregon ... More >> Oregon Health and Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux, France, 33076 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Candiolo, TO, Italy, 10060 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Leeds, United Kingdom, LS9 7TF Less <<
NCT00248482 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT01660906 Chronic Phase Chronic Myeloid ... More >>Leukemia Less << Phase 4 Completed - United States, California ... More >> Pacific Cancer Medical Center Anaheim, California, United States, 92801 United States, Connecticut Cancer Center Of Central Connecticut Southington, Connecticut, United States, 06489 United States, Maryland St. Agnes Healthcare, Inc. Baltimore, Maryland, United States, 21229 United States, Ohio Promedica Hematology & Oncology Assoicates Sylvania, Ohio, United States, 43560 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 France Local Institution Creteil Cedex, France, 94010 Local Institution Lille CEDEX, France, 59037 Local Institution Pierre Benite cedex, France, 69495 Local Institution Pringy Cedex, France, 74374 Local Institution Vandoeuvre les Nancy, France, 54511 Germany Local Institution Jena, Germany, 07747 Local Institution Koln, Germany, 50937 Local Institution Lubeck, Germany, 23562 Local Institution Mannheim, Germany, 68169 Local Institution Rostock, Germany, 18055 Italy Local Institution Catania, Italy, 95124 Local Institution Firenze, Italy, 50134 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00144 Local Institution Roma, Italy, 00161 Local Institution Torino, Italy, 10126 Korea, Republic of Local Institution Seoul, Korea, Republic of, 137-701 Less <<
NCT00171899 Chronic Myelogenous Leukemia Phase 4 Completed - Canada ... More >> Novartis Investigative Site Toronto, Canada Less <<
NCT01275196 - Completed - -
NCT00041197 Gastrointestinal Stromal Tumor Phase 3 Completed - United States, North Carolina ... More >> American College of Surgeons Oncology Group Durham, North Carolina, United States, 27705 Less <<
NCT00080678 Metastatic Cancer ... More >> Prostate Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00054431 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Relapsing Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00430066 Polycythemia Vera Phase 2 Completed - -
NCT01660906 - Completed - -
NCT00068380 Recurrent Gastric Cancer ... More >> Stage IV Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00068380 - Completed - -
NCT03424876 - Recruiting August 8, 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jian Li, MD Less <<
NCT00180921 Cancer of the Head and Neck|Ca... More >>rcinoma, Adenoid Cystic Less << PHASE2 UNKNOWN - Institut Gustave Roussy, Ville... More >>juif, 94800, France Less <<
NCT00428909 Chronic Myeloid Leukemia (CML) Phase 1 Completed - Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Republic of Less <<
NCT00947830 - Completed - Canada, Ontario ... More >> Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Less <<
NCT00514488 Chronic Myeloid Leukemia Phase 3 Completed - Italy ... More >> Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Bologna, Italy Less <<
NCT00049192 Chronic Myelogenous Leukemia, ... More >>BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00251225 Prostate Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00038649 Myelogenous Leukemia, Chronic,... More >> Chronic Phase Less << Phase 2 Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00251225 - Completed - -
NCT00854841 - - - -
NCT00038649 - Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - -
NCT00891527 Pulmonary Veno Occlusive Disea... More >>se Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Boston Childrens Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00891527 - Completed - -
NCT00415909 Chronic Myelogenous Leukemia Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00087152 - Completed - -
NCT00087152 Breast Cancer Phase 2 Completed - -
NCT00732784 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center location) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00415909 - Terminated(Slow Accrual) - -
NCT00427583 Malignant Peripheral Nerve She... More >>ath Tumors Less << Phase 2 Phase 3 Terminated(stopped due to slow... More >> recruitment and no effect) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Hamburg, Germany Less <<
NCT00287846 Desmoid Tumor Phase 1 Phase 2 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Hopital Edouard Herriot - Lyon Lyon, France, 69437 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Institut Curie Hopital Paris, France, 75248 Hopital Tenon Paris, France, 75970 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 Centre Paul Strauss Strasbourg, France, 67065 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Hopital Foch Suresnes, France, 92151 Institut Claudius Regaud Toulouse, France, 31052 Centre Hospitalier Universitaire Bretonneau de Tours Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT01926548 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00091078 Gastrointestinal Stromal Tumor Phase 2 Terminated - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00101088 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Terminated - United States, California ... More >> University of California Medical Center At Irvine-Orange Campus Orange, California, United States, 92868 Less <<
NCT00573326 Systemic Sclerosis PHASE2 UNKNOWN 2025-06-10 Università Politecnica delle M... More >>arche, Ancona, 60020, Italy Less <<
NCT01130688 Chronic Myelogenous Leukemia Phase 1 Terminated(Lack of enrollment) - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT02977312 Chronic Myeloid Leukemia, Chro... More >>nic Phase Less << COMPLETED 2025-02-15 Al Bashir Hospital, Amman, Jor... More >>dan|Jordan University Hospital, Amman, Jordan|King Hussein Cancer Center, Amman, Jordan Less <<
NCT00510653 Ovarian Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00601510 Gastric Cancer Phase 1 Completed - Germany ... More >> Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00333840 Chronic Myelogenous Leukemia Phase 3 Completed - -
NCT01392495 Pulmonary Arterial Hypertensio... More >>n Less << PHASE3 TERMINATED 2025-03-14 Novartis Investigative Site, M... More >>ineola, New York, 11501, United States|Novartis Investigative Site, Darlinghurst, New South Wales, 2010, Australia|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Vilnius, LT-08661, Lithuania|Novartis Investigative Site, London, NW3 2QG, United Kingdom Less <<
NCT00030667 Childhood Desmoplastic Small R... More >>ound Cell Tumor Childhood Synovial Sarcoma Gastrointestinal Stromal Tumor Lung Metastases Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00707408 AML PHASE2 COMPLETED 2025-01-09 Nantes University Hopspital, N... More >>antes, 44093, France Less <<
NCT00314873 Thymic Carcinoma Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00372476 Breast Cancer Phase 4 Completed - Germany ... More >> Novartis Investigative Site Kiel, Germany, 24105 Less <<
NCT00333840 - Completed - -
NCT01392495 Pulmonary Arterial Hypertensio... More >>n Less << PHASE3 TERMINATED 2025-03-14 Novartis Investigative Site, M... More >>ineola, New York, 11501, United States|Novartis Investigative Site, Darlinghurst, New South Wales, 2010, Australia|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Vilnius, LT-08661, Lithuania|Novartis Investigative Site, London, NW3 2QG, United Kingdom Less <<
NCT00025415 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Undifferentiated Leukemia AIDS-related Peripheral/Systemic Lymphoma AIDS-related Primary CNS Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blastic Phase Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Gastrointestinal Stromal Tumor Intraocular Lymphoma Isolated Plasmacytoma of Bone Meningeal Chronic Myelogenous Leukemia Monoclonal Gammopathy of Undetermined Significance Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Central Nervous System Non-Hodgkin Lymphoma Primary Myelofibrosis Primary Systemic Amyloidosis Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma T-cell Large Granular Lymphocyte Leukemia Unspecified Adult Solid Tumor, Protocol Specific Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Hairy Cell Leukemia Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00510653 - Completed - -
NCT01188278 Leukemia, Myeloid, Chronic-Pha... More >>se (CML-CP) Less << COMPLETED 2025-01-13 -
NCT00583115 - Terminated(Unable to enroll su... More >>bjects) Less << - -
NCT00154388 Life Threatening Diseases Phase 2 Completed - -
NCT00338728 Anatomic Stage IV Breast Cance... More >>r AJCC v8 Estrogen Receptor Positive KIT Positive PDGFR Positive Postmenopausal Progesterone Receptor Positive Prognostic Stage IV Breast Cancer AJCC v8 Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00583115 Pulmonary Hypertension Phase 2 Terminated(Unable to enroll su... More >>bjects) Less << - United States, Indiana ... More >> Indiana University School of Medicine; Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT00237120 Chronic Myelogenous Leukemia i... More >>n Chronic Phase Less << PHASE3 COMPLETED 2025-06-07 -
NCT02129166 Healthy Volunteers Phase 1 Withdrawn(PI resigned) - -
NCT00036751 Primary Peritoneal Cavity Canc... More >>er Recurrent Ovarian Epithelial Cancer Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT00021229 - Terminated(Poor accrual) - -
NCT00045734 - Completed - -
NCT00042952 Ovarian Dysgerminoma ... More >> Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage II Malignant Testicular Germ Cell Tumor Stage II Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Testicular Seminoma Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00021229 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Terminated(Poor accrual) - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00981942 Nephrogenic Systemic Fibrosis Phase 3 Completed - Denmark ... More >> Department of Dermatology Aarhus, Denmark, 8000 Less <<
NCT00004932 Leukemia Phase 1 Completed - -
NCT00470470 Acral Lentiginous Malignant Me... More >>lanoma Recurrent Melanoma Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma Less << Phase 2 Completed - United States, California ... More >> University of California at Los Angeles (UCLA ) Los Angeles, California, United States, 90095 United States, Florida Mount Sinai Medical Center CCOP Miami Beach, Florida, United States, 33140 Good Samaritan Medical Center West Palm Beach, Florida, United States, 33401 Palm Beach Cancer Institute-Main Office West Palm Beach, Florida, United States, 33401 United States, New York New York University Langone Medical Center New York, New York, United States, 10016 Mount Sinai Medical Center New York, New York, United States, 10029 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT00470470 - Completed - -
NCT00045734 Adult Grade I Meningioma ... More >> Adult Grade II Meningioma Adult Grade III Meningioma Adult Meningeal Hemangiopericytoma Adult Meningioma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Maryland National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States, 20814 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00956072 Gastrointestinal Stromal Tumor Phase 3 Terminated(low accrual) - Italy ... More >> European Organization for Research and Treatment of Cancer Naples, Italy, 80131 Less <<
NCT00585221 - Terminated(PI terminated at th... More >>e recommendation of DSMC & IRB) Less << - -
NCT00585221 Gastrointestinal Stromal Tumor... More >>s Cancer Brain Solid Tumors Less << Phase 2 Terminated(PI terminated at th... More >>e recommendation of DSMC & IRB) Less << - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01175109 Chordoma Phase 1 Unknown December 2013 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT02204644 CML, CML-CP,MMR,TKI Phase 3 Completed - China, Tianjin ... More >> Hospital of Blood Diseases, Chinese Academy of Medical Sciences Tianjin, Tianjin, China, 300020 Less <<
NCT03440515 Gastrointestinal Stromal Tumor... More >>(GIST) Less << Phase 2 Completed - -
NCT00045188 Male Breast Cancer ... More >> Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02896842 Leukemia, Myelogenous, Chronic... More >>, BCR-ABL Positive Less << Phase 2 Completed - France ... More >> CHU angers Angers, France CH d'Annecy Annecy, France CH argenteuil Argenteuil, France CHU Bordeaux Bordeaux, France Institut Bergonié Bordeaux, France CH Boulogne Boulogne, France CHU CAEN Caen, France CH de Dieppe Dieppe, France CH Dunkerque Dunkerque, France CH Versailles Le Chesnay, France CHU Lille Lille, France CHU Lyon Lyon, France CH Meaux Meaux, France Hopital Bon secours Metz, France CHU Nice Nice, France Hopital La Source Orléans La Source, France Hopital Necker Paris, France CHU Rennes Rennes, France Hopital Purpan Toulouse, France Less <<
NCT00479934 Scleroderma, Localized ... More >> Scleroderma, Systemic Less << Phase 2 Completed - France ... More >> Service de Dermatologie et services de médecine interne et vasculaire - Hôpital St André - CHU de Bordeaux Bordeaux, France, 33076 Service de Rhumatologie, Hôpital Pellegrin-Tondu CHU de Bordeaux Bordeaux, France, 33076 Service de Dermatologie - CHG Libourne Libourne, France, 33500 Service de dermatologie - CHU de Limoges Limoges, France, 87042 Service de Médecin interne - Hôpital central Nancy, France, 54035 Service de Médecine interne - Hôpital Saint Louis Paris, France, 75475 Service de Dermatologie - CHG Périgueux Perigueux, France, 24000 Service de Dermatologie - service de médecine interne et vasculaire - hopital haut Lévêque - av.de magellan Pessac, France, 33604 Service de Rhumatologie - CHU de Strasbourg Strasbourg, France, 67098 Service de Dermatologie - CHU de Toulouse - Hopital Purpan Toulouse, France, 31059 Toulouse Cedex Service de Médecine interne - CHU de Tours Tours, France, 37044 Néphrologie et Médecine interne - CH de Valenciennes Valenciennes, France, 59322 Less <<
NCT00446316 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations) Pittsburgh, Pennsylvania, United States, 15232 / 15213 Less <<
NCT01568645 Pulmonary Hypertension Phase 1 Withdrawn - -
NCT02576080 Gastrointestinal Stromal Tumor Phase 3 Not yet recruiting October 2020 -
NCT00101660 Chronic Myeloid Leukemia ... More >> Philadelphia-Positive Myeloid Leukemia Less << Phase 2 Completed - -
NCT00570635 Gastrointestinal Stromal Tumor... More >>s Gastrointestinal Neoplasms Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02115 Less <<
NCT02204722 Chronic Myeloid Leukemia Phase 4 Terminated(Sponsor's decision ... More >>to halt the study.) Less << - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138736 Less <<
NCT00022490 Leukemia Phase 2 Terminated - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01148134 - Terminated(Analysis of the fir... More >>st 10 patients did not show anyt trend toward differences in PK profiles between imatinib vs no imatinib groups.) Less << - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00511303 Chronic Myeloid Leukemia PHASE2 COMPLETED - -
NCT02115386 Philadelphia Positive (Ph+) Ch... More >>ronic Myeloid Leukemia Less << Phase 3 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 125167 Less <<
NCT00896129 - Completed - Italy ... More >> Nuovo ospedale "Torrette" Ancona, Italy Unità Operativa Ematologica - Università degli Studi di Bari Bari, Italy, 70124 Ospedali Riuniti Bergamo, Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Sezione di Ematologia e Trapianti Spedali Civili Brescia, Italy, 21125 Azienda ASL di Cagliari Cagliari, Italy, 9121 Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Ematologia 1 - Centro Trapianto di Midollo Milano, Italy, 20122 Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy, 80131 Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" Napoli, Italy, 80131 Ospedale S. Luigi Gonzaga Orbassano, Italy, 10043 Ospedale Cervello Palermo, Italy, 90146 Azienda ASL di Pescara Pescara, Italy, 61100 Università di Pisa, Azienda Ospedaliera Pisana Pisa, Italy, 72100 Ospedale S.Maria delle Croci Ravenna, Italy, 48100 Ospedali Riuniti - Div. di Ematologia Reggio Calabria, Italy, 85100 Università La Sapienza Roma, Italy, 00100 Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Azienda USL 9 Treviso - U.O. di Ematologia Treviso, Italy, 31100 Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT00290485 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Unknown - Canada, Quebec ... More >> Maisonneuve-Rosemont Hospital Recruiting Montreal, Quebec, Canada, h1t 2m4 Contact: Pierre Dubé, MD    (514) 252-3822    pierredube@videotron.qc.ca    Principal Investigator: Pierre Dubé, MD Less <<
NCT00101660 - Completed - -
NCT00112632 Gastrointestinal Stromal Tumor Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria, A-1090 Germany Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13122 Universitaetsklinikum Bonn Bonn, Germany, D-53105 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Less <<
NCT01437202 - Completed - Canada ... More >> Princess Margaret Hospital, University of Toronto Toronto, Canada Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of Less <<
NCT02602314 Chronyc Myeloid Leukemia Phase 4 Recruiting February 2024 Italy ... More >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Massimo Pini          Principal Investigator: Massimo Pini          Sub-Investigator: Federico Monaco          Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi G. Salesi Recruiting Ancona, Italy Contact: Serena Rupoli          Principal Investigator: Serena Rupoli          Sub-Investigator: Anna Rita Scortecchini          Az.Ospedaliera S.G.Moscati Not yet recruiting Avellino, Italy Contact: Fausto Palmieri          Principal Investigator: Fausto Palmieri          Sub-Investigator: Raffaele Palmieri          UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Italy Contact: Giorgina Specchia          Principal Investigator: Giorgina Specchia          Sub-Investigator: Antonella Russo          Ematologia Torre 6 piano 4 - ASST Papa Giovanni XXIII Recruiting Bergamo, Italy Contact: Alessandro Rambaldi          Principal Investigator: Alessandro Rambaldi          Sub-Investigator: Giulia Quaresmini          Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Recruiting Bologna, Italy Contact: Gianantonio Rosti          Principal Investigator: Gianantonio Rosti          Sub-Investigator: Gabriele Gugliotta          USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia Not yet recruiting Brescia, Italy Contact: Domenico Russo          Principal Investigator: Domenico Russo          Sub-Investigator: Michele Malagola          ASL N.8 -Ospedale A. Businco Recruiting Cagliari, Italy Contact: Emilio Usala          Principal Investigator: Emilio Usala          Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Not yet recruiting Catania, Italy Contact: Francesco Di Raimondo          Principal Investigator: Francesco Di Raimondo          Sub-Investigator: Fabio Stagno          U.O. di Medicina Interna - ASUR Marche 8 - Ospedale Civile Not yet recruiting Civitanova Marche, Italy Contact: Riccardo Centurione          Principal Investigator: Riccardo Centurione          Sub-Investigator: Jacopo Olivieri          Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi Not yet recruiting Cona, Italy Contact: Francesco Cavazzini          Principal Investigator: Francesco Cavazzini          Sub-Investigator: Enrico Lista          S.C. Ematologia ASO S. Croce e Carle Recruiting Cuneo, Italy Contact: Davide Rapezzi          Principal Investigator: Davide Rapezzi          Sub-Investigator: Roberto Sorasio          Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Not yet recruiting Firenze, Italy Contact: Antonella Gozzini          Principal Investigator: Antonella Gozzini          Sub-Investigator: Barbara Scappini          IRCCS_AOU San Martino-IST.Clinica Ematologica Recruiting Genova, Italy Contact: Marco Gobbi          Principal Investigator: Marco Gobbi          Sub-Investigator: Micaela Bergamaschi          ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Recruiting Lecce, Italy Contact: Nicola Di Renzo          Principal Investigator: Nicola Di Renzo          Sub-Investigator: Giovanni Reddiconto          Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Recruiting Messina, Italy Contact: Caterina Musolino          Principal Investigator: Caterina Musolino          Sub-Investigator: Sabina Russo          Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Recruiting Messina, Italy U.O. di Ematologia- Ospedale dell'Angelo - Mestre Recruiting Mestre, Italy Contact: Renato Bassan          Principal Investigator: Renato Bassan          Sub-Investigator: Rosaria Sancetta          UO Ematologia - AOU Policlinico di Modena Recruiting Modena, Italy Contact: Roberto Marasca          Principal Investigator: Roberto Marasca          Sub-Investigator: Giovanna Leonardi          Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli Recruiting Napoli, Italy Contact: Mario Annunziata          Principal Investigator: Mario Annunziata          Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Recruiting Napoli, Italy Contact: Fabrizio Pane          Ospedale San Gennaro - ASL Napoli 1 Not yet recruiting Napoli, Italy Contact: Lucia Mastrullo          Principal Investigator: Lucia Mastrullo          Sub-Investigator: Maria Rosaria Esposito          S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Not yet recruiting Novara, Italy Contact: Monia Lunghi          Principal Investigator: Monia Lunghi          U.O. CTMO Ematologia - Osp. S. Francesco Recruiting Nuoro, Italy Contact: Alessandro Murgia          Principal Investigator: Alessandro Murgia          Sub-Investigator: Maria Monne          Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Not yet recruiting Orbassano, Italy Contact: Giovanna Rege          Principal Investigator: Giovanna Rege          Sub-Investigator: Carmen Fava          Ospedali Riuniti "Villa Sofia-Cervello" Recruiting Palermo, Italy Contact: Francesco Fabbiano          Principal Investigator: Francesco Fabbiano          Sub-Investigator: Alessandra Malato          U.O. di Ematologia con trapianto - Centro di Riferimento Regionale per le coagulopatie rare nel bambino e nell'adulto Dipart. Biomedico di Medicina Interna - A.U. Policlinico "Paolo Giaccone" Not yet recruiting Palermo, Italy Contact: Sergio Siragusa          Principal Investigator: Sergio Siragusa          Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore Recruiting Pesaro, Italy Contact: Giuseppe Visani          Principal Investigator: Giuseppe Visani          Sub-Investigator: Sara Barulli          Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto Recruiting Piacenza, Italy Contact: Daniele Vallisa          Principal Investigator: Daniele Vallisa          Sub-Investigator: Elena Trabacchi          Az.Ospedaliera S.G.Moscati Not yet recruiting Potenza, Italy Contact: Michele Pizzuti          Principal Investigator: Michele Pizzuti          Sub-Investigator: Angela Matturro          Dipartimento Oncologico - Ospedale S.Maria delle Croci Not yet recruiting Ravenna, Italy Contact: Maria Salvucci          Principal Investigator: Maria Salvucci          Sub-Investigator: Roberto Zanchini          Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Bruno Martino          Principal Investigator: Bruno Martino          Sub-Investigator: Caterina Alati          Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Recruiting Reggio Emilia, Italy Contact: Paolo Avanzini          Principal Investigator: Paolo Avanzini          Sub-Investigator: Isabella Capodanno          Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Recruiting Roma, Italy Contact: Agostino Tafuri          Principal Investigator: Agostino Tafuri          Sub-Investigator: Enrico Montefusco          Divisione Ematologia - Università Campus Bio-Medico Not yet recruiting Roma, Italy Contact: Marianna De Muro          Principal Investigator: Marianna De Muro          Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Recruiting Roma, Italy Contact: Simona Sica          Principal Investigator: Simona Sica          Sub-Investigator: Federica Sorà          UOC Pronto Soccorso e Accettazione Ematologica - Dipartimento Biotecnologie Cellulari ed Ematologia - Università degli Studi di Roma "Sapienza" Not yet recruiting Roma, Italy Contact: Massimo Breccia          Principal Investigator: Massimo Breccia          Sub-Investigator: Giuliana Alimena          U.O.C. Ematologia - Ospedale S. Eugenio Recruiting Rome, Italy Contact: Elisabetta Abruzzese          Principal Investigator: Elisabetta Abruzzese          Unità Operativa di Oncologia Giovanni Paolo II "Vito Fazzi" Recruiting Rossano, Italy Contact: Francesco Iuliano          Principal Investigator: Francesco Iuliano          Sub-Investigator: Maria Aquila Santoro          Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          Sub-Investigator: Nicola Sgherza          Ematologia - Dipartimento di Medicina Clinica e Sperimentale Not yet recruiting Sassari, Italy Contact: Claudio Fozza          Principal Investigator: Claudio Fozza          Sub-Investigator: Francesco Longu          A.O. Santa Maria - Terni S.C Oncoematologia Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          Principal Investigator: Debora Luzi          Clinica Ematologica-Centro Trapianti e Terapie cellulari Azienda Ospedaliero-Universitaria, Udine Not yet recruiting Udine, Italy Contact: Mauro Tiribelli          Principal Investigator: Mauro Tiribelli          Sub-Investigator: Federico De Marchi          Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Not yet recruiting Verona, Italy Contact: Massimiliano Bonifacio          Principal Investigator: Massimiliano Bonifacio          Sub-Investigator: Luigi Scaffidi          ULSS N.6 Osp. S. Bortolo Not yet recruiting Vicenza, Italy Contact: Eros Di Bona          Principal Investigator: Eros Di Bona Less <<
NCT03516279 Chronic Phase Chronic Myelogen... More >>ous Leukemia, BCR-ABL1 Positive Minimal Residual Disease Less << Phase 2 Not yet recruiting August 31, 2031 United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Amer M. Zeidan    203-737-2572    amer.zeidan@yale.edu    Principal Investigator: Amer M. Zeidan Less <<
NCT00081133 Leukemia Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01391611 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 2 Terminated(Lack of efficacy - ... More >>Futility endpoint reached) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00015860 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Oregon Oregon Cancer Institute Portland, Oregon, United States, 97239 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01391611 - Terminated(Lack of efficacy - ... More >>Futility endpoint reached) Less << - -
NCT00905593 - - - Mexico ... More >> Novartis Investigative Site Guadalajara, Jalisco, Mexico Novartis Investigative Site Mexico City, Mexico Less <<
NCT03381053 - Recruiting January 1, 2022 China, Shanghai ... More >> 180 Fenglin Road Recruiting Shanghai, Shanghai, China, 200032 Contact: Hou Ying yong, doctor    13681972385 ext 86    You.yingyong@zs-hospital.sh.cn Less <<
NCT00254267 Advanced Gastrointestinal Stro... More >>mal Tumor Less << Phase 2 Completed - -
NCT01114087 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Tumors Less << Not Applicable Completed - France ... More >> Department of Biology of reproduction (TENON Hospital-APHP) Paris, France, 75012 Less <<
NCT00109707 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Hypereosinophilic Syndrome Systemic Mastocytosis Less << Phase 1 Phase 2 Completed - -
NCT00006343 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT01271166 Advanced Colorectal Cancer Phase 1 Terminated - Australia ... More >> Novarts Investigative Site Melbourne, Australia Less <<
NCT00786812 Chronic Myeloid Leukemia Phase 4 Completed - Brazil ... More >> Novartis Investigative Site Belo Horizonte, MG, Brazil, 30130-100 Novartis Investigative Site Curitiba, PR, Brazil, 80060-900 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Porto Alegre, RS, Brazil, 90035-903 Novartis Investigative Site Campinas, SP, Brazil, 13083-970 Novartis Investigative Site Jaú, SP, Brazil, 17210-080 Novartis Investigative Site Ribeirao Preto, SP, Brazil, 14048-900 Novartis Investigative Site São Paulo, SP, Brazil, 01401-901 Novartis Investigative Site São Paulo, SP, Brazil, 05403-000 Less <<
NCT00415857 - Terminated(Vaccine sponsor cea... More >>sed operations.) Less << - -
NCT00265798 - Active, not recruiting - -
NCT00044304 Hypereosinophilic Syndrome Phase 2 Recruiting January 1, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00415857 Leukemia Phase 2 Terminated(Vaccine sponsor cea... More >>sed operations.) Less << - United States, Texas ... More >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00058747 Leukemia, Myeloid, Chronic Phase 2 Terminated(Business decision o... More >>f the sponsor) Less << - United States, Alabama ... More >> Birmingham, Alabama, United States United States, California La Jolla, California, United States Los Angeles, California, United States United States, Colorado Denver, Colorado, United States United States, Connecticut Farmington, Connecticut, United States United States, Illinois Chicago, Illinois, United States United States, Massachusetts Boston, Massachusetts, United States United States, Missouri St. Louis, Missouri, United States United States, New York New York City, New York, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United Kingdom Liverpool, United Kingdom London, United Kingdom Less <<
NCT00265798 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00193349 Lung Cancer Phase 2 Completed - -
NCT00055874 Leukemia Phase 3 Completed - -
NCT00316953 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Meningeal Chronic Myelogenous Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Relapsing Chronic Myelogenous Leukemia Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00064233 Leukemia Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00427999 - Completed - -
NCT00427999 Prostate Cancer Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Reichenhall, Germany, 83435 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hamburg, Germany, 22607 Novartis Investigative Site Kassel, Germany, 34131 Novartis Investigative Site Markkleeberg, Germany, 04416 Novartis Investigative Site Passau, Germany, 94032 Novartis Investigative Site Planegg, Germany, 82152 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00337454 Chronic Myelogenous Leukemia Phase 1 Phase 2 Completed - Japan ... More >> Local Institution Nagoya-Shi, Aichi, Japan, 467-8602 Local Institution Nagoya, Aichi, Japan, 464-8681 Local Institution Nagoya, Aichi, Japan, 466-8550 Local Institution Maebashi, Gunma, Japan, 371-0821 Local Institution Nishinomiya-Shi, Hyogo, Japan, 663-8501 Local Institution Kagoshima-Shi, Kagoshima, Japan, 890-0064 Local Institution Isehara-Shi, Kanagawa, Japan, 259-1193 Local Institution Sendai, Miyagi, Japan Local Institution Nagasaki City, Nagasaki, Japan Local Institution Okayama-Shi, Okayama, Japan, 700-0082 Local Institution Moriguchi, Osaka, Japan, 570-8540 Local Institution Iruma-Gun, Saitama, Japan, 350-0495 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 431-3192 Local Institution Bunkyo-Ku, Tokyo, Japan, 113-8677 Local Institution Chuo-Ku, Tokyo, Japan, 104-0045 Local Institution Shinjuku-Ku, Tokyo, Japan, 160-8582 Local Institution Shinjuku-Ku, Tokyo, Japan, 162-8666 Local Institution Kanagawa, Japan Local Institution Kyoto, Japan Local Institution Tochigi, Japan, 329-0498 Local Institution Tokyo, Japan Less <<
NCT01490775 Chronic Phase CML Not Applicable Terminated(Study was terminate... More >>d due to lack of funding) Less << - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, North Carolina Rex Cancer Center - Wakefield Raleigh, North Carolina, United States, 27614 Less <<
NCT00298987 Leukemia, Myeloid, Chronic ... More >> Leukemia, Lymphocytic, Acute, L2 Less << Phase 2 Completed - -
NCT00117299 Sarcoma Phase 2 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland, FIN-00029 Less <<
NCT01227746 - Unknown December 2014 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore Contact: Ross Andrew Soo , MBBS    65 6772 4624    Ross_Soo@nuhs.edu.sg    Principal Investigator: Ross Andrew Soo, MBBS Less <<
NCT00458848 Leukemia Phase 2 Completed - -
NCT01073436 - Terminated(Closed prematurely ... More >>due to low accrual.) Less << - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00267085 Chronic Myeloid Leukemia ... More >> Minimal Residual Disease Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01746836 Chronic Phase Chronic Myelogen... More >>ous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Less << Phase 2 Active, not recruiting January 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00267085 - Completed - -
NCT00041990 Chronic Myelogenous Leukemia Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT00529763 Leukemia Phase 2 Active, not recruiting October 22, 2022 China, Beijing ... More >> Local Institution Beijing, Beijing, China, 100044 China, Fujian Local Institution Fuzhou, Fujian, China, 350001 China, Guangdong Local Institution Guangzhou, Guangdong, China, 510515 China, Jiangsu Local Institution Nanjing, Jiangsu, China, 210029 Local Institution Suzhou, Jiangsu, China, 215006 China, Shanghai Local Institution Shanghai, Shanghai, China, 200025 Local Institution Shanghai, Shanghai, China, 200433 China, Sichuan Local Institution Chengdou, Sichuan, China, 610041 China, Tianjin Local Institution Tianjin, Tianjin, China, 300020 China, Zhejiang Local Institution Hangzhou, Zhejiang, China, 310003 Less <<
NCT00042003 Chronic Myelogenous Leukemia Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT00529763 - Active, not recruiting - -
NCT00042016 Chronic Myelogenous Leukemia Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States Scripps Clinic Escondido, California, United States USC/Norris Cancer Center Los Angeles, California, United States United States, Minnesota Metro-Minnesota CCOP St. Louis Park, Minnesota, United States United States, New York New York Medical College Valhalla, New York, United States United States, South Carolina Liberty Hematology/Oncology Columbia, South Carolina, United States United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT00101816 - Completed - -
NCT00661180 Chronic Myelogenous Leukemia Phase 2 Completed - United States, Oregon ... More >> Portland, Oregon, United States, 97239 France Lyon Cedex, France, 69437 Paris, France, 75010 Poitiers Cedex, France, 86021 Less <<
NCT00644878 Chronic Myelogenous Leukemia -... More >> Chronic Phase Less << Phase 4 Completed - United States, California ... More >> USC Norris Cancer Center Jane Anne Nohl Los Angeles, California, United States, 90033 United States, Florida Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch Miami Shores, Florida, United States, 33138 United States, Georgia Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States, 30912 United States, Idaho Kootenai Medical Center Dept.ofKootenai Med.Ctr. Coeur d'Alene, Idaho, United States, 83814 United States, Indiana Indiana Blood and Marrow Institute Beach Grove, Indiana, United States, 46107 United States, Iowa University of Iowa Hospitals & Clinics Univ of Iowa Hosp & Clinic Iowa City, Iowa, United States, 52242 United States, Louisiana LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States, 70115 United States, Maryland St. Agnes Hospital Baltimore, Maryland, United States, 21229 United States, New York Montefiore Medical Center Medical Center Bronx, New York, United States, 10467 SUNY Upstate Medical Center Syracuse, New York, United States, 13210 Westchester Medical Center Munger Pavillion (2) Valhalla, New York, United States, 10595 United States, North Carolina Wake Forest University Baptist Medical Center Hematology and Oncology Winston-Salem, North Carolina, United States, 27157 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29615 United States, Tennessee University of Tennessee Cancer Institute Cancer Institute Memphis, Tennessee, United States, 38104 United States, Texas South Texas Institute of Cancer S. Tex Inst.- Corpus Christi Corpus Christi, Texas, United States, 78405 Baylor College of Medicine - Breast Care Dan L Duncan Cancer Ctr Houston, Texas, United States, 77030 United States, Utah Central Utah Clinic Central Utah Clinic (7) Provo, Utah, United States, 84604 United States, Wisconsin Froedert Memorial Lutheran Hospital Dept.ofFroedert Memorial Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01110668 Gastrointestinal Stromal Tumor Phase 2 Completed - Turkey ... More >> Novartis Investigative Site Adana, Turkey Novartis Investigative Site Ankara, Turkey Novartis Investigative Site Istanbul, Turkey Novartis Investigative Site Izmir, Turkey Less <<
NCT00101816 Chronic Myeloid Leukemia ... More >> Blast Crisis Less << Phase 2 Completed - -
NCT01394666 - Completed - -
NCT00866736 Chronic Myeloid Leukemia Phase 2 Completed - Japan ... More >> Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan, 113-8677 Less <<
NCT01901666 Chronic Myelogenous Leukemia ... More >> Short Stature Less << Phase 4 Unknown December 2014 India ... More >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, UT, India, 160012 Contact: anil bhansali, MBBS,MD,DM    9316977995    anilbhansaliendocrine@rediffmail.com Less <<
NCT01368523 Chronic Myelogenous Leukemia Phase 4 Completed - Poland ... More >> Novartis Investigative Site Gdansk, Poland Novartis Investigative Site Poznan, Poland Novartis Investigative Site Warsaw, Poland Less <<
NCT01524848 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Denmark ... More >> Aarhus University Hospital, dept. of Oncology Aarhus, Denmark, DK-8000 Aarhus C Herlev Hospital, dept. of Oncology Herlev, Denmark, 2730 Finland Helsinki University Hospital, dept. of oncology Helsingfors, Finland, FI-00029 Kuopio University Hospital Cancer Center Kuopio, Finland, FI-70029 Germany Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg Berlin, Germany, 13125 Universitätsklinikum Essen, Innere klinik und Poliklinik Essen, Germany, DE-45122 Studienzentrale chirurgische klinik, Universitäts medizin Mannheim Mannheim, Germany, DE-68167 Norway Dept of Oncology, Haukeland University Hospital Bergen, Norway, N-5021 Norwegian Radium Hospital Oslo, Norway, N-0310 Dept of Oncology, St Olav Hospital Trondheim, Norway, N-7006 Sweden Dept of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden, SE-413 45 Dept of Oncology, Linköping University Hospital Linköping, Sweden, SE-581 85 Dept of Oncology, Skane University Hospital Lund, Sweden, SE-221 85 Radiumhemmet, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Dept of Oncology, Norrland University Hospital Umeå, Sweden, SE-901 85 Dept of Oncology, Academic Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT01279473 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan Less <<
NCT01478373 - Completed - -
NCT01215487 - Recruiting October 2019 Canada, British Columbia ... More >> Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT01562847 - Unknown June 2015 Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT01206088 CML Nilotinib... More >> Imatinib Resistant Imatinib Intolerant Less << Phase 4 Completed - Korea, Republic of ... More >> St. Mary hospital, Catholic medical center Seoul, Korea, Republic of Less <<
NCT00982488 Leukemia Phase 2 Completed - -
NCT01478373 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Finland ... More >> Novartis Investigative Site HUS, Finland, FIN-00029 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Torino, TO, Italy, 10153 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Novartis Investigative Site Barcelona, Spain, 08041 Less <<
NCT00413270 - - - Canada, Alberta ... More >> Novartis Investigative Site Calgary, Alberta, Canada Novartis Investigative Site Edmonton, Alberta, Canada Canada, British Columbia Novartis Investigative Site Burnaby, British Columbia, Canada Novartis Investigative Site Vancouver, British Columbia, Canada Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada Canada, Newfoundland and Labrador Novartis Investigative Site St. John's, Newfoundland and Labrador, Canada Canada, Nova Scotia Novartis Investigative Site Halifax, Nova Scotia, Canada Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada Novartis Investigative Site Hamilton, Ontario, Canada Novartis Investigative Site London, Ontario, Canada Novartis Investigative Site Oshawa, Ontario, Canada Novartis Investigative Site Ottawa, Ontario, Canada Novartis Investigative Site Toronto, Ontario, Canada, q Novartis Investigative Site Windsor, Ontario, Canada Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada Novartis Investigative Site Sherbrooke, Quebec, Canada Canada, Saskatchewan Novartis Investigative Site Saskatoon, Saskatchewan, Canada Canada Novartis Investigative Site Quebec, Canada Less <<
NCT00718562 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Niigata-city, Niigata, Japan, 951-8520 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT00688766 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Terminated(Based on Independen... More >>t Data Monitoring Committee (IDMC) recommendation.) Less << - -
NCT03673501 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Not yet recruiting March 2022 United States, Georgia ... More >> Georgia Cancer Specialists Not yet recruiting Sandy Springs, Georgia, United States, 30342 Contact: Gina D'Amato Less <<
NCT00793871 Gastrointestinal Neoplasms, Ga... More >>strointestinal Stromal Tumors Less << Phase 4 Completed - China, Jiangsu ... More >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 Less <<
NCT00493181 - Completed - -
NCT00982488 - Completed - -
NCT00264160 Leukemia, Myeloid, Chronic Phase 2 Phase 3 Completed - Israel ... More >> Novartis Investigative Site Haifa, Israel Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Petach Tikva, Israel Novartis Investigative Site Tel Hashomer, Israel Less <<
NCT00793871 - Completed - -
NCT01694277 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Recruiting December 2022 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33000 Less <<
NCT00493181 Leukemia Chro... More >>nic Myelogenous Leukemia Chronic Myeloid Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00302016 - - - -
NCT00199186 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Lymphoid Blastic Phase of Chronic Myeloid Leukemia Less << Phase 2 Unknown - Germany ... More >> Medizinische Klinik II, Johann Wolfgang Goethe Universität Recruiting Frankfurt/Main, Germany, 60590 Contact: Oliver G Ottmann, M.D.    ++49-69-6301-0 ext 6221    ottmann@em.uni-frankfurt.de Less <<
NCT00323791 Kidney Cancer Phase 2 Terminated(slow accrual) - United States, New Jersey ... More >> Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Less <<
NCT00482703 - Completed - -
NCT01289028 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 155226 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Halle/'Saale, Germany, 06120 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Taormina, ME, Italy, 98039 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Padova, PD, Italy, 35100 Novartis Investigative Site Aviano, PN, Italy, 33081 Novartis Investigative Site Torino, TO, Italy, 10153 Less <<
NCT01003054 Chronic Myelogenous Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77070 Less <<
NCT01440959 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 Less <<
NCT01440959 - Completed - -
NCT02398825 Chronic Myeloid Leukemia ... More >> Chronic Phase Adults Less << Phase 2 Recruiting December 2020 Italy ... More >> Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi Recruiting Ancona, Italy Contact: Serena Rupoli          Principal Investigator: Serena Rupoli          Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Recruiting Bologna, Italy, 40138 Contact: Gianantonio Rosti, Dr.          Principal Investigator: Gianantonio Rosti, Dr.          Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Recruiting Catania, Italy Contact: Fabio Stagno          Principal Investigator: Fabio Stagno          Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano Recruiting Milano, Italy Contact: Alessandro Iurlo          Principal Investigator: Alessandro Iurlo          Milano Unità Trapianto di Midollo Ist. Nazionale Tumori Recruiting Milano, Italy Contact: Francesco Spina          Principal Investigator: Francesco Spina          Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto Recruiting Piacenza, Italy Contact: Daniele Vallisa          Principal Investigator: Daniele Vallisa Less <<
NCT00482703 Myeloid Leukemia, Chronic Phase 1 Phase 2 Completed - Japan ... More >> Local Institution Nagoya, Aichi, Japan, 464-8681 Local Institution Nishinomiya-Shi, Hyogo, Japan, 663-8501 Local Institution Kagoshima-Shi, Kagoshima, Japan, 890-0064 Local Institution Isehara-Shi, Kanagawa, Japan, 259-1193 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 431-3192 Local Institution Bunkyo-Ku, Tokyo, Japan, 113-8677 Local Institution Chuo-Ku, Tokyo, Japan, 104-0045 Local Institution Shibuya-Ku, Tokyo, Japan, 150-8935 Local Institution Kyoto, Japan Less <<
NCT00130195 Acute Lymphoblastic Leukemia Phase 2 Completed - Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan, 466-8550 Less <<
NCT00006053 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT02001818 Chronic Myeloid Leukaemia Phase 2 Recruiting December 2021 Australia, South Australia ... More >> Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Tim Hughes, MBBS, MD,FRACP, FRCPA    +61 8 822 3330    timothy.hughes@health.sa.gov.au    Principal Investigator: Tim Hughes, MBBS, MD, FRACP, FRCPA Less <<
NCT01289028 - Completed - -
NCT01227135 Leukemia Phase 2 Unknown - United Kingdom ... More >> Royal Liverpool University Hospital Recruiting Liverpool, England, United Kingdom, L7 8XP Contact: Contact Person    44-151-706-4297    r.e.clark@liverpool.ac.uk    Imperial College London Recruiting London, England, United Kingdom, W12 0HS Contact: Contact Person    44-20-8383-1627    d.marin@imperial.ac.uk    Gartnavel General Hospital Recruiting Glasgow, Scotland, United Kingdom, G12 0YN Contact: Contact Person    44-141-301-7881    t.holyoake@clinmed.gla.ac.uk Less <<
NCT03426722 Gastrointestinal Stromal Tumor... More >>s (GISTs) Less << Phase 3 Recruiting March 31, 2020 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Yoon-Koo Kang, MD, PhD Less <<
NCT00258271 Leukemia Phase 1 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01091207 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135710 Less <<
NCT00293124 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Austria ... More >> AKH, Universitätsklinik für Innere Medizin 1 Vienna, Austria, 1090 Bosnia and Herzegovina Institute of Oncology Sarajevo Sarajevo, Bosnia and Herzegovina Bulgaria SBALO National Oncology Center Sofia, Bulgaria, 1527 National Oncological Center Hospital Sofia, Bulgaria Sofia Cancer Center compl. Mladost , Sofia, Bulgaria Croatia Clinical Hospital Split, Center of Oncology Split, Croatia University Hospital Rebro Zagreb, Croatia Czech Republic FN Bulovka Prague, Czech Republic, 186 00 Radioterapeticko-onkologicke. Oddeleni FN Motol Prague, Czech Republic Lithuania Lithuanian Oncology Center, Vilnius, Lithuania Romania Institutul Oncologic Bucuresti Bucuresti, Romania Institutul Oncologic Cluj Cluj-Napoca, Romania, 400015 Emergency Clinical County Hospital , Clin Oncol. Dep Craiova, Romania Serbia Institut za onkologiju i Beograd, Serbia Slovakia National Institute of Oncology Bratislava, Slovakia Slovenia Oncology Institute Ljubljana Ljubljana, Slovenia Less <<
NCT03092128 - Recruiting June 2020 China, Guangdong ... More >> Institute of Clinical Pharmacology, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Wei Zhuang, Ph. D    86-13427526343    zhuangw@mail2.sysu.edu.cn    Contact: Min Huang, Professor    +86 020 87331409 ext 101    huangmin@mail.sysu.edu.cn Less <<
NCT00777036 Leukemia Phase 2 Active, not recruiting September 23, 2021 -
NCT00276926 Hypereosinophilic Syndrome|Chr... More >>onic Eosinophilic Leukemia (CEL)|Myeloproliferative Disorders Less << PHASE2 UNKNOWN - Istituto di Ematologia e Oncol... More >>ogia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna, Bologna, 40138, Italy|Dipartimento di Medicina Interna - Università di Genova, Genova, 16100, Italy|Dipartimento di Biochimica e Biotecnologie Mediche - Università degli Studi di Napoli "Federico II", Napoli, 80131, Italy|Divisione di Ematologia - Università degli Studi di Napoli "Federico II", Napoli, 80131, Italy|S.C. Medicina Interna II ed Ematologia - Laboratorio di Medicina Interna e Molecolare - A.O. San Luigi, Orbassano, 10043, Italy|Divisione di Ematologia - IRCCS Policlinico S. Matteo, Pavia, 27100, Italy|U.O. Ematologia - Dipartimento di Oncologia ed Ematologia, Presidio Ospedaliero di Ravenna, Ravenna, 48100, Italy|U.O. Ematologia - Arcispedale Santa Maria Nuova, Reggio Emilia, 42100, Italy|Cattedra di Ematologia - Università "Tor Vergata", Roma, 00133, Italy|Cattedra di Ematologia - Università "La Sapienza", Roma, 00161, Italy|Divisione di Ematologia - Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013, Italy|U.O.C. Ematologia e Trapianti - Policlinico "Le Scotte", Siena, 53100, Italy|U.O. Medicina II Divisione - Ospedale Santa Chiara, Trento, 38100, Italy|Clinica Ematologica - Policlinico Universitario, Udine, 33100, Italy Less <<
NCT00511121 Chronic Myeloid Leukemia Phase 2 Terminated - -
NCT01392469 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - United States, Florida ... More >> Novartis Investigative Site Tampa, Florida, United States, 33606 Novartis Investigative Site Weston, Florida, United States, 33331 United States, New York Novartis Investigative Site Mineola, New York, United States, 11501 Australia, New South Wales Novartis Investigative Site Darlinghurst, New South Wales, Australia, 2010 Belgium Novartis Investigative Site Bruxelles, Belgium, 1070 Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Berlin, Germany, 12683 Novartis Investigative Site Hannover, Germany, 30625 Italy Novartis Investigative Site Roma, RM, Italy, 00161 Lithuania Novartis Investigative Site Vilnius, Lithuania, LT-08661 United Kingdom Novartis Investigative Site London, United Kingdom, NW3 2PR Less <<
NCT00388895 Acute Lymphoblastic Leukemia ... More >> Cromosome Philadelphia Positive Less << Phase 2 Completed - Spain ... More >> Clínica Universitaria de Navarra Pamplona, Navarra, Spain Hospital General de Alicante Alicante, Spain Hospital "Duran I Reynals" Barcelona, Spain Hospital "Santa Creu i Sant Pau" Barcelona, Spain Hospital Clínico y Provincial de Barcelona Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Germans Trias i Pujol Barcelona, Spain Hospital Universitario "Germans Trias i Pujol" Barcelona, Spain Hospital Valle Hebrón-Materno Infantil Barcelona, Spain Hospital Valle Hebrón Barcelona, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Juan Canalejo La Coruña, Spain Fundación Jiménez Díaz Madrid, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Gregorio Marañón Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital General Universitario Morales Meseguer. Murcia, Spain . Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain Hospital Carlos Haya Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Dureta Palma de Mallorca, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitario Marqués de Valdecilla Santander, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Clínico de Valencia Valencia, Spain Hospital La Fe Valencia, Spain Less <<
NCT00349518 Chronic Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 2 Phase 3 Withdrawn - Hungary ... More >> Local Institution Budapest, Hungary Italy Local Institution Bologna, Italy Local Institution Orbassano (To), Italy Local Institution Roma, Italy Netherlands Local Institution Nijmegen, Netherlands Local Institution Rotterdam, Netherlands Poland Local Institution Gdansk, Poland Local Institution Katowice, Poland Local Institution Krakow, Poland Local Instiution Lodz, Poland Local Institution Lublin, Poland Local Institution Warsaw, Poland Russian Federation Local Institution Moscow, Russian Federation Local Institution St.Petersburg, Russian Federation United Kingdom Local Institution Cambridge, Cambridgeshire, United Kingdom Local Institution Glasgow, Central, United Kingdom Local Institution London, Greater London, United Kingdom Local Institution Liverpool, Merseyside, United Kingdom Local Institution Newcastle, Tyne And Wear, United Kingdom Local Institution Birmingham, West Midlands, United Kingdom Less <<
NCT00006052 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT00777036 - Active, not recruiting - -
NCT00618501 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00297570 Leukemia, Myeloid, Philadelphi... More >>a-Positive Less << Phase 3 Unknown - Israel ... More >> Department of Hematology, Sheba Medical Center Recruiting Tel-Hashomer, Israel, 52621 Principal Investigator: Izhar Hardan, MD Less <<
NCT00045422 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00006357 Endometrial Cancer ... More >> Gastrointestinal Stromal Tumor Ovarian Cancer Sarcoma Small Intestine Cancer Less << Phase 1 Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Aarhus Kommunehospital Aarhus, Denmark, DK-8000 Rigshospitalet Copenhagen, Denmark, 2100 Herlev Hospital - University Hospital of Copenhagen Herlev, Denmark, DK-2730 France Centre Leon Berard Lyon, France, 69373 Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Academisch Ziekenhuis Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA United Kingdom Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT01762969 CML Phase 2 Recruiting January 2020 Israel ... More >> Rabin Medical Center Recruiting Petah tikva, Israel, 49100 Contact: Liat vid       vidallit@yahoo.com    Contact: Ofer , Shpilberg Less <<
NCT00006475 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT01491763 Acute Lymphoblastic Leukemia P... More >>h Positive Less << PHASE4 UNKNOWN 2025-12-22 Hospital Central de Asturias, ... More >>Oviedo, Asturias, Spain|H. Son Llatzer, Palma de Mallorca, Baleares, Spain|Hospital Germans Trias i Pujol and all Hospital Pethema, Badalona, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Canarias, Tenerife, Canarias, Spain|Hospital general de Castellón, Castello, Castellón, Spain|Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coru?a, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Hospital de Navarra, Pamplona, Navarra, Spain|Hospital General de Albacete, Albacete, Spain|Hospital de Alcorcón, Alcorcón, Spain|Hospital General de Alicante., Alicante, Spain|Hospital de Cabue?es, Asturias, Spain|Hospital de Badalona Germans Trias i Pujol, Badalona, Spain|Hospital Clinic y Provincial de Barcelona, Barcelona, Spain|Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau., Barcelona, Spain|Hospital de la Santa Creu i Sant Pau., Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital de la santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Duran i Reynals - ICO L'Hospitalet, Barcelona, Spain|Basurtuko Ospitalea, Basurto, Spain|Complejo Hospitalario de Cáceres, Cáceres, Spain|Complejo Hospitalario Reina Sofía, Córdoba, Spain|Area Hospitalaria Juan Ramón Jimenez, Huelva, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital del SAS de Jerez de la Frontera, Jerez de la Frontera, Spain|Hospital general de Jerez de la Frontera, Jerez de la Frontera, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Complexo Hospitalario Xeral-Calde, Lugo, Spain|Clínica La Concepción, Madrid, Spain|Clínica Puerta de Hierro, Madrid, Spain|Hospital 12 de Octubre. Madrid, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital de Fuenlabrada, Madrid, Spain|Hospital de la Princesa, Madrid, Spain|Hospital de Madrid, S.A.- Norte Hospital General, Madrid, Spain|Hospital Gregorio Mara?ón, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario Princcipe de Asturias, Madrid, Spain|Althaia, Xarxa Asistencial de Manresa, Manresa, Spain|Hospital General Univeristario Morales Messeguer, Murcia, Spain|Hospital Sta. Maria del Rosell, Murcia, Spain|. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital de Mérida, Mérida, Spain|Hospital del Río Carrión, Palencia, Spain|Hospital de Gran Canaria Doctor Negrín, Palma De Gran Canaria, Spain|Clínica Universitaria de Navarra, Pamplona, Spain|Hospital de Montecelo, Pontevedra, Spain|Corporació Sanitaria Parc Taulí, Sabadell, Spain|Hospital Clínico de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario, Salamanca, Spain|Hospital de Donostia, San Sebastián, Spain|Hoaspital Marqués de Valdecilla, Santander, Spain|Hospital General de Segovia, Segovia, Spain|Complejo Hospitalario Regional Virgen del Rocío, Sevilla, Spain|Hospital Joan XIII de, Tarragona, Spain|Hospital Joan XXIII, Tarragona, Spain|Hospital Clínico de Valencia., Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario, Valencia, Spain|Hospital Clínic, Valencia, Spain|Hospital Dr Pesset, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico de Valladolid, Valladolid, Spain|Complejo Hospitalario Xeral-Cies, Vigo, Spain|Hospital do Meixoeiro, Vigo, Spain|Hospital Txagorritxu, Vitoria, Spain|Hospital Clínico Lozano Blesa, Zaragoza, Spain Less <<
NCT01506336 Gastro Intestinal Stromal Tumo... More >>r Less << Phase 2 Completed - France ... More >> Institute Gustave Roussy (IGR) Villejuif, France, 94815 Less <<
NCT00045604 Lung Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00028847 Leukemia Phase 1 Phase 2 Unknown - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Clinique Universitaire De Mont-Godinne Mont-Godinne Yvoir, Belgium, 5530 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 10P 1HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 RC Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, 6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00053248 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> UCLA Department of Medicine, Division of Hematology/Oncology Los Angeles, California, United States, 90095 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT00180830 Cancer Phase 2 Terminated - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 Netherlands Emma Kinderziekenhuis AMC Amsterdam, Netherlands, 1100 DE United Kingdom Birmingham Children’s Hospital Birmingham, United Kingdom, B4 6NH Less <<
NCT00039377 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Less << Phase 2 Completed - -
NCT00039377 - Completed - -
NCT01650805 Chronic Myeloid Leukemia Phase 3 Terminated(Study terminated ba... More >>sed on evaluation of safety data.) Less << - -
NCT01650805 - Terminated(Study terminated ba... More >>sed on evaluation of safety data.) Less << - -
NCT00812240 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - -
NCT00354068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00744081 AML Phase 2 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany Less <<
NCT00052494 Lung Cancer Phase 1 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00362466 Leukemia Phase 3 Terminated(Insufficient Enroll... More >>ment) Less << - -
NCT00573378 Chronic Myeloid Leukemia Phase 2 Withdrawn October 2016 United States, Michigan ... More >> Universtiy of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00112775 Leukemia Phase 2 Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00362466 - Terminated(Insufficient Enroll... More >>ment) Less << - -
NCT00219739 Chronic Myeloid Leukemia Phase 3 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00103844 - Completed - -
NCT02949570 CML, Chronic Phase Phase 2 Unknown April 2018 France ... More >> CHU Côte de Nacre Recruiting Caen, France, 14033 Contact: Hyacinthe Johnson- Ansah, MD    +33-2-31-27-25-39    johnsonansah-a@chu-caen.fr Less <<
NCT01907607 Advanced Gastrointestinal Stro... More >>mal Tumors Less << Phase 2 Active, not recruiting April 2019 France ... More >> Institut Bergonié Bordeaux, Gironde, France, 33076 Centre Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital de la Timone - AP-HM Marseille, France, 13385 Centre René Gauducheau Nantes, France, 44805 Hôpital Saint-Antoine (AP-HP) Paris, France, 75571 CHU de REIMS - Hôpital Robert Debré Reims, France, 51092 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00064285 Leukemia Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Ohio Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-5047 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00103844 Chronic Myeloid Leukemia ... More >> Philadelphia-Positive Myeloid Leukemia Less << Phase 2 Completed - -
NCT01025505 Treatment Ste... More >>m Cell Transplantation Less << Phase 2 Active, not recruiting December 2018 Italy ... More >> Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy Dipartimento Area Medica P.O. Ascoli Piceno, Italy, 63100 UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Ospedali Riuniti Bergamo, Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Sezione di Ematologia e Trapianti Spedali Civili Brescia, Italy, 21125 Osp. Reg. A. Di Summa Brindisi, Italy Servizio di Ematologia - CTMO - ASL 8 P.O. Binaghi Cagliari, Italy Ospedale Ferrarotto Catania, Italy, 95124 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Ospedale Niguarda "Ca' Granda" Milano, Italy, 20122 Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Ospedale di Rilievo Nazionale "A. Cardarelli" Napoli, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Ospedale S. Luigi Gonzaga Orbassano, Italy, 10043 Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy Ospedali Riuniti 'Villa Sofia-Cervello' Palermo, Italy Div. di Ematologia IRCCS Policlinico S. Matteo Pavia, Italy, 27100 Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore Pesaro, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy, 65100 Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S.Maria delle Croci Ravenna, Italy, 48100 Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Rimini Ospedale "Infermi" Rimini, Italy Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy, 00184 Università degli Studi - Policlinico di Tor Vergata Roma, Italy, 21100 U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SCDO Ematologia 2 AOU S.Giovanni Battista Torino, Italy Policlinico Universitario - Clinica Ematologia Udine, Italy, 33100 Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT00471328 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - -
NCT00538109 Leukemia, Myeloid, Chronic Not Applicable Completed - -
NCT01805843 - Completed - Austria ... More >> Medical University of Graz, Division of Pulmonology Graz, Austria, 8036 Less <<
NCT00471328 - Completed - -
NCT01690065 Chronic Myeloid Leukemia in My... More >>eloid Blast Crisis Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting December 2019 Korea, Republic of ... More >> Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Wook Kim, M.D., Ph.D.       dwkim@catholic.ac.kr    Principal Investigator: Dong-Wook Kim, M.D., Ph.D.          Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 682714 Principal Investigator: Hawk Kim, M.D., Ph.D.          Sub-Investigator: Jae-Hoo Park, M.D., Ph.D.          Sub-Investigator: Jae-Cheol Jo, M.D., Ph.D. Less <<
NCT00131274 Idiopathic Pulmonary Fibrosis ... More >> Lung Disease Pulmonary Fibrosis Less << Phase 2 Phase 3 Completed - -
NCT01099514 Metastatic Melanoma With KIT A... More >>berration Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Cancer Center Seoul, Korea, Republic of Less <<
NCT00481052 Chronic Myeloid Leukemia Phase 2 Active, not recruiting December 2018 Italy ... More >> Dipartimento Area Medica P.O. Ascoli Piceno, Italy, 63100 Unità Operativa Ematologica - Università degli Studi di Bari Bari, Italy, 70124 Ospedali Riuniti Bergamo, Italy, 24100 stituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Sezione di Ematologia e Trapianti Spedali Civili Brescia, Italy, 21125 Azienda Spedali Civili Brescia, Italy, 25100 ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Ospedale S. Luigi Gonzaga Orbassano, Italy, 10043 La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello Palermo, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S.Maria delle Croci Ravenna, Italy, 48100 Calabria Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Università La Cattolica del Sacro Cuore Roma, Italy, 00168 Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy, 00184 Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Policlinico Universitario - Clinica Ematologia Udine, Italy, 33100 Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT03264794 Non-small Cell Lung Cancer Phase 4 Not yet recruiting June 2022 -
NCT00973752 - Completed - -
NCT00973752 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01744665 CML Phase 2 Active, not recruiting February 1, 2021 -
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01005914 - Terminated(Increased rate of b... More >>acterial infections) Less << - -
NCT01397734 Chronic Myelogenous Leukemia Phase 1 Terminated(Lack of enrollment ... More >>and limited funding) Less << - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03023046 Adult Acute Lymphoblastic Leuk... More >>emia Adult Lymphoblastic Lymphoma Philadelphia Chromosome Positive Less << Phase 2 Recruiting December 1, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ryan D. Cassaday    206-606-1202    cassaday@seattlecca.org    Principal Investigator: Ryan D. Cassaday Less <<
NCT01073644 - Terminated(The study was prema... More >>turely discontinued due to poor recruitment on 18th April 2013. There were no safety concerns that led to the decision to terminate.) Less << - Philippines ... More >> Chong Hua Hospital Cebu City, Philippines Private Clinic Manila, Philippines Less <<
NCT00860535 Blast Phase Philadelphia Chrom... More >>osomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL) Less << Phase 1 Terminated - -
NCT02538926 B Acute Lymphoblastic Leukemia... More >> B Lymphoblastic Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent B Lymphoblastic Lymphoma Recurrent T Lymphoblastic Leukemia/Lymphoma Refractory B Lymphoblastic Lymphoma Refractory T Lymphoblastic Lymphoma T Acute Lymphoblastic Leukemia T Lymphoblastic Lymphoma Less << Phase 2 Withdrawn(Drugs unavailable) July 30, 2021 United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT01005914 Leukemia Phase 2 Terminated(Increased rate of b... More >>acterial infections) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01613053 - - - China, Sichuan ... More >> Novartis Investigative Site Chengdu, Sichuan, China, 610041 China Novartis Investigative Site Guang zhou, China, 510080 Novartis Investigative Site Shanghai, China, 200025 Less <<
NCT00815321 Chronic Myeloid Leukemia Phase 2 Completed - Singapore ... More >> Dept of Haematology, Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT00469014 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Chronic Myeloid Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00769782 Gastrointestinal Stromal Tumor... More >> Metastatic Cancer Less << Phase 2 Completed - Japan ... More >> Aichi Cancer Center Nagoya, Aichi, Japan, 464-8681 Aichi Medical University Nagoya, Aichi, Japan, 480-1195 Hirosaki University, School of Medicine Hirosaki, Aomori, Japan, 036-8562 National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan, 737-0023 Hokkaido University Hospital Sapporo, Hokkaido, Japan, 060-8648 Iwate Medical University Hospital Morioka, Iwate, Japan, 020-8505 Kanagawa Cancer Center Yokohama, Kanagawa, Japan, 241-0815 International Goodwill Hospital Yokohama, Kanagawa, Japan, 245-0006 Kochi Medical School Nankoku, Kochi, Japan, 783-8505 Kyoto Second Red Cross Hospital Kanigyou-ku, Kyoto, Japan, 602-8026 University of Miyazaki Hospital Kiyotake, Miyazaki, Japan, 889-1692 Niigata Prefectural Central Hospital Joetsu, Niigata, Japan, 943-0192 Nagaoka Chuo General Hospital Nagaoka, Niigata, Japan, 940-8653 Kawasaki Medical School Kurashiki, Okayama, Japan, 701-01 Ryukyu University Hospital Nishiharacho, Okinawa, Japan, 903-0215 Sakai Municipal Hospital Sakai, Osaka, Japan, 590-0064 Osaka University Hospital Suita, Osaka, Japan, 565-0871 Toyonaka Municipal Hospital Toyonaka, Osaka, Japan, 560-8565 Saitama Medical University International Medical Center Hidaka, Saitama, Japan, 350-1241 Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan, 431-3192 University of Yamanashi Hospital Chuo, Yamanashi, Japan, 409-3898 Kyushu University Hospital Fukuoka, Japan, 812-8582 Fukushima Medical University Hospital Fukushima, Japan, 960-1295 Kagoshima University Kagoshima, Japan, 890-8520 Kimitsu Chuo Hospital Kisarazu-city, Japan, 292-8535 Kochi Health Sciences Center Kochi, Japan, 781-8555 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Niigata University Medical and Dental Hospital Niigata, Japan, 951-8510 Niigata Cancer Center Hospital Niigata, Japan, 951-8566 Okayama University Hospital Okayama, Japan, 700-8558 Juntendo University Shizuoka Hospital Shizuoka, Japan, 410-2295 Shizuoka Cancer Center Shizuoka, Japan, 411-8777 Tokushima University Hospital Tokushima, Japan, 770-8503 Tokyo Metropolitan - Komagome Hospital Tokyo, Japan, 113-0021 Keio University Hospital Tokyo, Japan, 160-8582 Toyama University Hospital Toyama, Japan, 930-0194 Yamagata University Hospital Yamagata, Japan, 990-9585 Less <<
NCT00860535 - Terminated - -
NCT02401815 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Active, not recruiting March 2020 United States, Florida ... More >> Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States, 33136 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio OSU Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT01459757 - Completed - -
NCT00094029 - - - -
NCT02342600 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Withdrawn(Supporting company w... More >>ithdrew interest) Less << - -
NCT00618319 GIST Phase 2 Completed - United States, California ... More >> Reseach Facility Encinitas, California, United States Research Site Santa Monica, California, United States, 90404 United States, Texas Reseach Facility San Antonio, Texas, United States Less <<
NCT02269267 Leukemia, Myeloid, Chronic Phase 2 Active, not recruiting December 2021 United States, California ... More >> Helen Diller Family Comprehensive Cancer Center University of California San Francisco, California, United States, 94143 United States, Florida Moffit Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 United States, Massachusetts Beth Israel Deaconess Medical Center (Satellite site of Dana Farber) Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute of Wayne State University Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Weill Medical College of Cornell University New York, New York, United States, 10021 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77054 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132-2408 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 United States, Wisconsin Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01039519 Gastrointestinal Stromal Tumor Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health and Science University-Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00466726 Leukemia Phase 2 Completed - Italy ... More >> Universita Degli Studi di Bari Bari, Italy, 70124 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia Brescia, Italy Università di Catania - Cattedra di Ematologia - Ospedale 'Ferrarotto' Catania, Italy Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Federico II University Medical School Naples, Italy, 80131 S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Azienda Ospedale S. Luigi at University of Torino Orbassano, Italy, 10043 spedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Ospedale Sant' Eugenio Rome, Italy, 00144 Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Unità Operativa di Oncologia - Presidio Ospedaliero N. Giannetasio - Azienda ASL 3 Rossano, Italy Ematologia - Dipartimento di Medicina Clinica e Sperimentale Sassari, Italy Nouvo Policlinico "LE SCOTTE' Siena, Italy, 53100 Policlinico Universitario Udine Udine, Italy, 33100 Less <<
NCT00089960 Gastrointestinal Cancer Phase 2 Completed - -
NCT01039519 - Completed - -
NCT00457743 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Suita, Osaka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Less <<
NCT01646593 - - - -
NCT00457743 - Completed - -
NCT01689376 - - - -
NCT00466726 - Completed - -
NCT01169753 - Terminated(Slow Enrollment) - -
NCT01169753 Chronic Myeloid Leukemia Not Applicable Terminated(Slow Enrollment) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT01743300 Healthy Phase 1 Completed - -
NCT00363649 Leukemia Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00363649 - Completed - -
NCT02268370 Chronic Myeloid Leukemia Phase 2 Active, not recruiting October 2021 Canada, Alberta ... More >> Tom Baker Cancer Center Calgary, Alberta, Canada University of Alberta Hospital Edmonton, Alberta, Canada Canada, British Columbia Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z1M9 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Ottawa General Hospital Ottawa, Ontario, Canada Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Centre Hôpitallier Universitaire de Quebec - Hôpital de l'Enfant-Jésus Charlesbourg, Quebec, Canada Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada McGill University Health Centre Montreal, Quebec, Canada Less <<
NCT02108951 Philidelphia Positive Chronic ... More >>Myeloid Leukaemia Less << Phase 3 Terminated(Study was terminate... More >>d because of slow recruitment) Less << - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2605 Australia, New South Wales Novartis Investigative Site Kingswood, New South Wales, Australia, 2747 Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site St. Leonards, New South Wales, Australia, 2065 Australia, Queensland Novartis Investigative Site Douglas, Queensland, Australia, 4810 Novartis Investigative Site Nambour, Queensland, Australia, 4560 Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Fitzroy, Victoria, Australia, 3065 Novartis Investigative Site Geelong, Victoria, Australia, 3220 Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Australia, Western Australia Novartis Investigative Site Murdoch, Western Australia, Australia, 6150 Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Less <<
NCT01244750 - Active, not recruiting August 30, 2020 -
NCT01312818 - Terminated(Slow accrual) - -
NCT01312818 Acute Lymphoblastic Leukemia Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University if Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00811070 Chronic Myelogenous Leukemia Phase 2 Completed - Japan ... More >> Tohoku University Hospital Sendai-city, Miyagi, Japan, 980-8574 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Toyohashi Municipal Hospital Aichi, Japan, 441-8570 Japanese Red Cross Nagoya First Hospital Aichi, Japan, 453-8511 Aichi Cancer Center Aichi, Japan, 464-8681 Akita University Hospital Akita, Japan, 010-8543 Chiba University Hospital Chiba, Japan, 260-8677 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Harasanshin Hospital Fukuoka, Japan, 812-0033 Kobe City Medical Center General Hospital Hyogo, Japan, 650-0047 Hospital of Hyogo College of Medicine Hyogo, Japan, 663-8501 Kanazawa University Hospital Ishikawa, Japan, 920-8641 Tokai University Hospital Kanagawa, Japan, 259-1193 Kumamoto University Hospital Kumamoto, Japan, 860-8556 University Hospital,Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Okayama University Hospital Okayama, Japan, 700-8558 Osaka University Hospital Osaka, Japan, 565-0871 Kinki University School of Medicine Osaka, Japan, 589-8511 Saga University Hospital Saga, Japan, 846-8501 Hamamatsu Medical Univ. HP Faculty of Medicine Shizuoka, Japan, 431-3192 Tokyo Metropolitan Cancer&Infectious disease Ctr Komagome Hp Tokyo, Japan, 113-8677 Japanese Red Cross Medical Center Tokyo, Japan, 150-8935 Jikei University Hospital Daisan Tokyo, Japan, 201-8601 Less <<
NCT00811070 - Completed - -
NCT01751425 Chronic Myelogenous Leukemia, ... More >>BCR-ABL1 Positive Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission Minimal Residual Disease Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Less << Phase 1 Phase 2 Recruiting July 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge E. Cortes    713-794-5783       Principal Investigator: Jorge E. Cortes Less <<
NCT01490983 Chronic Myeloid Leukemia Not Applicable Terminated(Terminated due to l... More >>ack of funding) Less << - United States, North Carolina ... More >> UNC Healthcare Chapel Hill, North Carolina, United States, 27599 Rex Cancer Center Raleigh, North Carolina, United States, 27607 Rex Cancer Center - Wakefield Raleigh, North Carolina, United States, 27614 Less <<
NCT03205267 Chronic Myelogenous Leukaemia Phase 2 Recruiting October 2019 Germany ... More >> University Hospital Bonn Recruiting Bonn, Germany, 53127 Contact: Dominik Wolf, Prof. Dr.    +49 228 287 17233    dominik.wolf@ukb.uni-bonn.de Less <<
NCT02877368 - Completed - France ... More >> Chu de Reims Reims, France, 51092 Less <<
NCT00327678 Leukemia, Lymphocytic Phase 3 Completed - France ... More >> Group for Research in Adult Acute Lymphoblastic Leukemia - GRAALL - Lyon, France, 69 Less <<
NCT01271712 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Active, not recruiting May 31, 2019 -
NCT03465722 GIST Phase 3 Recruiting April 2023 -
NCT02108951 - Terminated(Study was terminate... More >>d because of slow recruitment) Less << - -
NCT00416884 Leukemia Phase 2 Terminated(Low enrollment) - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT03635814 Diabetic Macular Edema(DME) Phase 2 Recruiting November 8, 2019 Korea, Republic of ... More >> Samsung medical center Recruiting Seoul, Gangmam-gu, Korea, Republic of, 06351 Contact: Sewoong Kang, MD.PhD Less <<
NCT00416884 - Terminated(Low enrollment) - -
NCT00976612 - Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01319981 Leukemia Phase 2 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03389256 Lung Diseases ... More >> Neoplasms Respiratory Tract Diseases Thoracic Neoplasms Non-Small-Cell Lung Less << Phase 2 Not yet recruiting August 30, 2022 China, Sichuan ... More >> Sichuan Cancer Hospital Chengdu, Sichuan, China, 610041 West China Hospital, Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610041 Contact: Panwen Tian, MD    +8618036675920       Sichuan Provincial People's Hospital Not yet recruiting Chengdu, Sichuan, China, 610071 Contact: Rui Ao, MD    +8618036675290    aorui1040@hotmail.com Less <<
NCT01271712 - Active, not recruiting - -
NCT00454753 - - - Korea, Republic of ... More >> Local Institution Busan, Korea, Republic of, 602-702 Local Institution Busan, Korea, Republic of, 602-739 Local Institution Daegu, Korea, Republic of, 700-310 Local Institution Daegu, Korea, Republic of, 700-721 Local Institution Daegu, Korea, Republic of, 701-600 Local Institution Daegu, Korea, Republic of, 705-030 Local Institution Daegu, Korea, Republic of, 705-825 Local Institution Daejeon, Korea, Republic of, 301-721 Local Institution Gyeonggi-do, Korea, Republic of, 431-070 Local Institution Incheon, Korea, Republic of, 400-711 Local Institution Jellanamdo, Korea, Republic of, 519-809 Local Institution Jeollabuk-do, Korea, Republic of, 561-712 Local Institution Seoul, Korea, Republic of, 110-744 Local Institution Seoul, Korea, Republic of, 120-752 Local Institution Seoul, Korea, Republic of, 130-050 Local Institution Seoul, Korea, Republic of, 134-060 Local Institution Seoul, Korea, Republic of, 134-701 Local Institution Seoul, Korea, Republic of, 135-710 Local Institution Seoul, Korea, Republic of, 136-705 Local Institution Seoul, Korea, Republic of, 137-701 Local Institution Seoul, Korea, Republic of, 138-736 Local Institution Seoul, Korea, Republic of, 150-713 Local Institution Seoul, Korea, Republic of, 158-710 Local Institution Ulsan, Korea, Republic of, 682-061 Less <<
NCT02216578 Metastatic Gastrointestinal St... More >>romal Tumor Less << Phase 2 Recruiting August 2019 Belgium ... More >> U.Z. Leuven - Campus Gasthuisberg (147) Recruiting Leuven, Belgium Contact: Patrick Schöffski          Czechia University Hospital Motol (1905) Recruiting Prague, Czechia Contact: Katerina Kopeckova-Kubackova          France Institut Bergonie (228) Recruiting Bordeaux, France Contact: Antoine Italiano          Centre Leon Berard (227) Recruiting Lyon, France Contact: Jean-Yves Blay          Gustave Roussy (225) Recruiting Villejuif, France Contact: Olivier Mir          Germany UniversitaetsMedizin Mannheim (527) Recruiting Mannheim, Germany Contact: Bernd Kasper          Hungary Military Hospital - State Health Centre (3769) Recruiting Budapest, Hungary Contact: Zsuzanna papai          United Kingdom Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust (659) Recruiting Bebington, United Kingdom Contact: Ali Nasim          Royal Marsden Hospital - Chelsea, London (613) Recruiting Chelsea, United Kingdom Contact: Charlotte Benson          University College London Hospitals NHS Foundation Trust - University College Hospital (622) Recruiting London, United Kingdom Contact: Palma Dileo          The Christie NHS Foundation Trust (610) Not yet recruiting Manchester, United Kingdom Contact: Michael Leahy Less <<
NCT00359333 Sarcoma Malig... More >>nant Gastrointestinal Stromal Tumor Less << Phase 2 Completed - Taiwan ... More >> China Medical University Hospital Taichung, Taiwan Less <<
NCT00123487 - Completed - -
NCT00123487 Myeloid Leukemia, Chronic, Acc... More >>elerated Phase Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Less << Phase 3 Completed - -
NCT00385203 - Completed - -
NCT01030718 Chronic Myelogenous Leukemia ... More >> Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - -
NCT00782834 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Terminated(Stopped early for f... More >>utility, unable to meet accrual goals) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00782834 - Terminated(Stopped early for f... More >>utility, unable to meet accrual goals) Less << - -
NCT00075218 Gastrointestinal Stromal Tumor Phase 3 Completed - -
NCT00385203 Gastrointestinal Stromal Tumor... More >>s Soft Tissue Sarcomas Less << Phase 2 Completed - United Kingdom ... More >> Research Site Manchester, United Kingdom Research Site Sutton, United Kingdom Less <<
NCT01549548 - - - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT03459534 Leukemia, Myeloid, Chronic Pha... More >>se Less << Phase 3 Recruiting April 1, 2022 Korea, Republic of ... More >> The catholic university of Korea, Seoul ST. Marry's Hospital Recruiting Seoul, Korea, Republic of, 06591 Contact: Dong-Wook Kim, MD Less <<
NCT01030718 - Completed - -
NCT01866553 Chronic Myeloid Leukemia Phase 2 Terminated(insufficient enroll... More >>ment) Less << - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark Finland Helsinki University Hospital Helsinki, Finland Netherlands VU University Medical Center Amsterdam, Netherlands Norway Trondheim University Hospital Trondheim, Norway Sweden Uppsala University Hospital Uppsala, Sweden Less <<
NCT03291054 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Recruiting September 2019 United States, Michigan ... More >> U-M Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109-0944 Contact: Rashmi Chugh, MD    734-647-8902    rashmim@med.umich.edu    United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Richard D Carvajal, MD    646-317-6041    rdc2150@cumc.columbia.edu Less <<
NCT01068769 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00075218 - Completed - -
NCT02889328 Gastrointestinal Stromal Tumor... More >>s (GISTs) Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00022737 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01068769 - Active, not recruiting - -
NCT01323400 GIST Phase 2 Completed - France ... More >> Institut Bergonié Bordeaux, France Centre Georges François Leclerc Dijon, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France, F-69008 Hôpital de la Timone Marseille, France Institut Paoli Calmette Marseille, France Centre Alexis Vautrin Nancy, France Institut de Cancérologie de l'Ouest Nantes, France Hôpital St Antoine Paris, France Hôpital Tenon Paris, France CHU de Reims Reims, France Institut Cancerologie Neuwirth St Priest en Jarez, France Institut Gustave Roussy Villejuif, France Less <<
NCT01426334 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Terminated - United States, Colorado ... More >> University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Colorado, United States, 80217-3364 Less <<
NCT02627677 Chronic Phase Chronic Myeloid ... More >>Leukemia Less << Phase 3 Active, not recruiting December 31, 2022 Belgium ... More >> Cliniques Universitaire Saint-Luc (Site 058) Bruxelles, Belgium, 1200 Less <<
NCT01602952 Leukemia Leuk... More >>emia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Philadelphia Chromosome Hematologic Diseases Less << Phase 1 Phase 2 Completed - India ... More >> Local institution Mumbai, Maharashtra, India, 741-234 Local institution Mumbai, Mazagaon, India, 512-364 Korea, Republic of Local institution Daegu, Buk-gu, Korea, Republic of, 511-230 Local institution Jeonju, Deokjin-gu, Korea, Republic of, 212-789 Local institution Ulsan, Dong-gu, Korea, Republic of, 411-978 Local institution Anyang-si, Dongan-gu, Korea, Republic of, 751-231 Local institution Hwasun, Hwasun-eup, Korea, Republic of, 322-511 Local institution Seoul, Jongro-ku, Korea, Republic of, 231-855 Local institution Busan, Seo-gu, Korea, Republic of, 400-321 Seoul St. Mary's hospital Seoul, Seocho-gu, Korea, Republic of Local institution Suwon, Yeongtong-gu, Korea, Republic of, 781-512 Thailand Local institution Bangkok, Phyathai, Thailand, 215-714 Less <<
NCT00455221 Leukemia, Myeloid, Chronic Phase 1 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT03062436 Chronic Myeloid Leukemia ... More >> Treatment Free Remission Less << Not Applicable Recruiting December 2019 India ... More >> Command Hospital Recruiting Pune, Maharashtra, India, 411040 Contact: Sanjeevan Sharma, MD    2026347478    sanjeevanzsharma@hotmail.com Less <<
NCT00123474 Myeloid Leukemia, Chronic, Chr... More >>onic-Phase Less << Phase 3 Completed - -
NCT00036738 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Blastic Phase Childhood Acute Lymphoblastic Leukemia in Remission Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Disease Less << Phase 2 Active, not recruiting June 27, 2019 United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02607332 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00101647 - Completed - -
NCT01844765 Leukemia Leuk... More >>emia,Pediatric Leukemia, Myleiod Leukemia, Mylegenous, Chronic Leukemia, Mylegenous, Accelerated BCR-ABL Positive Myeloproliferative Disorder Bone Marrow Disease Hematologic Diseases Neoplastic Processes Imatinib Dasatinib Enzyme Inhibitor Protein Kinase Inhibitor Less << Phase 2 Active, not recruiting October 7, 2020 -
NCT00123474 - Completed - -
NCT00101595 Chronic Myeloid Leukemia ... More >> Leukemia, Lymphoblastic, Acute, Philadelphia-positive Less << Phase 2 Completed - -
NCT00101647 Chronic Myelogenous Leukemia Phase 2 Completed - -
NCT01389583 Gastrointestinal Stromal Tumor Phase 2 Recruiting October 2019 Taiwan ... More >> National Health Research of Institutes, Taiwan Cooperative Oncology Group Recruiting Tainan, Taiwan Principal Investigator: Kun-Huei Yeh, PhD          Principal Investigator: Chueh-Chuan Yen, PhD          Principal Investigator: Ken-Hong Lim, MD          Principal Investigator: Jen-Shi Chen          Principal Investigator: Cheng-Chung Wu, MS          Principal Investigator: Chang-Fang Chiu, PhD          Principal Investigator: Kuan-Der Lee, PhD          Principal Investigator: Kun-Ming Rau, MPH          Sub-Investigator: Ann-Lii Cheng, PhD          Sub-Investigator: Yu-Lin Lin, MD          Sub-Investigator: Ta-Chung Chao, MD          Sub-Investigator: Wen-Liang Fang, MD          Sub-Investigator: Ruey-Kuen Hsieh, MD          Sub-Investigator: Chun-Nan Yeh, MD          Sub-Investigator: Youngsen Yang, MD          Sub-Investigator: Tseng-Hsi Lin, PhD          Sub-Investigator: Mei-Due Yang, PhD          Sub-Investigator: Li-Yuan Bai, MD          Sub-Investigator: Wu-Chou Su, MD          Sub-Investigator: Yan-Shen Shan, PhD          Sub-Investigator: Nai-Jung Chiang, MD          Sub-Investigator: Yen-Yang Chen, MD Less <<
NCT01844765 - Active, not recruiting - -
NCT00352677 Chronic Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany Charite University of Medicine Berlin, Germany, 13353 Johann Wolfgang Goethe Universität Frankfurt am Main, Germany, 60590 University of Heidelberg Medical Clinic Mannheim, Germany, 68305 Israel Chaim Sheba Medical Center Tel Hashomer, Israel, 52621 Less <<
NCT00036738 - Active, not recruiting - -
NCT01802450 Chronic Myeloid Leukemia Phase 2 Unknown December 2016 Spain ... More >> Hospital Txagorritxu Vitoria, Alava, Spain, 01010 Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Complejo Hospitalario de Toledo - Hospital Virgen de la Salud Toledo, Castilla La Mancha, Spain, 45004 Complejo Hospitalario Universitario de Santiago Santiago de Compostela, La Coruña, Spain, 15706 Hospital San Pedro de La Rioja Logroño, La Rioja, Spain, 26006 Hospital POVISA Vigo, Pontevedra, Spain, 36211 Institut Catalá d'Oncologia L'Hospitallet Barcelona, Spain, 08907 Hospital de León León, Spain, 24071 Hospital Universitario de la Princesa Madrid, Spain, 28006 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Virgen del Rocío Sevilla, Spain, 41013 Less <<
NCT02081378 Chronic Myelogenous Leukemia ... More >> Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting December 20, 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Hematology / Oncology Recruiting Boston, Massachusetts, United States, 02215 Contact: Shannon Milillo    617-632-6840    shannon_milillo@dfci.harvard.edu    Principal Investigator: Daniel J. DeAngelo          United States, Michigan University of Michigan Comprehensive Cancer Center SC Recruiting Ann Arbor, Michigan, United States, +1 48109 0944 Contact: Shelagh L. Elliott    734-232-0759    shelagh@med.umich.edu    Principal Investigator: Moshe Talpaz          United States, New York Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Recruiting New York, New York, United States, 10065 Contact: Michael Mauro J. Mauro, MD    212-639-3107    maurom@mskcc.org    Principal Investigator: Michael J. Mauro          United States, Oregon Oregon Health and Science University SC-6 Recruiting Portland, Oregon, United States, 97239 Contact: Bianca Gille    503-494-4603    gille@ohsu.edu    Principal Investigator: Michael J. Heinrich          United States, Texas University of Texas/MD Anderson Cancer Center UT MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Contact: Jorge E Cortes, MD    713-794-5783    Jcortes@mdanderson.org    Principal Investigator: Jorge E. Cortes          United States, Utah Huntsman Cancer Institute SC Recruiting Salt Lake City, Utah, United States, 84112 Contact: Aaron Ernst       aaron.ernst@hci.utah.edu    Principal Investigator: Michael W. Deininger          Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Paris Cedex 10, Cedex 10, France, 75475 Novartis Investigative Site Recruiting Bordeaux, France, 33076 Germany Novartis Investigative Site Recruiting Berlin, Germany, 13353 Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Jena, Germany, 07740 Italy Novartis Investigative Site Recruiting Roma, RM, Italy, 00161 Japan Novartis Investigative Site Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Seocho-gu, Korea, Republic of, 06591 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28006 Less <<
NCT03170180 Stomach Neoplasms Phase 2 Recruiting October 31, 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park    234106820       Principal Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT02352558 Hematologic Malignancy Phase 1 Active, not recruiting - United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Tennessee West Clinic Germantown, Tennessee, United States, 38138 United States, Texas Cancer Care Centers of South Texas San Antonio, Texas, United States, 78217 Cancer Care Centers of South Texas - HOAST San Antonio, Texas, United States, 78229 United States, Virginia Virginia Cancer Specialists, P.C. Fairfax, Virginia, United States, 22031 Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists, PC Vancouver, Washington, United States, 98684 Less <<
NCT03214718 Chronic Myeloid Leukemia Patie... More >>nts Less << Not Applicable Not yet recruiting August 5, 2019 -
NCT00049569 L1 Childhood Acute Lymphoblast... More >>ic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Non-T, Non-B Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00335868 Leukemia Phase 2 Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00100997 Leukemia Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 Less <<
NCT00384228 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Less << Phase 1 Phase 2 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT01043874 Philadelphia Chromosome Positi... More >>ve Chronic Myelogenous Leukemia in Chronic Phase Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 453-8511 Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 807-8556 Novartis Investigative Site Hiroshima-city, Hiroshima, Japan, 734-8551 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-8556 Novartis Investigative Site Sendai-city, Miyagi, Japan, 983-8520 Novartis Investigative Site Nagasaki-city, Nagasaki, Japan, 852-8501 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8519 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Aomori, Japan, 030-8553 Novartis Investigative Site Gifu, Japan, 501-1194 Novartis Investigative Site Kyoto, Japan, 602-8566 Novartis Investigative Site Saga, Japan, 849-8501 Less <<
NCT00445822 - Unknown December 2012 Germany ... More >> University Children's Hopsital, Technical University of Dresden, Fetscherstr. 74 Recruiting Dresden, Saxonia, Germany, D-01307 Contact: Meinolf Suttorp, Prof. Dr.    +49 351 458 ext 3522    meinolf.suttorp@uniklinikum-dresden.de Less <<
NCT01243489 Chronic Myelogenous Leukemia (... More >>CML) Less << Phase 4 Unknown October 2014 Germany ... More >> Onkologische Schwerpunktpraxis Celle Celle, Germany, 29221 Onkozentrum Dresden, Gemeinschaftspraxis Dres. Göhler & Dörfel Dresden, Germany, 01127 Gemeinschaftspraxis Hämatologie - Onkologie, BAG Freiberg-Richter / Jacobasch / Illmer / Wolf Dresden, Germany, 01307 Gemeinschaftspraxis für Hämatologie und Onkologie Erfurt, Germany, 99085 St.-Antonius-Hospital, Klinik für Hämatologie und Onkologie Eschweiler, Germany, 52249 IFS - Interdisziplinäres Facharztzentrum Sachsenhausen Frankfurt, Germany, 60596 Hämato-Onkologische Schwerpunktpraxis, Dres. Michael Metz, Andreas Ammon, Dirk Meyer Göttingen, Germany, 37073 MediProjekt, Gesellschaft für Medizinstatistik und Projektentwicklung Hannover, Germany, 30171 Praxis für Innere Medizin, Onkologie und Hämatologie, Dr. Hahnfeld Jena, Germany, 07743 Universitätsklinikum Jena, Klinik für Innere Medizin II Jena, Germany, 07747 Gemeinschaftspraxis Dr. Siehl, Dr. Söling und Prof. Dr. Hirschmann Kassel, Germany, 34117 Gemeinschaftspraxis, Dres. Neise, Lollert Krefeld, Germany, 47805 Gemeinschaftspraxis, Dres. Ursula Vehling-Kaiser, Doris Greif Landshut, Germany, 84028 Internistische Schwerpunktpraxis Dr. Tschechne Lehrte, Germany, 31275 Onkologische Schwerpunktpraxis, Dres. Uthgenannt, Kisro, Weber Lübeck, Germany, 23562 Onkonet GbR, Praxis Dres. Weidenbach & Balser Marburg, Germany, 35037 Hämatologisch onkologische Schwerpunktpraxis Mayen, Germany, 56727 Nordbadpraxis München, Germany, 80797 Hämato - Onkologische Praxisgemeinschaft, Dr. Schmidt München, Germany, 81241 Praxis Dr. Walter Paderborn, Germany, 33102 Fachärzte für Innere Medizin, Hämatologie & Onkologie Rostock Rostock, Germany, 56727 Hämatologisch-Onkologische Gemeinschaftspraxis Würselen Würselen, Germany, 52146 Gemeinschaftspraxis für Innere Medizin, Hämatologie und Internistische Onkologie Würzburg, Germany, 97970 Less <<
NCT00769327 Leukemia Phase 2 Completed - Italy ... More >> Centro Oncologico Basilicata Rionero in Vulture, Potenza, Italy Ospedale Civile Alessandria Alessandria, Italy, I-15100 Dipartimento Area Medica P.O. Ascoli Piceno, Italy, 63100 S.G. Moscati Hospital Avellino, Italy, 83100 Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy Unità di Oncoematologia Azienda Ospedaliera Garibaldi Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Azienda Ospedaliera di Firenze Firenze, Italy, 50011 Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria Foggia, Italy Clinica Ematologica - DiMI - Università degli Studi di Genova Genova, Italy Clinica Ematologica - Università degli Studi Genova, Italy A.O. Universitaria Policlinico Martina di Messina Messina, Italy Azienda ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Universtià degli Studi di Napoli "Federico II" - Facoltà di medicina e chirurgia Napoli, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga Orbassano, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy, 65100 Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità operativa complessa di Ematologia Reggio Emilia, Italy A.O Umberto I Roma, Italy Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy Ospedale S.Eugenio Roma, Italy Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Azienda ospedaliera S. Maria di Terni Terni, Italy SCDO Ematologia 2 AOU S.Giovanni Battista Torino, Italy Policlinico Universitario Udine Udine, Italy, 33100 Policlinico G. B. Rossi - Borgo Roma Verona, Italy, 37134 Ospedale San Bortolo Vicenza, Italy, 36100 Less <<
NCT01774630 Leukemia, Myelogenous, Chronic... More >>, BCR-ABL Positive Less << Phase 2 Recruiting April 2020 France ... More >> CHU Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS, MD          Principal Investigator: Martine GARDEMBAS, MD          Institut Bergonié Not yet recruiting Bordeaux, France, 33076 Contact: Gabriel ETIENNE, Dr       G.Etienne@bordeaux.unicancer.fr    Principal Investigator: Gabriel ETIENNE, Dr          Sub-Investigator: Josy REIFFERS, Pr          Sub-Investigator: François-Xavier MAHON, Pr          Sub-Investigator: Anna SCHMITT, Dr          Chu Estaing Not yet recruiting Clermont- Ferrand, France, 63003 Contact: Marc BERGER, MD, PhD          Principal Investigator: Marc BERGER, MD,PhD          Centre Hospitalier de Versailles - Hôpital André Mignot - Service de Médecine B Recruiting Le Chesnay, France, 78157 Contact: Philippe ROUSSELOT, Pr       prousselot@ch-versailles.fr    Principal Investigator: Philippe ROUSSELOT, Pr          Hôpital Claude Huriez, Service des Maladies du Sang Not yet recruiting Lille, France, 59037 Contact: Marie-Pierre NOEL, Dr       mp-noel@chru-lille.fr    Principal Investigator: Marie-Pierre NOEL, Dr          Sub-Investigator: Valérie COITEUX, Dr          Sub-Investigator: Nathalie CAMBIER, Dr          Institut Paoli Calmette, Service Hématologie 3 Not yet recruiting Marseille, France, 13273 Contact: Aude CHARBONNIER, Dr       charbonniera@marseille.fnclcc.fr    Principal Investigator: Aude CHARBONNIER, Dr          Sub-Investigator: Norbert VEY, Dr          Sub-Investigator: Thomas PREBET, Dr          Sub-Investigator: Jerôme REY, Dr          Sub-Investigator: Anne ETIENNE, Dr          Sub-Investigator: Evelyne D'INCAN, Dr          CHU Hôtel Dieu, Service d'Hémato-Cancérologie Not yet recruiting Nantes, France, 44035 Contact: Viviane DUBRUILLE, Dr       viviane.dubruille@chu-nantes.fr    Principal Investigator: Viviane DUBRUILLE, Dr          Sub-Investigator: Béatrice MAHE, Dr          Sub-Investigator: CLAVERT Aline, Dr          Sub-Investigator: Nicolas BLIN, Dr          CHU de Nice, Service Hématologie Clinique Recruiting Nice, France, 06202 Contact: Laurence LEGROS, Dr       legros.l@chu-nice.fr    Principal Investigator: Laurence LEGROS, Dr          Sub-Investigator: Jean-Michel KARSENTI, Dr          Hôpital Saint Louis, Service des Maladies du Sang Not yet recruiting Paris, France, 75475 Contact: Philippe ROUSSELOT, Pr       philippe.rousselot@chu-stlouis.fr    Principal Investigator: Philippe ROUSSELOT, Pr          Sub-Investigator: Delphine REA, Dr          Hôpital Necker-Enfants Malades, Service d'Hématologie Not yet recruiting Paris, France, 75743 Contact: Bruno VARET, Pr       bruno.varet@nck.aphp.fr    Principal Investigator: Bruno VARET, Pr          Sub-Investigator: Agnès BUZYN, Pr          Sub-Investigator: Felipe SUAREZ, Dr          Hôpital Haut Lévêque, Service Hématologie Recruiting Pessac, France, 33604 Contact: François-Xavier MAHON, Pr       Francois-Xavier.Mahon@umr5540.u-bordeaux2.fr    Principal Investigator: François-Xavier MAHON, Pr          Sub-Investigator: Gérald MARIT, Pr          Centre Hospitalier Lyon Sud, Service Hématologie Recruiting Pierre Benite, France, 69495 Contact: Franck NICOLINI, Dr       franck.nicolini@chu-lyon.fr    Principal Investigator: Franck NICOLINI, Dr          Sub-Investigator: Mauricette MICHALLET, Pr          Sub-Investigator: Xavier THOMAS, Dr          Sub-Investigator: Fiorenza BARACCO, Dr          Sub-Investigator: Hélène LABUSSIERE, Dr          Sub-Investigator: Marie DETRAIT, Dr          Sub-Investigator: Youcef CHELGHOUM, Dr          Sub-Investigator: Sophie DUCASTELLE, Dr          CHRU de Poitiers Not yet recruiting Poitiers, France, 86021 Contact: François GUILHOT, Md, PhD          Principal Investigator: François GUILHOT, Md, PhD          CH d'Annecy Recruiting Pringy, France, 74374 Contact: Pascale CONY-MAKHOUL, Dr       pconymakhoul@ch-annecy.fr    Principal Investigator: Pascale CONY-MAKHOUL, Dr          Sub-Investigator: Bernadette CORRONT, Dr          Hôpital Pontchaillou Recruiting Rennes, France, 35033 Contact: Martine ESCOFFRE-BARBE, Dr       martine.escoffre-barbe@chu-rennes.fr    Principal Investigator: Martine ESCOFFRE-BARBE, Dr          Sub-Investigator: Bernard Marc, Dr          Sub-Investigator: Charles DAURIAC, Dr          Sub-Investigator: Stanislas NIMUBONA, Dr          Sub-Investigator: Xavier CAHU, Dr          Sub-Investigator: Thierry LAMY DE LA CHAPELLE, Dr          Sub-Investigator: Roch HOUOT, Dr          Sub-Investigator: Sophie DE GUIBERT, Dr          CHU de Toulouse, Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Françoise RIGAL-HUGUET, Dr       huguet.f@chu-toulouse.fr    Sub-Investigator: Lucie OBERIC, Dr          Sub-Investigator: Guy LAURENT, Pr          Sub-Investigator: Christian RECHER, Pr          Sub-Investigator: Anne HUYNH, Dr          Sub-Investigator: Loïc YSEBAERT, Dr          Principal Investigator: Françoise RIGAL-HUGUET, Dr          CHU de Tours Not yet recruiting Tours, France, 37044 Contact: Emmanuel GYAN, MD          Principal Investigator: Emmanuel GYAN, MD          CH Valence Recruiting Valence, France, 26953 Contact: Jixing LIU, MD          Principal Investigator: Jixing LIU, MD          CHU Brabois, Service de Médecine A Not yet recruiting Vandoeuvre Les Nancy, France, 54500 Contact: Agnès-Paule GUERCI, Dr       a.guerci@chu-nancy.fr    Principal Investigator: Angès-Paule GUERCI, Dr Less <<
NCT02326311 Leukemia, Chronic Myeloid Phase 3 Recruiting January 2020 Italy ... More >> Policlinico Universitario di Milano Recruiting Milano, Italy Contact: Alessandra Iurlo, MD Less <<
NCT01077544 Chronic Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 1 Completed - United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie Chicago, Illinois, United States, 60611 Brazil Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site Sao Paulo, SP, Brazil Novartis Investigative Site São Paulo, SP, Brazil, 08270-070 France Novartis Investigative Site Bordeaux, Aquitaine, France, 33076 Novartis Investigative Site Lille cedex, France, 59037 Novartis Investigative Site Paris, France, 75571 Novartis Investigative Site Poitiers, France, 86021 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Roma, RM, Italy, 00161 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117997 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Birmingham, United Kingdom, B4 6NH Novartis Investigative Site Bristol, United Kingdom, BS2 8BJ Less <<
NCT00342056 - Completed - United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Belgium Katholieke Universiteit Leuven, U Hospitals UZ Gasthuisberg Leuven, Belgium Less <<
NCT01077544 - Completed - -
NCT00081926 Chronic Myelogenous Leukemia Phase 4 Completed - United States, New Jersey ... More >> Novartis RIGHT Trial Hotline East Hanover, New Jersey, United States Less <<
NCT01043874 - Completed - -
NCT00156286 Small Cell Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Univeristy of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00514969 Chronic Myeloid Leukemia Phase 2 Completed - Italy ... More >> Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna Bologna, Italy Less <<
NCT00066326 Leukemia Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00376467 Acute Lymphoblastic Leukemia PHASE2 COMPLETED 2025-02-11 Azienda Ospedaliera - Nuovo Os... More >>pedale "Torrette", Ancona, Italy|Az.Ospedaliera S.G.Moscati, Avellino, Italy|Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy|Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy|Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy|Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia, Catanzaro, Italy|Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Ferrara, Italy|Ospedale Niguarda " Ca Granda", Milano, Italy|Centro Oncologico Modenese - Dipartimento di Oncoematologi, Modena, Italy|Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Napoli, Italy|Servizio Sanitario Nazionale - Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" - Struttura Complessa di Ematologia - Div. TERE- 4° piano - Padiglione Palermo, Napoli, Italy|zienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Napoli, Italy|U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani, Nocera Inferiore, Italy|Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2, Orbassano, Italy|La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello, Palermo, Italy|Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy|U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy|Ematologia - Ospedale San Carlo, Potenza, Italy|Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia, Roma, Italy|S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy|U.O.C. Ematologia - Ospedale S.Eugenio, Roma, Italy|Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy|Divisione di Ematologia, Azienda Policlinico "Umberto I", Università degli Studi "La Sapienza", Rome, 00161, Italy|Azienda Sanitaria Locale Viterbo - Polo Ospedaliero Centrale - Ospedale Di Ronciglione - U.O. di Ematologia, Ronciglione, Italy|Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, S. G. Rotondo, Italy|Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy|Divisione di Ematologia dell' Università degli Studi di Torino - "Città della Salute e della Scienza di Torino", Torino, Italy|Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi, Verona, Italy Less <<
NCT00425646 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00390897 Chronic Myeloid Leukaemia Phase 4 Completed - -
NCT01126892 Chronic Myeloid Leukemia Phase 3 Completed - Colombia ... More >> Hospital San José, Bogotá, Colombia Bogota, Colombia Venezuela Banco Municipal de Sangre Caracas, Venezuela Less <<
NCT02888964 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 2 Completed - France ... More >> CHR Annecy Annecy, France Institut Bergonié Bordeaux, France CH Versailles Le Chesnay, France CHU Lille Lille, France IPC Marseille, France CHU archet 1 Nice, France St Louis Paris, France CHU Poitiers Poitiers, France CHU Purpan Toulouse, France Less <<
NCT00085475 Sarcoma Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Bergonie Bordeaux, France, 33076 CHU de la Timone Marseille, France, 13385 Netherlands Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Center Leiden, Netherlands, 2300 CA United Kingdom Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00010049 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0316 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00253565 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00062205 Sarcoma Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00031915 Childhood Malignant Fibrous Hi... More >>stiocytoma of Bone Sarcoma Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, District of Columbia Washington Hospital Center Washington, District of Columbia, United States, 20010 United States, Illinois Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0912 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021-6007 Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00633295 Gastrointestinal Stromal Tumor... More >>s (GIST) Less << Phase 2 Completed - Israel ... More >> Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Tel Aviv, Israel Novartis Investigative Site Tel Hashomer, Israel Less <<
NCT03697668 Plasmodium Falciparum Malaria ... More >>(Drug Resistant) Less << Phase 2 Recruiting December 31, 2019 Vietnam ... More >> A Tuc Recruiting Hương Hóa, Quang Tri, Vietnam, 520000 Contact: Tuan A Tran, MD    +84982290426    tuanhuonghoa@gmail.com Less <<
NCT00244829 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00074308 Recurrent Melanoma ... More >> Stage III Melanoma Stage IV Melanoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00074308 - Completed - -
NCT00372567 Gastrointestinal Stromal Tumor Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Michigan ... More >> Pfizer Investigational Site Detroit, Michigan, United States, 48201 Pfizer Investigational Site Farmington Hills, Michigan, United States, 48334 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 Germany Pfizer Investigational Site Goettingen, Germany, 37075 Pfizer Investigational Site Hamburg, Germany, 22767 Hong Kong Pfizer Investigational Site Lai Chi Kok, Kowloon, Hong Kong, 0 Pfizer Investigational Site Tuen Mun, New Territories, Hong Kong, 0 Pfizer Investigational Site Hong Kong, Hong Kong, 0 Italy Pfizer Investigational Site Bologna, Italy, 40138 Pfizer Investigational Site Milano, Italy, 20133 Pfizer Investigational Site San Giovanni Rotondo, Italy, 71013 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Spain Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Valencia, Spain, 46009 United Kingdom Pfizer Investigational Site Glasgow, United Kingdom, G12 0YH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site London, United Kingdom, NW1 2PG Pfizer Investigational Site London, United Kingdom, SW3 6JJ Pfizer Investigational Site London, United Kingdom, W1 Pfizer Investigational Site Manchester, United Kingdom, M20 4BX Less <<
NCT01347216 - Recruiting June 2020 Belgium ... More >> Dept. of Pneumology, University Recruiting Leuven, Belgium Contact: Marion Delcroix, MD, PhD          Principal Investigator: Marion Delcroix, MD, PhD          Germany DRK-Klinikum Köpenick Recruiting Berlin, Germany Contact: Christian Opitz, MD, PhD          Principal Investigator: Christian Opitz, MD, PhD          Lung Centre, University of Giessen Recruiting Giessen, Germany Contact: Ardeschir Ghofrani, MD, PhD          Principal Investigator: Ardeschir Ghofrani, MD          Sub-Investigator: Melanie Thamm, MD          Department of Pulmology; Hannover Medical School Recruiting Hannover, Germany Contact: Marius M Hoeper          Principal Investigator: Marius M Hoeper, MD, PhD          Sub-Investigator: Karen Olsson, MD          German Heart Centre Recruiting Munich, Germany Contact: Harald Kaemmerer, MD,. PhD          Principal Investigator: Harald Kaemmerer, MD, PhD          Ireland Mater Misericordiae Recruiting Dublin, Ireland Contact: Sean Gaine, MD, PhD          Principal Investigator: Sean Gaine, MD, PhD          Italy Department of Cardiovascular and Respiratory Sciences, University La Sapienza Recruiting Rome, Italy Contact: Dario Vizza, MD, PhD          Principal Investigator: Dario Vizza, MD, PhD          Switzerland Dept. for Rheumatology, University Hospital Recruiting Zurich, Switzerland Contact: Oliver Distler, MD, PhD          Principal Investigator: Oliver Distler, MD, PhD Less <<
NCT00261846 Chronic Myeloid Leukemia Phase 2 Completed - -
NCT02142036 Metastatic Cancer Phase 2 Active, not recruiting January 2022 Norway ... More >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 Less <<
NCT01616238 Acute Lymphoblastic Leukaemia Phase 3 Recruiting June 30, 2022 Netherlands ... More >> Erasmus MC Suspended Rotterdam, Netherlands United Kingdom NHS Lanarkshire - Monklands Suspended Airdrie, United Kingdom Blackpool Victoria Hopsital Recruiting Blackpool, United Kingdom Contact: Dr Paul Cahalin          Royal Bournemouth Hospital Suspended Bournemouth, United Kingdom Bradford Royal Infirmary Suspended Bradford, United Kingdom Bristol Haematology and Oncology Centre Suspended Bristol, United Kingdom University Hospital of Wales Suspended Cardiff, United Kingdom Castle Hill Hospital Suspended Cottingham, United Kingdom Russells Hall Hospital Suspended Dudley, United Kingdom Ninewells Hospital Suspended Dundee, United Kingdom NHS Lothian - Western General Hospital Suspended Edinburgh, United Kingdom Beatson West of Scotland Cancer Centre Suspended Glasgow, United Kingdom New Victoria Hospital and Southern General Hospital Suspended Glasgow, United Kingdom Northwick Park Hospital Suspended Harrow, United Kingdom St James' Hospital, Leeds Recruiting Leeds, United Kingdom Contact: Prof. David Bowen          Leicester Royal Infirmary Suspended Leicester, United Kingdom Royal Liverpool University Hospital Suspended Liverpool, United Kingdom King's College Hospital NHS Foundation Trust Suspended London, United Kingdom St Bartholomew's Hospital Suspended London, United Kingdom St George's Hospital Suspended London, United Kingdom The Christie Hospital Recruiting Manchester, United Kingdom Contact: Dr Samar Kulkarni          James Cook University Hospital Suspended Middlesbrough, United Kingdom Churchill Hospital, Oxford Suspended Oxford, United Kingdom Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Dr Hannah Hunter          Poole General Hospital Suspended Poole, United Kingdom St Helen's & Knowlsey Teaching Hospitals Suspended Prescot, United Kingdom Salisbury District Hospital Suspended Salisbury, United Kingdom Royal Hallamshire Hospital Suspended Sheffield, United Kingdom Royal MarsdenHospital Suspended Sutton, United Kingdom Great Western Hospital Suspended Swindon, United Kingdom Musgrove Park Recruiting Taunton, United Kingdom Contact: Dr Simon Bolam          Torbay Hospital Suspended Torquay, United Kingdom The Hillingdon Hospital Withdrawn Uxbridge, United Kingdom Sandwell General Hospital Suspended West Bromwich, United Kingdom Arrowe Park Hospital Suspended Wirral, United Kingdom Less <<
NCT00990249 - Completed - -
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT00261846 - Completed - -
NCT00476190 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Children's Hospital of Boston Boston, Massachusetts, United States, 02115 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 Canada, British Columbia Vancouver Cancer Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada Canada, Nova Scotia QEII, Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve Rosemont Montreal, Quebec, Canada, H1T 2M4 Hopital Notre-Dame Montreal, Quebec, Canada McGill University Department of Oncology Montreal, Quebec, Canada Less <<
NCT00990249 Leukemia Lymp... More >>homa Allogeneic Haematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT02611492 Philadelphia Chromosome Positi... More >>ve Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting December 2025 France ... More >> Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Hervé Dombret, MDPhD    +33 (0)1 57 27 68 47    herve.dombret@aphp.fr Less <<
NCT00877045 - Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30341 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT01460160 Leukemia, Pediatric Phase 2 Active, not recruiting May 28, 2021 -
NCT01460160 - Active, not recruiting - -
NCT00039364 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Austria ... More >> Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Belgium U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre de Lutte Contre le Cancer, Georges-Francois Leclerc Dijon, France, 21079 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Institut Gustave Roussy Villejuif, France, F-94805 Italy Azienda Ospedaliera di Padova Padova, Italy, 35100 Netherlands Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00002514 Leukemia Phase 3 Completed - -
NCT00061945 Acute Undifferentiated Leukemi... More >>a B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia L1 Adult Acute Lymphoblastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Adult Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00110058 Leukemia Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00137111 - Active, not recruiting - -
NCT02508532 Gastrointestinal Stromal Tumor... More >>s (GIST) Other Relapsed or Refractory Solid Tumors Less << Phase 1 Recruiting May 2019 United States, California ... More >> Sarcoma Oncology Center Recruiting Santa Monica, California, United States, 90403 United States, Florida Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Belgium Leuven Cancer Institute University Hospitals Leuven Recruiting Leuven, Belgium, 3000 France Centre Leon Berard Recruiting Lyon, France, 69008 Institut Gustave Roussy Recruiting Paris, France, 94805 Germany University of Duisburg-Essen Recruiting Essen, Germany, 45122 Italy Fondazione IRCCS - Istituto Nazinale dei Tumori Recruiting Milan, Italy, 20133 Korea, Republic of Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Netherlands Erasmus MC Cancer Institute Recruiting Rotterdam, Netherlands, 3015 Poland Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w Warszawie Recruiting Warsaw, Poland, 02-781 Spain Vall d' Hebron Institute of Oncology (VHIO) Recruiting Barcelona, Spain, 08305 United Kingdom Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Less <<
NCT01085617 Leukemia Muco... More >>sitis Oral Complications Less << Phase 3 Recruiting July 2023 United Kingdom ... More >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2833 Less <<
NCT00444795 - Completed - Korea, Republic of ... More >> Keimyung University Dongsan Medical Center Jung-gu, Daegu, Korea, Republic of, 100-712 Daegu Catholic University Medical Center Nam-gu, Daegu, Korea, Republic of, 705-718 GangNeung Asan Hospital Gangneung-si, Gangwon-do, Korea, Republic of, 210-711 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 The Catholic University of Korea, St. Vincent's Hospital Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Hwasun Hospital, Chonnam National University Cheonnam, South Jeolla Province, Korea, Republic of, 519-809 Hallym University Sacred Heart Hospital Anyang, Korea, Republic of, 431-070 Pusan National University Hospital Busan, Korea, Republic of, 602 739 Kosin University Gospel Hospital Busan, Korea, Republic of, 602-702 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Dong-A University Medical Center (Dong-A University Hospital) Busan, Korea, Republic of, 602-715 Dong-A University Medical Center, Department of Medicine, Division of Hemato-Oncology Busan, Korea, Republic of, 602-715 Pusan National University Hospital Busan, Korea, Republic of, 602-739 Hwasun Hospital, Chonnam National University Cheonnam, Korea, Republic of, 519-809 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700 712 Kyungpook National University Medical Center Daegu, Korea, Republic of, 702-210 Daegu Catholic University Medical Center (DCUMC) Daegu, Korea, Republic of, 705-718 Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Inje University Ilsan Paik Hospital Goyang, Korea, Republic of, 411-706 Chosun University Hospital Gwang Joo, Korea, Republic of, 501-717 Pusan National University Hospital Gyeongsangnam-do, Korea, Republic of, 626-770 Wonkwang University School of Medicine and Hospital (WUH) Iksan -Si, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Hospital Incheon, Korea, Republic of, 405-760 Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Yeungnam University Medical Center Nam-gu, Korea, Republic of, 705-717 Seoul National University Bundang Hospital Seongnam-si, Korea, Republic of, 463-707 Seoul National University Hospital (SNUH) Seoul, Korea, Republic of, 110-744 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 110-746 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-872 KyungHee University Medical Center Seoul, Korea, Republic of, 130-872 Samsung Medical Center, Dept. of Medicine, Div. of Hematology/Oncology Seoul, Korea, Republic of, 135-710 Samsung Medical Center/Division of Hematology-Oncology, Department of Medicine Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Asan Medical Center/Department of Oncology Seoul, Korea, Republic of, 138-736 Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea Cancer Center Hospital Seoul, Korea, Republic of, 139-706 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of, 158-710 Seoul National University Hospital Seoul, Korea, Republic of, 3080 Seoul ST. Mary's Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of, 682-714 Yonsei University Wonju College of Medicine, Wonju Christian Hospital Wonju-si, Korea, Republic of, 220-701 Less <<
NCT00167180 Leukemia, Myeloid, Chronic ... More >> Lymphomas Multiple Myeloma Myelodysplastic Syndrome Leukemia, Lymphocytic, Acute Leukemia, Lymphocytic, Chronic AML Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00167180 - Completed - -
NCT00137111 Lymphoblastic Leukemia, Acute Phase 3 Active, not recruiting November 2020 United States, Tennessee ... More >> St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT00061945 - Completed - -
NCT00429910 - Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00444795 - Completed - -
NCT01005758 Leukemia Phase 2 Unknown - -
NCT02733445 - Completed - -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00640692 - Terminated(Insufficient enroll... More >>ment) Less << April 2011 -
NCT00882206 Leukemia Lymp... More >>homa Less << Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55455 Less <<
NCT00306202 Leukemia Phase 1 Active, not recruiting October 4, 2022 Austria ... More >> Local Institution Vienna, Austria, 1090 France Local Institution Nantes, France, 44093 Local Institution Paris Cedex 10, France, 75475 Local Institution Paris Cedex 12, France, 75571 Germany Local Institution Berlin, Germany, 13353 Local Institution Frankfurt, Germany, 60590 Local Institution Hannover, Germany, 30625 Italy Local Institution Monza (mi), Italy, 20052 Netherlands Local Institution Rotterdam, Netherlands, 3015 GJ United Kingdom Local Institution Manchester, Greater Manchester, United Kingdom, M27 4HA Local Institution Bristol, Somerset, United Kingdom, BS2 8BJ Local Institution Sutton, Surrey, United Kingdom, SM2 5PT Local Institution Birmingham, West Midlands, United Kingdom, B4 6NH Less <<
NCT00882206 - Terminated(Slow accrual) - -
NCT01460498 Leukemia Phase 1 Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03610971 Chronic Phase Chronic Myeloid ... More >>Leukemia Chronic Myeloid Leukemia, Chronic Phase Less << Phase 2 Not yet recruiting January 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Anthony McLaughlin    813-745-5941    anthony.mclaughlin@moffitt.org    Contact: Kendra Sweet, M.D.    813-745-8986    kendra.sweet@moffitt.org    Principal Investigator: Kendra Sweet, M.D. Less <<
NCT00346632 Acute Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Less << Phase 1 Terminated(Terminated due to s... More >>uboptimal dosing schedule) Less << - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, New Jersey Contact Kyowa Princeton, New Jersey, United States, 08540 United States, New York Weill Cornell/New York Presbyterian Hospital New York, New York, United States, 10021 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01665001 Precursor Lymphoid Neoplasms Phase 2 Unknown August 2018 Poland ... More >> Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch Not yet recruiting Gliwice, Poland, 44-101 Contact: Sebastian Giebel, MD    0048322788523    sgiebel@io.gliwice.pl Less <<
NCT03331211 - Recruiting September 1, 2019 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Xutao Guo    008613802426709 ext 1    gxt827@126.com Less <<
NCT01428635 Leukemia Chro... More >>nic Myeloid Leukemia Myelofibrosis Less << Phase 2 Active, not recruiting January 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02353052 - Unknown - China, Shanghai ... More >> 180 Fenglin Road Recruiting Shanghai, Shanghai, China, 200032 Contact: Yingyong Hou, doctor    86-13681972385    hou.yingyong@zs-hospital.sh.cn    Principal Investigator: Yingyong Hou, doctor          Sub-Investigator: Xin Zhang, doctor          Sub-Investigator: Rongkui Luo, master          Sub-Investigator: Wei Yuan, master Less <<
NCT00346632 - Terminated(Terminated due to s... More >>uboptimal dosing schedule) Less << - -
NCT01862965 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT01254188 Chronic Myeloid Leukemia Phase 3 Completed - -
NCT01254188 - Completed - -
NCT03624530 Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Tyrosine Kinase Inhibitor Minimal Residual Disease Allogeneic Hematopoietic Stem Cell Transplantation Less << Phase 2 Phase 3 Recruiting July 2022 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-62787883    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT01914484 Chronic Phase Chronic Myeloid ... More >>Leukemia Accelerated Phase Chronic Myeloid Leukemia Blastic Phase Chronic Myeloid Leukemia Philadelphia Positive Acute Lymphoblastic Leukemia Resistant to Tyrosine Kinase Inhibitor Therapy Less << Phase 1 Phase 2 Unknown July 2016 Canada, Ontario ... More >> Princess Margaret Hospital / University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Sima Bogomilsky, RN BScN CON(C)    416-946-4646    sima.bogomilsky@uhn.on.ca    Contact: Sonal Malhotra, M.Sc., Ph.D,CCRP    416-946-4501 ext 3449    sonal.malhotra@uhn.ca    Principal Investigator: Dennis Kim, MD/PhD          Sub-Investigator: Jeffrey H Lipton, MD/PhD Less <<
NCT01553981 Lung Diseases, Interstitial Phase 3 Completed - India ... More >> SGPGIMS Lucknow, UP, India, 226014 Less <<
NCT01883219 Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Stem Cell Transplantation Minimal Residual Disease Less << Phase 2 Unknown November 2017 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin, MD    +86-020-61641613    lansinglinren@hotmail.com Less <<
NCT00306202 - Active, not recruiting - -
NCT00920868 Solid Tumor M... More >>etastatic Colorectal Cancer Less << Phase 1 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, North Carolina Duke Univeristy Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01548170 Cancer Phase 1 Completed - Spain ... More >> Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Less <<
NCT01429610 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 2 Active, not recruiting January 1, 2019 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Chollanamdo, Korea, Republic of Hematologic Oncology Clinic, National Cancer Center Ilsan, Kongki, Korea, Republic of Division of Hematology-Oncology, Dong-A University College of Medicine Busan, Korea, Republic of Dong-A University College of Medicine Busan, Korea, Republic of Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae-Paik Hospital Busan, Korea, Republic of Kosin University College of Medicine, Kosin University Gospel Hospital Busan, Korea, Republic of Catholic University of Daegu School of Medicine Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungpook National Unviersity Hospital Daegu, Korea, Republic of Yeungnam University College of Medicine Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Chung-Ang University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soonchunhyang University Hospital Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of Less <<
NCT03632135 Recurrent Glioblastoma Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Mark D. Anderson, MD    601-984-5517    manderson4@umc.edu    United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Nicholas Marko, MD    513-558-3559    nicholas.marko@uc.edu    Contact: , RN          Toledo University Recruiting Toledo, Ohio, United States, 43614 Contact: Jason Schroeder, MD    419-383-4000    Jason.Schroeder5@UToledo.edu    Contact: Stephanie Smiddy, RN    419-383-6962    stephanie.smiddy@UToledo.edu    United States, Pennsylvania The Penn State Univeristy College of Medicine Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Dawit Aregawi, MD    717-531-3828    daregawi@PennStateHealth.psu.edu    Allegheny Health Network Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Tulika Ranjan, MD    412-770-3039    Tulika.RANJAN@ahn.org    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Steven Jubelirer, MD    304-388-8380    steven.jubelirer@camc.org    Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org Less <<
NCT00511069 Leukemia Phase 2 Completed - Italy ... More >> Policlinico "S.Orsola-Malpighi"-Istituto di Ematologia "L e A Seragnoli" Bologna, Italy, 40138 Less <<
NCT02847377 Carcinoma, Non-Small-Cell Lung Early Phase 1 Recruiting March 27, 2019 France ... More >> CGFL Recruiting Dijon, France, 21079 Less <<
NCT02281760 BRAF V600E Mutation Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03746054 Chronic Myeloid Leukemia (CML) Phase 3 Not yet recruiting March 2023 -
NCT02954523 EGFR Gene Mutation ... More >> Nonsmall Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting November 2021 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Jeanette Crawford, RN    202-687-0893    crawfojg@georgetown.edu    Contact: Tisdrey Torres, RN    202-687-9861    tt665@georgetown.edu    Principal Investigator: Giuseppe Giaccone, MD PhD          Sub-Investigator: Chul Kim, MD          United States, New Jersey John Theurer Cacner Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Allison Abate    551-996-0233    alison.abate@hackensackmeridian.org    Principal Investigator: Martin Gutierrez, MD Less <<
NCT01916785 Chronic Myelogenous Leukemia, ... More >>BCR/ABL Positive Less << Phase 2 Completed - Canada ... More >> Southern Alberta Cancer Research Institute Calgary, Canada Hôpital Charles LeMoyne Greenfield Park, Canada Queen elisabeth II Health Sciences Center Halifax, Canada CH Pierre LeGardeur Lachenaie, Canada Moncton City Hospital Moncton, Canada Hôpital Général Juif - Sir. Mortimer B. Davis Montréal, Canada Hôpital Maisonneuve-Rosemont Montréal, Canada Hôpital Royal Victoria Montréal, Canada Hôpital de l'Enfant Jésus - Centre hospitalier affilié universitaire de Québec Québec, Canada Pavillon Hôtel-Dieu de Québec - Centre hospitalier universitaire de Québec Québec, Canada France CHU Angers Angers, France Hôpital Avicenne Bobigny, France Institut Bergonie Bordeaux, France Hopital MORVAN Brest, France CH René Dubos Cergy Pontoise, France Hôpital d'Instruction de Armées Percy Clamart, France Hopital Henri MONDOR Creteil, France Hôpital Claude Huriez Lille, France CH Lyon Sud Lyon, France Institut Paoli-Calmettes Marseille, France Hôpital d'Annecy Metz Tessy, France C.H.U. Brabois Nancy, France CHU Hoptel dieu Nantes, France Hôpital l'Archet 1 Nice, France CHU Caremeau Nimes, France Hopital Saint Louis Paris, France Hôpital Necker-Enfants Malades Paris, France Hôpital St Antoine Paris, France CHU Poitiers Poitiers, France CHU Rennes - Pontchaillou Rennes, France Centre René Huguenin Saint Cloud, France Hôpital Purpan Toulouse, France CHRU Bretonneau Tours, France Central Hospital Versailles, France Less <<
NCT00427791 Leukemia Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00427791 - Completed - -
NCT01098500 - Completed - -
NCT02331914 - Recruiting January 2019 Netherlands ... More >> Antoni van Leeuwenhoek Hospital Not yet recruiting Amsterdam, Netherlands Contact: N. Steeghs, MD, PhD       n.steeghs@nki.nl    Principal Investigator: N. Steeghs, MD, PhD          University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: A. K. Reyners, MD, PhD    +31 50 361 2821    a.k.l.reyners@umcg.nl    Principal Investigator: A. K. Reyners, MD, PhD          Leiden University Medical Center Not yet recruiting Leiden, Netherlands Contact: A. J. Gelderblom, MD, PhD       A.J.Gelderblom@lumc.nl    Principal Investigator: A. J. Gelderblom, MD, PhD          University Medical Center St. Radboud Not yet recruiting Nijmegen, Netherlands Contact: W. T. van der Graaf, MD, PhD       Winette.vanderGraaf@radboudumc.nl    Principal Investigator: W. T. van der Graaf, MD, PhD          Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: R. H. Mathijssen, MD, PhD       a.mathijssen@erasmusmc.nl    Principal Investigator: R. H. Mathijssen, MD, PhD Less <<
NCT01098500 - Completed - -
NCT01641107 Philadelphia Positive ... More >> BCR-ABL Positive Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting November 2019 Italy ... More >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy Azienda Ospedaliera - Papa Giovanni XXIII Bergamo, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi Ferrara, Italy Policlinico di Careggi Firenze, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Unità Operativa Complessa - Medicina Generale - Sezione di Ematologia - Ospedale Versilia USL 12 Toscana Lido di Camaiore, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy U.O. di Ematologia- Ospedale dell'Angelo - Mestre Mestre, Italy Ospedale Niguarda " Ca Granda" Milano, Italy UO Ematologia - AOU Policlinico di Modena Modena, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Orbassano, Italy Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia Perugia, Italy Div. di Ematologia di Muraglia - CTMO Ospedale San Salvator Pesaro, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Ospedale "Infermi" Rimini, Italy Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy UOC di Ematologia e Trapianti di Cellule Staminali Emopoietiche - AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Siena, Italy Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista Torino, Italy Azienda U.L.S.S.9 - U.O. di Ematologia Treviso, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy ULSS N.6 Osp. S. Bortolo Vicenza, Italy Less <<
NCT00598091 Refractory Solid Tumors ... More >> Pancreatic Adenocarcinoma Less << Phase 1 Terminated(Low accrual, unable... More >> to meet endpoint in timely manner) Less << - United States, North Carolina ... More >> UNC Lineberger, Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States Less <<
NCT00606008 Anaplastic Astrocytoma ... More >> Glioblastoma Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03165721 Paraganglioma ... More >> Gastrointestinal Stromal Tumors Carcinoma, Renal Cell Renal Neoplasms Pheochromocytoma Less << Phase 2 Recruiting December 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02883036 - Not yet recruiting - China, Guangdong ... More >> Department of hematology,Nanfang Hospital Not yet recruiting Guangzhou, Guangdong, China, 510515 Contact: Xiaoli Liu, MD    86-020-61641616    lxl2405@126.com    Contact: Na Xu, MD    86-020-61641615    292347668@qq.com Less <<
NCT00750659 Chronic Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Stem Cell Transplantation Less << Phase 2 Completed - Israel ... More >> Chaim Sheba Medical Center Tel-Hashomer, Israel, 52621 Less <<
NCT01392170 Leukemia Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02172365 - Unknown July 2016 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Dennis Kim, MD/PhD    +1-416-946-4501 ext 2464    dr.dennis.kim@uhn.ca    Contact: Nancy Vukovic    +1-416-946-4501 ext 2464    nancy.vukovic@uhn.ca Less <<
NCT02222272 - Unknown December 2015 Denmark ... More >> Rigshospitalet Copenhagen, Denmark Finland Helsinki University Central Hospital Helsinki, Finland Germany University of Freiburg Freiburg, Germany University of Muenster Muenster, Germany Hungary St Ivan & St Laszlo Hospital Budapest, Hungary Israel Chaim Sheba Medical Centre Tel-Hashomer, Israel Poland Medical University of Silesia Katowice, Poland Russian Federation St Petersburg State Medical Pavlov University St Petersburg, Russian Federation Saudi Arabia King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia United Kingdom Hammersmith London, United Kingdom Less <<
NCT01810718 Chronic Graft Versus Host Dise... More >>ase Less << Phase 1 Completed - Israel ... More >> Chaim Sheba Medical Center Tel Hashomer, Israel Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Trapianti Midollo Osseo - Div. di Ematologia 2 - Ospedale S. Martino Genova, Italy Ospedale Panico Lecce, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy Ospedale Niguarda Ca' Grande Milano, Italy U.O. Ematologia I - Centro Trapianti di Midollo - Ospedale Maggiore - Policlinico Mangiagalli e Regina Elena Milano, Italy Ospedale San Carlo Potenza, Italy Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli Reggio Calabria, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Clinica Ematologica - AOU Santa Maria Della Misericordia Udine, Italy Less <<
NCT01743989 Leukemia, Myeloid, Ph1-Positiv... More >>e Less << Phase 3 Recruiting May 28, 2020 -
NCT00606008 - Completed - -
NCT00827138 Chronic Myeloid Leukemia Phase 1 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Kansas The University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 United States, Maryland Sidney Kimmel Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00257647 - Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, IL91120 Less <<
NCT00795756 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Completed - Italy ... More >> USC Ematologia, Ospedale Civile Alessandria, (al), Italy USC Ematologia, Ospedali Riuniti Bergamo, (bg), Italy, 24128 Divisione di Ematologia - Spedali Civili Brescia, (bs), Italy Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Ematologia e centro TMO, Istituti Ospedalieri Cremona, (cr), Italy Ematologia - AOU Careggi Firenze, (fi), Italy Ematologia e centro TMO - IRCSS Mangiagalli Regina Elena Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Raffaele Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Gerardo Monza, (mi), Italy Oncoematologia e TMO - Dipartimento Oncologico La Maddalena Palermo, (pa), Italy Ematologia 2 - Ospedale San Giovanni Battista Torino, (to), Italy Medicina Interna I - Ospedale di Circolo Varese, (va), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Ematologia - Ospedale San Bortolo Vicenza, (vi), Italy Less <<
NCT01392170 - Terminated(Slow Accrual) - -
NCT00788775 Mucosal Lentiginous Melanoma ... More >> Acral Melanoma Melanoma Less << Phase 2 Completed - United States, California ... More >> The Angeles Clinic and Research Institute Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00788775 - Completed - -
NCT03131986 - Recruiting March 30, 2019 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Yuk Man Cheung, MBBS(HK)    852-22554361 ext 1654    drcarolcheung@gmail.com    Contact: Crosby Lu, MMedSc    852-22551654    khlu@hku.hk Less <<
NCT01004497 Acute Lymphoblastic Leukemia Phase 2 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonju, Chonbuk, Korea, Republic of, 561-712 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 St. Vincent's Hospital, The Catholic University of Korea Suwon, Kyonggi-do, Korea, Republic of, 442-723 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT01334996 - Recruiting October 2020 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55901 Contact: Joseph H Butterfield, MD    507-284-3783    butterfield.joseph@mayo.edu Less <<
NCT03556384 Gastrointestinal Stromal Tumor... More >>s Sdh GIST Cancer Less << Phase 2 Recruiting September 2024 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Elaine Eng       e1eng@ucsd.edu    Principal Investigator: Adam M Burgoyne, MD, PhD          Sub-Investigator: Jason K Sicklick, MD Less <<
NCT01872442 Chronic Phase of Chronic Myelo... More >>id Leukemia Less << Phase 2 Active, not recruiting December 2018 -
NCT00895297 Chronic Myeloid Leukemia Phase 2 Terminated(Slow recruitment. N... More >>o safety concerns during this study.) Less << - France ... More >> E Herriot Hospital Lyon, France Germany University Hospital Hamburg, Germany Uniklinik Leipzig Leipzig, Germany Stiftung Deutsche Klinik für Diagnostik Wiesbaden, Germany Switzerland University Hospital Basel, Switzerland, 4031 Hopitaux Universitaires de Geneve Geneva, Switzerland United Kingdom Hammersmith Hospital London, United Kingdom, W12 0NN Less <<
NCT02048371 Liposarcoma O... More >>steogenic Sarcoma Ewing/Ewing-like Sarcoma Rhabdomyosarcoma Less << Phase 2 Recruiting December 2020 United States, California ... More >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Torie Fechner    626-256-4673    tfechner@coh.org    Principal Investigator: Warren Chow, MD          Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Magnolia Manzano    323-361-8156    mmanzano@chla.usc.edu    Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Sant Chawla, MD          Stanford University Recruiting Stanford, California, United States, 94305 Contact: Maria Ahern    650-725-6413    mahern@stanford.edu    Principal Investigator: Kristen Ganjoo, MD          United States, Florida Mayo Clinic - Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO    904-953-7292    Attia.Steven@mayo.edu    Principal Investigator: Steven Attia, DO          H. Lee Moffitt Terminated Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rasima Cehic    312-695-2082    rasima.cehic@northwestern.edu    Principal Investigator: Mark Agulnik, MD          United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Michele Niland    317-278-0778    mniland@iupui.edu    Principal Investigator: Daniel Rushing, MD          United States, Massachusetts Dana Farber/Partners Cancer Care Terminated Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Minnesota Recruiting Rochester, Minnesota, United States, 55905 Contact: Elizabeth Smith    507-293-3817    Smith.Elizabeth6@mayo.edu    Principal Investigator: Scott Okuno, MD          United States, North Carolina Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28203 Contact: Michelle Treadwell    980-442-2332    Michelle.Treadwell@carolinashealthcare.org    Principal Investigator: Michael Livingston, MD          Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Colleen Piechocki    919-681-1883    colleen.piechocki@duke.edu    Principal Investigator: Richard Riedel, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43202 Contact: Comprehensive Cancer Center    800-293-5066    Jamesline@osumc.edu    Principal Investigator: David Liebner, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: David Boody-Alter    503-418-9655    boodyalt@ohsu.edu    Principal Investigator: Lara Davis, MD          United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Melissa Sindler    615-875-0060    melissa.m.sindler@vanderbilt.edu    Principal Investigator: Vicky Keedy, MD          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Justin Parker    801-587-4702    justin.parker@hci.utah.edu    Principal Investigator: Jennifer Wright, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore    206-288-6425    romoore@seattlecca.org    Principal Investigator: Elizabeth Loggers, MD, PhD Less <<
NCT01771458 Reccurent/Metastatic Solid Tum... More >>or Disease Less << Phase 2 Unknown December 2016 France ... More >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 Less <<
NCT01698905 Chronic Myeloid Leukemia Phase 2 Active, not recruiting February 6, 2025 -
NCT02164240 Gastrointestinal Stromal Tumor Phase 1 Active, not recruiting May 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02336724 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting June 2019 China, Jiangsu ... More >> Nanjing Bayi Hospital Nanjing, Jiangsu, China Less <<
NCT00103701 Leukemia, Myeloid, Chronic-pha... More >>se Leukemia, Lymphoblastic, Acute, Philadelphia-positive Less << Phase 1 Completed - United States, California ... More >> Local Institution Los Angeles, California, United States United States, Texas Local Institution Houston, Texas, United States Less <<
NCT03353753 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Active, not recruiting December 2020 -
NCT02767063 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 1 Phase 2 Recruiting June 2021 France ... More >> Martine GARDEMBAS Recruiting Angers, France Contact: Martine GARDEMBAS    02.41.35.44.75    MaGardembas@chu-angers.fr    Pascale CONY.MAKHOUL Recruiting Annecy, France Contact: Pascale CONY.MAKHOUL    04.50.63.64.31    pconymakhoul@ch-annecygenevois.fr    Thorsten BRAUN Recruiting Bobigny, France Contact: Thorsten BRAUN    01.48.95.54.58    Thorsten.braun@avc.aphp.fr    Etienne Recruiting Bordeaux, France Contact: Gabriel Etienne    05.56.33.04.76    G.Etienne@bordeaux.unicancer.fr    CHU Côte de Nacre Not yet recruiting Caen, France Contact: Hyacynthe Johnson-Ansah    02.31.27.25.39    Johnsonansah-a@chu-caen.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Marc BERGER       mberger@chu-clermontferrand.fr    CH Henri Mondor Recruiting Créteil, France Contact: ROY Lydia          Rousselot Recruiting Le Chesnay, France Contact: Philippe Rousselot    01.39.63.89.09    phrousselot@ch-versailles.fr    CHU Lille Recruiting Lille, France Contact: COITEUX Valérie          CHU de LIMOGES Not yet recruiting Limoges, France Contact: Amélie PENOT    05.55.05.66.42    Amelie.penot@chu-limoges.fr    Franck NICOLINI Recruiting Lyon, France Contact: Franck NICOLINI    04.72.11.74.01    franck.nicolini@chu-lyon.fr    Institut P Calmette Recruiting Marseille, France Contact: CHARBONNIER Aude          Viviane DUBRUILLE Recruiting Nantes, France Contact: Viviane DUBRUILLE    02.40.08.32.71    Viviane.dubruille@chu-nantes.fr    Hopital l'Archet Not yet recruiting Nice, France Contact: Laurence LEGROS    04.92.03.58.41    legros.l@chu-nice.fr    Eric JOURDAN Recruiting Nimes, France Contact: Eric JOURDAN    04.66.68.32.31    eric.jourdan@chu-nimes.fr    Hôpital La Source Recruiting Orléans, France Contact: BENBRAHIM Omar          Delphine REA _St louis Recruiting Paris, France Contact: Delphine REA    01.42.49.96.49    delphine.rea@aphp.fr    Simona LAPUSAN_St Antoine Recruiting Paris, France Contact: Simona LAPUSAN    01.49.28.34.42    Simona.lapusan@sat.aphp.fr    Cayssials Recruiting Poitiers, France Contact: Emilie Cayssials    : 05.49.44. 44.72    e.cayssials@chu-poitiers.fr    CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: ESCOFFRE-BARBE Martine          Hôpital René Huguenin Not yet recruiting Saint-Cloud, France Contact: Sylvie GLAISNER    01.47.11.15.30    Sylvie.glaisner@curie.net    Institut Universitaire contre le Cancer Not yet recruiting Toulouse, France Contact: Françoise HUGUET    05.31.15.63.56    Huguet.françoise@iuct-oncopole.fr    CHU Tours Not yet recruiting Tours, France Contact: DARTIGEAS Caroline Less <<
NCT00233961 Leukemia Phase 1 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01019798 Non Small Cell Lung Cancer Phase 2 Unknown December 2011 Taiwan ... More >> Section of Hematology, Department of Medicine,Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Cheng-Jeng Tai, M.D.    886-2-27372181 ext 3903    cjtai@tmu.edu.tw    Principal Investigator: Cheng-Jeng Tai, M.D. Less <<
NCT00137449 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - United States, Massachusetts ... More >> Pfizer Investigational Site Boston, Massachusetts, United States, 02115 France Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Milano, Italy, 20133 Less <<
NCT00375219 Chronic Myeloid Leukemia Phase 2 Completed - -
NCT00905398 Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated due to excessive toxicity and low compliance to the protocol scheme.) Less << July 2015 -
NCT01370980 - Unknown September 2014 Switzerland ... More >> Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV Recruiting Lausanne, Vaud, Switzerland, 1010 Contact: Bugnon Olivier    +41 21 314 48 48    Olivier.Bugnon@hospvd.ch    Contact: Schneider Marie-Paule    +41 21 314 48 46    Marie-Paule.Schneider@hospvd.ch Less <<
NCT01059656 Dermatofibrosarcomas of DARIER... More >> FERRAND(DFSP) Less << Phase 2 Terminated(Decision of Study P... More >>rincipal Investigator) Less << - France ... More >> Hôpital Saint-Louis - Service de Dermatologie (Pole POPS) Paris, France, 75010 Less <<
NCT00137449 - Completed - -
NCT00819143 - Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00375219 - Completed - -
NCT02348957 - Active, not recruiting April 2019 -
NCT01724879 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Less << Phase 2 Completed - Germany ... More >> Robert Bosch Krankenhaus Stuttgart, Baden-Württemberg, Germany, 70376 Klinikum der Universität Regensburg Regensburg, Bayern, Germany, 93042 University Hospital of Frankfurt, Medical Dept. II Frankfurt, Hessen, Germany, 60590 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Essen Essen, NRW, Germany, 45147 Universitätsklinik Münster Münster, NRW, Germany, 48149 Universitätsklinik Dresden Dresden, Sachsen, Germany, 01307 Uniklinik Aachen Aachen, Germany, 52074 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 University Hospital Düsseldorf Düsseldorf, Germany, 40225 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Universitätsklinik Köln Köln, Germany, 50937 Universität Leipzig, José-Carreras-Haus Leipzig, Germany, 04103 Universitätskliniken Mainz Mainz, Germany, 55101 Klinikum Mannheim Mannheim, Germany, 68167 Universitätsklinikum Großhadern München, Germany, 81377 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Klinikum Oldenburg Oldenburg, Germany, 26133 Universität Rostock Rostock, Germany, 18055 Medizinische Universitätsklinik Ulm Ulm, Germany, 89070 Medizinische Poliklinik der Universität Würzburg Würzburg, Germany, 97070 Less <<
NCT01725204 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 2 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland Norway Bergen University Central Hospital Bergen, Norway Rikshospitalet Oslo, Norway Stavanger University Hospital Stavanger, Norway University Hospital of Northern Norway Tromsø, Norway St Olavs Hospital - Trondheim University Hospital Trondheim, Norway Sweden Linköping University Hospital Linköping, Sweden Sunderby Sjukhus Luleå, Sweden Lund University Hospital Lund, Sweden Karolinska University Hospital Stockholm, Sweden Sundsvall County Hospital Sundsvall, Sweden Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden Örebro University Hospital Örebro, Sweden Less <<
NCT03540654 - Recruiting December 2018 France ... More >> CHU Bordeaux Recruiting Bordeaux, France Contact: Stéphanie DULUCQ       stephanie.dulucq@chu-bordeaux.fr Less <<
NCT00767819 Progressive Sarcoma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT03045120 - Recruiting July 31, 2021 -
NCT02888977 - Recruiting December 2022 France ... More >> CH Versailles Recruiting Le Chesnay, France, 78150 Contact: Rousselot Philippe, MD          CHU Nimes Recruiting Nimes, France Contact: JOURDAN Eric          CH Reims Recruiting Reims, France Less <<
NCT01376427 Acute Lymphoblastic Leukemia P... More >>h Positive Less << Not Applicable Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr       jribera@iconcologia.net Less <<
NCT02888990 Leukemia, Lymphoblastic, Acute Phase 2 Completed - -
NCT00845221 Chronic Myeloid Leukemia Phase 4 Completed - France ... More >> CHU Amiens Amiens, France, 80000 Hôpital La Timone - CHU de Marseille Marseille, France, 13385 Hôpital de Brabois - CHU de Nancy Vendoeuvre les Nancy, France, 54511 Less <<
NCT01046487 Cancer Phase 1 Completed - France ... More >> Institut Bergonié Bordeaux, France, 33076 Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69008 Less <<
NCT02897245 - Recruiting December 2022 France ... More >> CH Versailles Recruiting Le Chesnay, France Contact: Rousselot Philippe       phrousselot@ch-versailles.fr Less <<
NCT00230334 Eosinophilia ... More >>Hypereosinophilic Syndrome Less << Phase 2 Withdrawn(Withdrawn by PI due ... More >>to insufficient accrual) Less << - -
NCT01933906 Chronic Phase Chronic Myeloid ... More >>Leukemia Less << Phase 1 Recruiting December 2019 Austria ... More >> Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung Recruiting Wels, Oberösterreich, Austria, 4600 Contact: Sonja Burgstaller, MD       sonja.burgstaller@klinikum-wegr.at    Principal Investigator: Sonja Burgstaller, MD          Universitätskliniken Innsbruck, Univ.-Klinik f.Innere Medizin V Hämtologie u. Onkologie Recruiting Innsbruck, Austria, A-6020 Contact: Michael Steurer, Prof. MD    +43 512 504 ext 81386    michael.steurer@i-med.ac.at    Contact: Elke Adamski-kondert@uki.at, Mag.    +43512504 ext 80308    elke.adamski-kondert@uki.at    Principal Investigator: Micheal Steurer, Prof.MD          Ordensklinikum Linz - Elisabethinen Recruiting Linz, Austria, A-4020 Contact: Veronika Buxhofer-Ausch, MD    +43 732 7676 ext 4409    veronika.buxhofer-ausch@ordensklinikum.at    Contact: Sarah Panholzer, Mag.    +43 732 7676 ext 4425    sarah.panholzer@elisabethinen.or.at    Principal Investigator: Veronika Buxhofer-Ausch, MD          Universitätsklinikum der PMU Salzburg, Universitätsklinik für Innere Medizin III Recruiting Salzburg, Austria, 5020 Contact: Richard Greil, MD       r.greil@salk.at    Contact: Stefanie Schumy, MA.rer.nat.    +43 57255 ext 25821    s.schumy@salk.at    Principal Investigator: Richard Greil, MD          Med. Univ. Wien, Univ.Klinik f. Innere Medizin I, Hematologie/Hemostaseologie Not yet recruiting Vienna, Austria, A-1090 Contact: Wolfgang Füreder, MD, Prof.    +43 1 40400 ext 44690    wolfgang.fuereder@meduniwien.ac.at    Contact: Susanne Herndlhofer    +43 1 40400 ext 45220    susanne.herndlhofer@meduniwien.ac.at    Principal Investigator: Wolfgang Füreder, MD, Prof.          Hanusch-Krankenhaus, 3. Medizinische Abteilung Not yet recruiting Vienna, Austria, A-1140 Contact: Thamer Sliwa, MD    +43191021 ext 57301    thamer.sliwa@wgkk.at    Contact: Kathrin Holzer, Mag.    +43191021 ext 85435    kathrin.holzer@wgkk.at    Principal Investigator: Thamer Sliwa, MD Less <<
NCT00159016 Metastatic Solid Tumors. Phase 2 Withdrawn(the PI is no longer ... More >>work at Hadassah) Less << - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT02546375 - Completed - -
NCT00852709 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Myeloproliferative Disorders Acute Lymphocytic Leukemia Acute Promyelocytic Leukemia Acute Leukemia Chronic Myelogenous Leukemia Myelofibrosis Chronic Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia Less << Phase 1 Terminated(Lack of accrual) - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016-7710 United States, Colorado University of Colorado Health Sciences Center and The Children's Hospital Aurora, Colorado, United States, 80045 United States, Florida Pediatrix Hematology/Oncology University of Florida College of Medicine Gainesville, Florida, United States, 32610-0296 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States, 37232-6310 United States, Texas M.D. Anderson Comprehensive Cancer Center Houston, Texas, United States, 77030 Canada, Alberta Southern Alberta Children's Cancer Program Calgary, Alberta, Canada, T3B6A8 Less <<
NCT00039585 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892-1906 Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00400569 Liposarcoma L... More >>eiomyosarcoma Fibrosarcoma Malignant Fibrous Histiocytoma Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02546375 - Completed - United Kingdom ... More >> Royal Liverpool Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Hammersmith Hospital London, United Kingdom, W12 0HS Nottingham University Hospital Nottingham, United Kingdom, NG5 1PB Less <<
NCT00400569 - Completed - -
NCT00461929 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Cell Tumors Chromosome Abnormality Less << Phase 4 Terminated(study terminated 12... More >>Feb09 due to low recruitment) Less << - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G 2M9 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02389972 - Completed - China, Hubei ... More >> Local Institution Wuhan, Hubei, China, 430022 Less <<
NCT00372567 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01804985 Chronic Myeloid Leukaemia Phase 2 Active, not recruiting May 2018 United Kingdom ... More >> University of Liveprool Liverpool, United Kingdom, L69 3GL Less <<
NCT00038194 Prostate Cancer Phase 1 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00702403 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Philadelphia Positive Adult Acute Lymphoblastic Leukemia Philadelphia Positive Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Relapsing Chronic Myelogenous Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Florida H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium Tampa, Florida, United States, 33612 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01755325 Chronic Myelogenous Leukemia Phase 3 Suspended(not enough patients) December 2018 China, Hubei ... More >> Union Hospital medical college Huazhong University of Science and Technology Wuhan, Hubei, China China, Jiangsu The NO.1 People's Hospital of Huaian Huaian, Jiangsu, China, 223002 The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China First Hospital Affiliated to Suzhou University Suzhou, Jiangsu, China China, Jiangxi The FIrst Affiliated Hospital, College of Medicine, Nanchang University Nanchang, Jiangxi, China, 330006 The Second Affiliated Hospital, College of Medicine, Nanchang University Nanchang, Jiangxi, China, 330006 The Tumor Hospital of Jiangxi Nanchang, Jiangxi, China, 330029 The NO.1 Hospital of Nanchang Nanchang, Jiangxi, China, 333008 China, Liaoning The Second Affiliated Hospital of Dalian Medical University Dalian, Liaoning, China China, Shanxi Xijing Hospital-Fourth Military Medical University Xi'an, Shanxi, China China, Zhejiang The FIrst Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China China The People's Hospital of Peking University Peking, China Ruijin Hospital Shanghai, China Less <<
NCT00045669 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 LaGrange Memorial Hospital LaGrange, Illinois, United States, 60525 Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Incorporated Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Michigan Lakeland Medical Center - St. Joseph Saint Joseph, Michigan, United States, 49085 United States, Missouri Siteman Cancer Center Saint Louis, Missouri, United States, 63110 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Less <<
NCT00510926 Myeloid Leukemia, Chronic, Chr... More >>onic-Phase Less << Phase 2 Completed - Italy ... More >> Policlinico S.Orsola-Malpighi, Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Bologna, Italy, 40138 Less <<
NCT00702403 - Completed - -
NCT01650467 - Withdrawn(Funding is late, unf... More >>orseeable.) Less << June 2017 France ... More >> Clinique du Parc Castelnau Le Lez, France, 34170 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 Less <<
NCT03171389 GIST, Malignant ... More >> KIT Exon 13 Mutation KIT Gene Mutation Less << Phase 2 Recruiting September 22, 2020 Germany ... More >> West German Cancer Center Recruiting Essen, NRW, Germany, 45122 Principal Investigator: Sebastian Bauer, Prof. Dr. Less <<
NCT00250042 Leukemia, Other ... More >> Cancer Less << Phase 2 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT00210119 Myeloid Leukemia, Chronic Phase 2 Terminated - France ... More >> Centre Hospitalier Universitaire de Bordeaux Bordeaux, France, 33076 Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest Bordeaux, France, 33076 Centre Hospitalier de Versailles Le Chesnay, France, 78150 Hôpital Edouard Herriot Lyon, France, 69437 Hôpital Archet Nice, France, 06200 Hôpital Saint Louis Paris, France, 75010 Centre Hospitalier Universitaire de Poitiers Poitiers, France, 86000 Less <<
NCT00580281 Gastric Cancer ... More >> Leukemia Chronic Myelogenous Leukemia Less << Not Applicable Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00551252 Mesothelioma Phase 2 Unknown December 2009 Italy ... More >> Medical Oncology, IRCCS San Matteo University Hospital Foundation Not yet recruiting Pavia, Italy, 27100 Principal Investigator: Camillo Porta, MD Less <<
NCT00146913 Chronic Myeloid Leukemia Phase 2 Unknown - France ... More >> Franck NICOLINI Lyon, France, 69437 Less <<
NCT00219765 Chronic Myeloid Leukemia Phase 1 Phase 2 Terminated - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00084513 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00509093 Leukemia Phase 2 Unknown - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01048320 Advanced Pancreatic Cancer Phase 1 Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00049127 Adult Anaplastic Oligodendrogl... More >>ioma Adult Mixed Glioma Adult Oligodendroglioma Recurrent Adult Brain Neoplasm Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01653314 Healthy Phase 1 Completed - -
NCT01092741 Leukemia Phase 2 Completed - United States, Texas ... More >> The University Of MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00171938 Glioblastoma Phase 2 Terminated - Brazil ... More >> Rio Grande, Brazil Less <<
NCT00050531 Leukemia, Myeloid, Chronic Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00079313 Chronic Myelomonocytic Leukemi... More >>a|Chronic Myelogenous Leukemia Less << PHASE2 COMPLETED 2010-10-25 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT03515018 Leukemia, Chronic Myeloid Phase 3 Recruiting May 1, 2020 China, Heilongjiang ... More >> the First Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150001 Contact: Jin Zhou, MD, PhD    008645185555951    zhoujin1111@126.com Less <<
NCT00049127 - Active, not recruiting - -
NCT02127372 - Terminated(The study was close... More >>d due to poor accrual) Less << - -
NCT00980018 Chronic Myelogenous Leukemia Phase 4 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States, 72205 United States, California USC Norris Cancer Center LAC & USC Medical Center Los Angeles, California, United States, 90033 Southwest Cancer Care Murrieta Poway, California, United States, 92064 United States, Colorado Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States United States, Florida Florida Cancer Institute New Port Richey, Florida, United States, 34655 Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 Ocoee, Florida, United States, *see dep* United States, Illinois Stroger Cook County Hospital John H. Stroger Hospital Chicago, Illinois, United States, 60612 United States, Indiana St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn Beech Grove, Indiana, United States, 46107 United States, Maryland St. Agnes Hospital Baltimore, Maryland, United States, 21229 United States, Missouri St. Louis University Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Northwest Cancer Specialists Salmon Creek Office Portland, Oregon, United States, 97210 Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 United States, Texas Texas Oncology, P.A. Bedford, Texas, United States, 76022 Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp Dallas, Texas, United States, 75231 Texas Oncology Texas Oncology - Sugar Land Dallas, Texas, United States, 75246 MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77031 Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) San Antonio, Texas, United States, 78229 Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada, L6R 3J7 Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Novartis Investigative Site Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT00301093 Leukemia Phase 1 Active, not recruiting January 1, 2019 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00022490 - Terminated - -
NCT02127372 Non-small Cell Lung Cancer Phase 1 Phase 2 Terminated(The study was close... More >>d due to poor accrual) Less << - -
NCT00421317 Melanoma PHASE2 TERMINATED 2025-03-07 Centre Francois Baclesse, Caen... More >>, 14076, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Centre Georges-Francois Leclerc, Dijon, 21079, France|Centre Oscar Lambret, Lille, 59020, France|Centre Hospitalier Regional Universitaire, Lille, 59035, France|Centre Leon Berard, Lyon, 69373, France|Centre Val d'Aurelle Paul Lamarque, Montpellier, 34298, France|Institut Curie, Paris, 75248, France|Centre Paul Strauss, Strasbourg, 67065, France|Hopital Universitaire de Hautepierre, Strasbourg, 67098, France|Institut Claudius Regaud, Toulouse, 31052, France|Centre Gustave Roussy, Villejuif, 94805, France Less <<
NCT00009906 Gastrointestinal Stromal Tumor Phase 3 Terminated - -
NCT00402662 Metastatic Melanoma Phase 2 Terminated(unexpected level of... More >> toxicity) Less << - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 Less <<
NCT00070499 Chronic Myelogenous Leukemia, ... More >>BCR-ABL1 Positive Chronic Phase of Disease Less << Phase 2 Active, not recruiting - -
NCT00760981 Graft vs Host Disease PHASE1 COMPLETED 2025-04-12 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, 98109, United States Less <<
NCT00093639 Leukemia Phase 1 Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00070499 - Active, not recruiting - -
NCT00904735 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Italy ... More >> Ospedale Civile Avellino Recruiting Avellino, Italy Contact: Contact Person    39-0825-203-232       Ospedale Bellaria Recruiting Bologna, Italy, I-40139 Contact: Alba A. Brandes, MD    39-51-622-5102    aa.brandes@yahoo.it    Azienda Ospedaliero Careggi Recruiting Florence, Italy, 50139 Contact: Contact Person    39-055-427-7111       Istituto Nazionale Neurologico Carlo Besta Recruiting Milan, Italy, 20133 Contact: Contact Person    39-02-2394-2341       Ospedale Civile di Rovigo Recruiting Rovigo, Italy, 45100 Contact: Contact Person    39-0425-393-016 Less <<
NCT01188889 Chronic Myeloid Leukemia Phase 1 Phase 2 Withdrawn(Unable to obtain suf... More >>ficient funding.) Less << December 2017 United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00114959 Myeloid Leukemia, Chronic ... More >> Myeloid Leukemia, Chronic, Accelerated-Phase Blast Phase Myeloid Leukemia, Chronic, Chronic-Phase Less << Phase 2 Terminated(Poor enrollment) - United States, Texas ... More >> Univ. of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00763763 Leukemia, Lymphocytic, Acute ... More >> Philadelphia Chromosome Blast Crisis Leukemia, Myeloid, Chronic Less << Phase 2 Completed - France ... More >> Service Clinique des Maladies du Sang Paris, France, 75010 Less <<
NCT00323362 - Terminated(Toxicity) - -
NCT00784446 Stage IV Colorectal Cancer Phase 1 Phase 2 Completed - Germany ... More >> Medical Clinic for Haematology and Oncology Cologne, NRW, Germany, 50937 Städische Kliniken Esslingen Esslingen, Germany, 73730 Klinikum St. Georg gGmbH Leipzig, Germany, 04129 Johannes-Gutenberg-Universität Mainz Mainz, Germany, 55131 Klinikum Mannheim Mannheim, Germany, 68167 Prosper-Hospital Recklinghausen, Germany, 45659 Leopoldina Krankenhaus Schweinfurt, Germany, 97422 Universitätsklinik Ulm Ulm, Germany, 89081 Less <<
NCT00573404 Gastrointestinal Stromal Tumor Phase 1 Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02103322 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Tumor Less << Phase 2 Phase 3 Completed - India ... More >> Kailash Cancer Hospital & Research Centre Vadodara, Gujurat, India, 391760 Srinivasam Cancer Care Hospitals India Pvt. Bangalore, Karnataka, India, 560076 Karnataka Caner Hospital Bengaluru, Karnataka, India, 560096 Lokmaya Hospital Pune, Maharashtra, India, 411044 Dr. G Viswanathan Speciality Hospitals Tiruchirappalli, Tamil Nadu, India, 620 008 Less <<
NCT00323362 Lung Cancer Phase 2 Terminated(Toxicity) - United States, New Jersey ... More >> Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 Less <<
NCT00161213 - Completed - -
NCT00114959 - Terminated(Poor enrollment) - -
NCT00367861 Sarcoma Gastr... More >>o-intestinal Stromal Tumors (GIST) Less << Phase 3 Completed - France ... More >> Institut Bergonié Bordeaux, France, 33000 Centre Oscar Lambret Lille, France, 59000 Centre Leon Berard Lyon, France, 69008 Hopital Edouard Herriot Lyon, France, 69008 Institut Paoli Calmette Marseilles, France, 13000 Hopitaux de La Timone Marseille, France, 13000 Centre Alexis Vautrin Nancy, France, 57000 Institut Gustave Roussy Villejuif, France, 94850 Less <<
NCT00015834 Blastic Phase Chronic Myelogen... More >>ous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Los Angeles (UCLA ) Los Angeles, California, United States, 90095 Less <<
NCT00161213 Pancreatic Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New Jersey CentraState Medical Center Freehold, New Jersey, United States, 07728 Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Jersey Shore Cancer Center at Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Central Jersey Oncology Group New Brunswick, New Jersey, United States, 08901 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 New Jersey Medical School Newark, New Jersey, United States, 07103 Less <<
NCT00015847 Leukemia Phase 2 Terminated - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT00015847 - Terminated - -
NCT02164903 - Active, not recruiting October 2018 -
NCT01865565 - Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT00028002 - Completed - -
NCT00222144 Lung Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT00028002 Gastrointestinal Stromal Tumor Phase 2 Completed - United States, Pennsylvania ... More >> Radiation Therapy Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00038610 - Completed - -
NCT01120821 Polycythemia Vera Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT00324987 - Terminated(The trial failed to... More >> accrue) Less << - -
NCT00324987 Gastrointestinal Stromal Tumor Phase 3 Terminated(The trial failed to... More >> accrue) Less << - -
NCT00038610 Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT05493215 Gastrointestinal Stromal Tumor... More >>s Less << PHASE2 RECRUITING 2025-12-25 Markey Cancer Center, Lexingto... More >>n, Kentucky, 40536, United States Less <<
NCT00940563 Advanced Gastrointestinal Stro... More >>mal Tumors Less << PHASE2 COMPLETED - Novartis Investigative Site, A... More >>ncona, Italy|Novartis Investigative Site, Aviano, Italy|Novartis Investigative Site, Bari, Italy|Novartis Investigative Site, Bergamo, Italy|Novartis Investigative Site, Bologna, Italy|Novartis Investigative Site, Candiolo, Italy|Novartis Investigative Site, Ferrara, Italy|Novartis Investigative Site, Firenze, Italy|Novartis Investigative Site, Genova, Italy|Novartis Investigative Site, Livorno, Italy|Novartis Investigative Site, Meldola, Italy|Novartis Investigative Site, Messina, Italy|Novartis Investigative Site, Milano, Italy|Novartis Investigative Site, Monserrato, Italy|Novartis Investigative Site, Napoli, Italy|Novartis Investigative Site, Nola, Italy|Novartis Investigative Site, Padova, Italy|Novartis Investigative Site, Palermo, Italy|Novartis Investigative Site, Perugia, Italy|Novartis Investigative Site, Pisa, Italy|Novartis Investigative Site, Ravenna, Italy|Novartis Investigative Site, Roma, Italy|Novartis Investigative Site, Rozzano, Italy|Novartis Investigative Site, Sassari, Italy|Novartis Investigative Site, Torino, Italy|Novartis Investigative Site, Verona, Italy Less <<
NCT06628739 Gastrointestinal Stromal Tumor... More >>, Malignant Less << COMPLETED 2023-05-31 The First Affiliated Hospital ... More >>of Sun Yat-sen University, Guangzhou, Guangdong, China Less <<
NCT05895942 GIST RECRUITING 2025-09-10 Xijing Hospital of Air Force M... More >>ilitary Medical University, Xi'an, Shaanxi, 710000, China Less <<
NCT00426179 Seasonal Allergic Rhinitis PHASE1|PHASE2 COMPLETED 2025-08-07 Novartis Investigative site, H... More >>orsham, United Kingdom Less <<
NCT06119789 Rare Malignant Neoplasm PHASE2 NOT_YET_RECRUITING 1933-08-01 -
NCT00632255 Chronic Myeloid Leukemia|Newly... More >> Diagnosed Less << COMPLETED 2025-05-09 Haematology Department. Cather... More >>ine Lewis Centre. Hammersmith Hospital. Du Cane Road., London, W12 0HS, United Kingdom Less <<
NCT04933669 Progression-free Survival|Gast... More >>rointestinal Stromal Tumor|Neoadjuvant Less << PHASE2 RECRUITING 2029-12-31 The First Affiliated Hospital,... More >> College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China Less <<
NCT01475110 Chronic Myeloid Leukaemia COMPLETED 2016-11-24 Centro Oncologico Basilicata, ... More >>Rionero in Vulture, Potenza, Italy|Ospedale, Alessandria, Italy|S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|S.G. Moscati Hospital, Avellino, Italy|Ospedale, Bari, Italy|Ospedale, Bologna, Italy|Azienda Spedali Civili, Brescia, 25100, Italy|Ospedale Ferrarotto, Catania, Italy|Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna, Ferrara, 44100, Italy|Policlinico di Careggi, Università delgi studi di Firenze, Firenze, Italy|Clinica Ematologica - Università degli Studi, Genova, Italy|Università degli Studi, Genova, Italy|Università di Genova, Genova, Italy|ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia, Lecce, 73100, Italy|A.O. Universitaria Policlinico Martina di Messina, Messina, Italy|U.O. Ematologia e Trapianto di Midollo - Ist. Scientifico Ospedale San Raffaele, Milano, 20132, Italy|Federico II, Napoli, Italy|Divisione di Medicina Interna-Ematologia, Ospedale San Luigi Gonzaga, Regione Gonzole 10, Orbassano, Italy|Azienda Ospedaliera di Padova, Padova, 35128, Italy|Ospedale Cervello, Palermo, 90146, Italy|Azienda Ospedaliera Universitaria - Policlinico Paolo Giaccone, Palermo, Italy|Dipartimento Oncologico - Ospedale S.Maria delle Croci, Ravenna, Italy|Ospedale, Reggio Calabria, Italy|Ospedale, Rimini, Italy|U.O. di Ematologia - Centro Oncologico Basilicata, Rionero in Vulture, Italy|Ematologia - Sapienza Università di Roma, Roma, Italy|Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, 00168, Italy|Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|U.O. Ematologia, Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy|Ospedale, Taranto, Italy|SCDO Ematologia 2 AOU S. Giovanni Battista, Torino, Italy|Policlinico Universitario - Clinica Ematologia, Udine, 33100, Italy|Policlinico G. B. Rossi - Borgo Roma, Verona, 37134, Italy Less <<
NCT00613171 Systemic Sclerosis, Scleroderm... More >>a Less << PHASE2 COMPLETED 2010-01-13 Novartis Investigator Site, Ch... More >>icago, Illinois, 60611, United States|Novartis Investigator Site, Baltimore, Maryland, 21224, United States|Novartis Investigator Site, Boston, Massachusetts, 02118, United States|Novartis Investigator Site, Erlangen, Germany|Novartis Investigator Site, Florence, Italy|Novartis Investigator Site, Zurich, Switzerland|Novartis Investigator Site, London, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.03mL

0.41mL

0.20mL

10.13mL

2.03mL

1.01mL

20.26mL

4.05mL

2.03mL

References

 

Historical Records

Categories